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Abstract
Viruses are highly adapted to their evolved hosts and have developed mechanisms 
to improve their ability to infect them1, 2 including targeting host chemokines and/or 
their function2'4. When herpesviruses infect animals other than their natural host, the 
disease outcome is frequently different. Laboratory mouse strains {Mus musculus) have 
not been identified as natural hosts to MHV-68 in the wild5. In this study, a natural host 
to MHV-68, the wood mouse (Apodemus sylvaticus)5, was used to study the infection.
The aim of this study was to ascertain the role of the MHV-68 Ml gene product in 
infection, in particular during the pathogenesis elicited by infection. Little is known 
regarding its function. It is known that Ml is a secreted protein and it is not essential for 
latency establishment. In laboratory mouse strains, Ml suppresses reactivation from 
latency6. This Ml activity appears to be IFN-y dependent and results in the activation of 
Vp4+CD8+ T cells6'8. Literature suggests that the Ml protein shares functional 
similarities with the chemokine-binding proteins resulting from the closely related 
genes, M3 and M49.
In order to determine the effect of Ml expression in MHV-68 infection of a 
natural host, the wood mouse, in vivo experiments were performed using vMlstop virus 
and its genetically repaired counterpart, vMlrev virus. In the wood mouse Ml 
expression was found not to be essential for latency establishment or lytic replication. 
Ml expression led to the maintenance of alternatively activated macrophages in the lung 
and the regulation of cytokine expression by airway, and alveolar epithelial cells and 
macrophages. Ml expression was seen together with a significant decrease in the 
mainly pro-inflammatory cytokines TNF-a and MIPl-a, and in the growth factor HGF. 
Furthermore, Ml expression was associated with significant increase in the expression 
of the anti-inflammatory cytokine CCSP by Clara cells present in the airways. This 
cytokine expression profile favours an anti-inflammatory response and could explain the 
more severe pathogenesis seen in the absence of the Ml.
This study demonstrated that the expression of Ml in the BALB/c mouse is much 
reduced compared to the wood mouse. This indicates that the role of the Ml is more 
significant in the natural host. There was no increase in IFN-y expression in the wood 
mouse infection indicating that the previously described IFN-y mediated Ml role is 
imlikely to be present in the wood mouse.
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Viruses are non cellular microorganisms which are unable to replicate outside 
living cells10. They are omnipresent on the planet10, n. Some viruses are widespread 
such as the gammaherpesvirus, Epstein Barr virus (EBV) which infects approximately 
90% of the world’s population12. There is evidence that viruses evolved alongside their 
hosts and developed mechanisms to improve their ability to infect these1, 2. These 
include the acquisition of genes and genetic functions of host origin, by targeting host 
chemokines and their function 2'4. When herpesviruses infect animals other than the 
natural host, the disease outcome is frequently different. For example, ovine herpesvirus 
type 2 (OvHV2) and alcelaphine herpes virus 1 (A1HV-1) persist sub-clinically in their 
natural host, sheep and wildebeest respectively. However, these infections can be fatal 
when heterologous species such as cattle are infected, leading to malignant catarrhal 
fever (MCF)13. Murid herpesvirus 68 (MHV-68) the virus of interest in this study is 
most commonly studied in laboratory mouse strains. However, these mice (Mus 
musculus) have not been identified as natural hosts to MHV-68 infection in the wild 5. 
In this study, a natural host to MHV-68, the wood mouse (Apodemus sylvaticus)5, was 
used to study the infection.
MHV-68 is a gammaherpesviruses. Heipesviruses show high sequence 
conservation14'17 and consequently share biological properties. These shared properties 
include viral protein interaction with host cells. Gammaherpesviruses are host specific 
and include human infecting EBV and Kaposi’s sarcoma associated herpesvirus 
(KSHV) . The host specificity and the fact that these viruses infect humans make 
infection studies unfeasible. The disease syndromes seen in humans due to EBV and 
KSHV infection are not fully replicated in the infection of non human primates19. In 
order to investigate gammaherpesvirus pathogenesis it is most adequate to examine 
these in their natural hosts and the alternatives would be to study herpesvirus saimiri 
(HVS) or MHV-68 infection20'26. MHV-68, unlike other gammaherpesviruses, can be 
easily replicated in vitro and is a natural pathogen of free living rodents19, 27. These 
features make MHV-68 a very useful tool in the study of gammaherpesvims infection in 
a natural host28,29. The natural route of infection of MHV-68 is thought to be intranasal 
which leads to an acute pneumonia28. This was the method used to infect the animals in 
this study.
The aim of this study was to ascertain the role of the MHV-68 Ml gene product in 
infection, in particular in the pathogenesis elicited by infection. Little is known 
regarding its function. It is known that Ml is a secreted protein and it is not essential for
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latency establishment. In laboratory mouse strains, Ml suppresses reactivation from 
latency6. This Ml activity appears to be IFN-y dependent and results in the activation of 
Vp4+CD8+ T cells6'8. The recent literature suggests that the Ml protein shares 
functional similarities with the chemokine-binding proteins resulting from the closely 
related genes, M3 and M49.
In order to bring the study and the methods used into perspective, the present 
introductory chapter reviews general immune responses to viral infection and the 
general features of herpesviruses including MHV-68. In the immune responses review, 
special emphasis is laid on responses seen in the respiratory system as this is the main 
site where pathological changes are seen following infection with MHV-68. Cytokine 
secretion will also be discussed as cytokines are suspected to be the main target of the 
Ml protein.
1.1 The immune system and viral infection
The immune system consists of a complex system of strategies to impede invasion 
by foreign organisms or proliferation of altered cells and thus avoid disease30'32. This 
system can be divided into innate and adaptive immunity (Figure 1.1). Innate immunity 
entails those effects which are immediate and do not take into account any previous 
exposure to the invading pathogen. Components of the innate system include the 
physical barrier created by cells, complement activation, cytotoxicity by Natural killer 
(NK) cells and phagocytosis by antigen presenting cells (APC)31. Adaptive immunity is 
employed when the host has been primed previously to the invading pathogen and 
provides a more specific response mediated by B and T cells31, 33. The distinction 
between the two types of immunity is not clear cut and several components are part of 
both, such as Toll-like Receptor (TLRs) and Interferon (IFN) signalling31, 33. The 
recognition of pathogens is mostly through TLR present on cellular surfaces. APC 
prime T cells to the antigens through major histocompatibility complex (MHC) Class II 
molecules34. MHC molecules are cell surface presentation molecules. There are two 
types of MHC, MHC Class I and MHC Class II. MHC Class I molecules are ubiquitous 
in cells and class II molecules are expressed mostly by APC cells such as B-cells, 
monocytes/macrophages and dendritic cells (DC). MHC Class II molecules can also be 
expressed in non APC cells in the presence of cytokines such as IFN-y35,36. MHC Class 
I molecules present antigen to cytotoxic T cells (CTLs)/CD8+ T T-cell37. Once
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activated, the CD8+ T cells undergo clonal expansion, to generate more cells that can 
complex with antigen30, 37. Interference with MHC presentation disables antigen 
detection and thus decreases CD8+ T cells activation3840. When CD8+ T cells are 
activated, they release cytotoxic perforin, and granulysin and the apoptosis inducer, 
granzyme, all leading to cell death37. In MHV-68 infection, expression of K3, a early 
lytic protein, leads to the ubiquination of MHC class I proteins4042 and the transporter 
associated with antigen processing (TAP)42, 43 in infected cells. As a result of 
ubiquination, proteins are degraded through a proteosome-dependent mechanism. K3 
also inhibits the expression of endogenous p53 in lytically infected cells3840. HHV-8 
expresses K3 similarly to MHV-68, and also K5 which acts on the intercellular adhesion 
molecules (ICAM) and CD86. In HHV-8, ubiquination of MHC class I results in the 
diversion of molecules into the TsglOl-endocytic pathway and ultimate lisosomal 
digestion3840. MHC Class II molecules present processed antigen to helper T- 
cells/CD4+ T cells. The antigen presented by MHC Class II molecules is mostly 
exogenous to the cell presenting it and results from phagocytosis by the APC cells30,36. 
Phagocytosis induces maturation of DC and maturation leads to gradual loss of the 
phagocytic ability and increases the expression of MHC Class II molecules44. With 
maturation there is also increased expression of cytokines such as those modulating T 
and B cells31, 45, 46. Viruses including MHV-68 inhibit maturation of bone marrow 
derived immature DC from transgenic mice with BALB/c background47. MHV-68 
infection of mature DC leads to the establishment of latent infection47, 4S. With DC 
maturation, C-C motif receptor 7 (CCR7) expression occurs, which modulates migration 
of DC to lymph nodes where they present the antigen on their surface and prime naive T 
cells49,50.
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Chapter 1 Introduction
1.1.1 The respiratory tract
1.1.1.1 The airways
The airways are composed of pseudostratified columnar ciliated cells and mucin 
producing goblet cells, which form a physical barrier against external particles, 
including viruses51'54. The mucociliary escalator is responsible for the removal of almost 
90% of inhaled exogenous material and allows the exchange of nutrients, gases and 
water. Mucus is produced by epithelial goblet cells and subepithelial glands, and is 
composed mainly of mucins and, to a lesser extent, other substances such as 
immunoglobulins. Mucus is beneficial for the response against viruses but if present in 
excess can cause obstruction of the airway. Viruses can target mucin production as a 
means of entry to the host cell51*55
Airway epithelial cells comprised of clara cells and respiratory epithelial cells 
form a well “knitted”, mostly impermeable barrier, due to tight intercellular junctions 
(tight junctions, adherens junctions, gap junctions and desmosomes)55. These junctions 
function as physical binders and take part in intercellular chemical communication55. 
The physical “wall” they form is of major importance because it hinders viral access to 
basolateral membrane receptors on the epithelial cells. Cells possess numerous pattern 
recognition receptors (PRRs). These receptors, upon the detection of pathogens, initiate 
cellular pathways. Receptors can be present extracellularly or intracellularly and 
include TLR, NOD-like receptors (NLRs) and RIG-I like receptors (RLRs)56. TLRs 
implicated in viral recognition are the endosome bound TLR3, TLR7, TLRS and TLR9. 
They can induce activation of enzymes, such as mitogen-activated protein (MAP) 
kinases and transcription factors such as NF-kB and interferon regulatory factors 3 and 
7 (IRF3 and IRF7). The NF-kB is a cytosolic protein complex which controls DNA 
transcription. Following TLR activation, epithelial cells respond to viral infection by 
inducing secretion of substances such as cytokines and chemokines51. One of the most 
potent anti-viral chemokines produced upon TRL activation is Type I Interferon (IFN) 
57. IFN Type I (further described in Section 1.1.2.1) effects include inhibition of viral 
replication57"59 and of cellular immunoproteosomes60. Secretion of cytokines by airway 
epithelial cells is generally seen at the basolateral surface, an example being the 
secretion of MIPl-a and TNF-ot in Influenza A infection55. The purpose of basolateral 
secretion is thought to be modulation of inflammatory cell migration into areas adjacent 
to the airways55. In vivo work using tracheal tissue from guinea pigs and rats has
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determined that cellular migration occurs in the airways within the first 12 to 24 hours 
and proliferating changes are initiated 15 to 24 hours post stimulus 61.
1.1.1.2 The lung
The lung parenchyma enables the exchange of noxious gases, such as CO2 present 
in the host’s blood with O2 present in the atmosphere. Gas exchange takes place in the 
pulmonary alveoli. Most (-90%) of the alveolar surface is covered by the spindloid-like 
(flattened and long) pneumocytes type I, responsible for the gas exchange. The 
remaining space is occupied by the surfactant producing and cuboidal, type II 
pneumocytes. Once there is an immune challenge, type I and type II pneumocytes can 
activate PICK, NF-kB pathways and WNT signalling51 and trigger cytokine cascades 
leading to migration of inflammatory cells55. If the noxious incident induces irreversible 
cell damage, this results in necrosis/apoptosis. The slender type I pneumocytes are the 
cell type most susceptible to injury. However there is also targeting of type II 
pneumocytes by pathogens including viruses. In H5N1 infection of human ex-vivo 
pulmonary cells viral RNA interacts with cellular receptors and secondarily modulates 
cytokine expression and metabolism in type II pneumocytes .
Apoptosis is the ATP-dependent programmed cell death which is induced by 
caspases, proteolytic enzymes that degrade cellular proteins. Caspase activation can 
follow the extrinsic pathway through ligand binding to tumour necrosis factor receptor 
(TNFR) or Fas receptor. Apoptosis can also be induced following the intrinsic pathway 
by an intracellular effector, such as p53 or members of the Bel protein family63. Bcl-2, 
Bc1-xl and Bcl-w exhibit anti-apoptotic potential and the proteins which bind to Bcl-2, 
Bax, Bak and Bok exhibit pro-apoptotic potential64,65. Morphologically, apoptosis is 
characterized by individual cell shrinkage, chromatin condensation and nuclear 
fragmentation. The cellular components are released into cell membrane enclosed 
vesicles which are phagocytosed, but there is no induction of an inflammatory 
response64’66.
Necrosis is cell death following a chemical or physical injury to the cell. 
Traditionally it was considered not to be ATP-dependent, but research has found that 
necrosis can also be a type of programmed cell death with ATP consumption, referred 
to as necroptosis67. Receptor interaction protein (RIP 1) plays a major role in this 
pathway. Morphologically, necrosis is characterized by organelle swelling and plasma
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membrane rupture. The release of cellular components into the environment elicits an 
inflammatory response, resulting frequently in the death of neighbouring cells. Unlike 
in apoptosis, protein synthesis still occurs during necrosis. Likely this represents a host 
response to viruses to signal APC to mount the adequate immune response68.
Regeneration of the denuded alveolar surface is mainly by proliferation of type II 
pneumocytes which leads to thickening of the blood-air barrier and partial impairment 
of gas exchange62. As regeneration progresses the type II pneumocytes differentiate into 
type I pneumocytes. In rats type I pneumocytes have also been shown to possess this 
proliferative ability69. In mice there is evidence for the presence of other stem cells 
niches in the lung besides type II pneumocytes70.
1.1.2 Cytokines
Cytokines are inter-cellular signalling molecules and exert functions through 
binding to specific cellular receptors. The effect of cytokines is varied and includes 
induction of growth, cellular functions including cytotoxicity, cellular migration or 
secretion of other cytokines ’ * J . Viruses evolve alongside their hosts and viruses 
such as poxviruses and herpesviruses evade the immune system by targeting cytokine 
effects and influence intracellular signalling by the host3,4. The present evidence is that 
viruses evolved and introduced secretion of these proteins into their replication process 
in order to increase their ability to infect and persist in the host72, 73. By increasing the 
migration of the adequate cell type, viruses increase the availability of target cells. By 
decreasing certain cells types that would identify virally infected cells, viruses evade 
viral clearance.
1.1.2.1 Chemokines
Chemokines (CKs) are grouped into four classes depending on the N-terminus: 
CXC (a), CC (P), CX3C (y) and C (5). CKs bind to G-protein coupled receptors (GPCR) 
on cell surfaces and can modulate leukocyte migration and activation by binding to 
these receptors74,75. To.further increase cellular migration to specific sites, CKs interact 
with glycosaminoglycans (GAGs) on the endothelium or matrix76, 77. The GAG-CK 
complex acts as an attractant for leukocytes, via receptors complementary to the 
secreted CK. Furthermore, chemokines produced by perivascular inflammatory cells 
such as macrophages, can be released into the circulation through transcytosis and
8
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induce migration of intravascular cells to the sites of infection78. CKs also induce 
activation of mitogen activated protein kinases (MAPKs), such as Janus-N-terminal 
kinase 1 and 2, extracellular signal regulator kinase 1 and 2 (ERK1, ERK2) and p3 879.
The strategies employed by viruses to alter CK action include mimicking CKs or 
their receptors and binding to the CKs themselves80. The aim of viral CK targeting is 
mainly to modulate migration of immune cells to sites of infection3,74> 75, 79, The MHV- 
68 M3 gene, encodes for M3/vCKBP3 which binds to a broad range of chemokines and 
impairs their function * . In the absence of M3 there is an increase in RANTES, MIP- 
la, and MIP-3p, all associated with T cell activation. In the wood mouse, M3 drives the 
B cell dominated inflammatory response and iBALT formation9. In MHV-68 infection, 
B cells are the main cell type where latent replication occurs ’ . Therefore it is of
benefit to the virus to increase the availability of B cells which is achieved partly by 
preventing T cell activation9. In HSV-1 and HSV-2 infection, a viral secreted protein, 
glycoprotein G (gG), has been found to bind to chemokines through their 
glycosaminoglycan domain. This binding has been shown to increase inflammatory cell 
migration through GPRC signalling and phosphorylation of MAPKs79. KSHV encodes 
for viral proteins some of which are homologous to cellular proteins in the human host 
(Table IT)73, 83. Most of these proteins are produced during lytic replication84. KSHV 
encoded proteins include vMIPl and vMIP2 which are homologues of human MIP-1 
and MIP-2 and are implicated in the establishment of both the sarcoma and lymphoma 
associated with infection85. Also in KSHV, the open reading frame (ORF) 74 encodes 
for vGPCR, a viral chemokine receptor that has been shown to be associated with the 
development of the KS and to have an angiogenic potential86.
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ORF Gene
product
Function
K2 vIL-6 Activation of gpl30, B cell growth factor and angiogenesis
K6 vCCLl CCR5 and CCR8 agonist, chemotaxis of Th2 cells and 
monocytes, angiogenesis
K4 vCCL2 CCR3 and CCR8 agonist, chemotaxis of Th2 cells and 
monocytes, angiogenesis
K4.1 vCCL3 CCR4 agonist, chemotaxis of Th2 cells, induction of VEGF-A, 
angiogenesis
K7 vIAP Inhibition of apoptosis, downregulation of vGPRC expression
ORF 16 vBcl-2 Inhibition of viral and BAX mediated apoptosis
K9 vIRFl Cellular transformation, inhibition of p300, p53, TGF-P and 
type I IFN
K11.5 vIRF2 Inhibition of Fas mediated apoptosis, inhibition of type I IFN 
and NF-kB
K10.6 vIRF3 Inhibition of p53, NF-kB and Fas mediated apoptosis
ORF 74 vGPCR Transformation, inducer of VEGF secretion
Table 1.1 KSHV encoded proteins sharing homology with human proteins
1.1.2.2 Interferons
Interferon (IFN) synthesis occurs following various signals, primarily Interferon 
regulatory factors (IRFs) but also nuclear factor kappa-light-chain-enhancer of activated 
B cells (NF-kB) and activation transcription factor 2 (ATF2). When IFNs are bound to 
their receptors, the Jak-STAT pathway is initiated which results in the formation of 
activated STAT1/2-IRF-9 complex that localises in the nucleus51. The complex is 
composed of a receptor, Janus kinase (JAK) and signal transducer and activator of 
transcription (STAT). This complex regulates gene expression for a variety of genes, 
including p53 (a pro-apoptotic protein)87 and antiviral proteins, such as dsRNA- 
activated kinase R (PKR)88. One effect of PKR is protein phosphorylation of translation 
initiation factor (eIF-2), This impedes mRNA translation of both host and viral genes 
and thus is of highest importance in anti-viral defence mechanisms . PKR also induces 
nitric oxide production via a Fas-dependent pathway90. HSV-1 virion degradation has 
been shown to occur following PKR activation. However, this degradation can be 
blocked by ICP34.5, a HSV-1 viral product91. Once signal transduction occurs, the 
receptor-ligand undergoes endosomal digestion92.
Type I IFNs include IFN-a and IFN-p. IFN-a can be produced by virus-infected 
leukocytes and epithelial cells. Type I IFNs are of major relevance in the host anti-viral
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response since they induce the host cell to express different proteins which interfere 
with the viral replication, protein synthesis or trafficking processes 51. IFN-a and IFN-p 
have been shown to induce DC mediated differentiation of B cells into plasma cells and 
clonal expansion of memory T cells93,94, In Influenza A infection, abrogation of type I 
IFN signalling has been associated with a decreased expression of cytokines . The 
expression of IFN-a and IFN-P is mainly regulated by IRF3 and IRF751. KSHV LANA 
proteins have been found to bind to the IFN-p promoter and thus compete with IRF3, 
resulting in decreased expression of IFN-p95. IFN expression is not always of benefit to 
viral evasion. In human primary airway epithelial cells from patients with chronic 
obstructive pulmonary disease (COPD), there is an increase in susceptibility to 
rhinovirus infection despite an increase in IFN expression following infection96.
IFN-y is the only known type II interferon and it is mainly produced by activated 
T, NK, B and dendritic cells as well as monocytes/macrophages. Its secretion can be 
induced by interleukin (IL)-12 and IL-18 and decreased by IL-4, transforming growth 
factor-p (TGF-p) and glucocorticoids92,97. The IFN-y receptor is present on most cells. 
An important role in the immune response induced by IFN-y is the induction of the 
expression of MHC Class I and II molecules92,97, By modulating the synthesis of these 
molecules IFN-y plays a fundamental role in the host recognition of viral antigens and 
the response to these31. In MHV-68 infection significant upregulation of IFN-y secretion 
is seen in latent infectio 98. IFN-y has been identified as key in controlling reactivation99, 
100 through its interaction with ORF50 promoters101. ORF 50 encodes for replication and 
transcription factor (RTA). The IFN-y effect is cell type specific. IFN-y treatment of 
cells harvested from MHV-68 infected mice leads to a decrease in viral reactivation 
frequency and cytopathic effect in macrophage dominated but not in B cell dominated 
populations82. IFN-y upregulation in MHV-68 infection has been associated with 
resistance to secondary infections98.
1.1.2.3 TNF-a
Tumour necrosis factor a (TNF-a) is a proinflammatory cytokine, known to be a 
strong inducer of cellular apoptosis102'105 proliferation and differentiation106,107. TNF-a 
is mainly produced by macrophages and monocytes. However, TNF-a is also expressed 
by cells such as CD8+ T cells, microglia, epithelial cells and smooth muscle cells108, 
TNF-a can exist in two forms: either as a membrane boimd (mTNF-a) or a soluble form
11
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I09. TNF-a binds to two cellular receptors: TNFRl/p55 and TNFR2/p75. These 
receptors are predominantly membrane bound. TNFR1 is present in a wide spectrum of 
cells whereas TNFR2 is present in lymphocytes, epithelial cells110 endothelial cells, 
cardiomyocytes, and some neuronal cells111. Endoepithelial cells are epithelial cells 
dervived from the endoderm and include respiratory epithelial cells. Binding of TNF-a 
to TNFR1 or TNFR2 activates downstream pathways and/or leads to detachment of the 
membrane bound receptors into solution112. Contrary to what is seen in TNFR1, the 
TNFR2 family lacks a death domain. TNFR1 activation generally leads to inflammation 
and apoptosis and this receptor has been shown to be essential in secondary lymphoid 
follicle formation113'115. TNFR2 activation on the other hand, generally leads to cell 
activation, proliferation, and migration116, 117. The downstream pathway activated by 
TNF-a binding depending also on the strength of the signal and the existing conditions 
(i.e. the presence of other cytokines, targeted cell types). Binding of mTNF-a will lead 
mainly to apoptosis and anergy of the surrounding cells. On the other hand, the binding 
of the soluble form mostly induces cytokine expression. Apoptosis at times, is 
convenient since programmed cell death enables the host to destroy the inciting 
intracellular stimulus i.e. virus, alongside the targeted cell whilst necrosis does not. 
TNF-a induces apoptosis through various mechanisms including activation of the 
proapoptotic Fas pathway and/or decreasing cellular resistance to Fas-dependent 
apoptosis or inhibition of Bcl-2 [. Other TNF-a mediated apoptosis induction 
mechanisms include, activation of caspase 3 and increased expression of cytokines 
secreted by macrophages (TNF-a, MIP-la, MIP-2 and IL-6)112, 118. IFN-y has been 
reported as potentiating the TNF-a anti-apoptotic effect102. Other effects associated with 
TNF-a include enhancement of pulmonary epithelial cell permeability through the 
decrease in expression of zona occludens (ZOl - part of the tight junction complex) 
and/or functional opening of the tight junction barrier112.
1.1.2.4 TGF-p
TGF-P known functions include chemotaxis of fibroblasts and induction of 
apoptosis119. In the lungs of mice, TGF-p has been reported to promote DNA repair in 
type II pneumocytes120 and promote differentiation of progenitor bronchiolar cells121. 
Various cells including fibroblasts, macrophages, regulatory T cells and epithelial cells 
produce TGF-p.
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In MHV-68 infection there is an increase in TGF-p expression by alveolar 
fibroblasts, alveolar macrophages and latently-infected pneumocytes122. In the latently 
infected pneumocytes, the increase in TGF-p was seen alongside increases in expression 
of TNF-a and IFN-y122. In MHV-68 infection of aged (15-18 months) mice, fibroblasts 
showed an increased expression in TGF-p receptors123. However, instead of pro- 
apoptotic potential these cells showed resistance to apoptosis independent of the viral 
titre123. TGF-p mediated resistance to apoptosis in human primary lung fibroblasts has 
been associated with an increase in plasminogen activator inhibitor 1 (PAI-1)124. TGF-p 
expression in mouse primary bronchiolar-alveolar cell lines (composed mostly of type II 
pneumocytes and fewer Clara cells) and pulmonary fibroblasts has been reported to be 
increased by TNF-a125'127. This TNF-a induced increase in TGF-p expression was also 
observed in RAW 624 cells (murine macrophage cell line) co-cultured with A549 cells 
(human lung adenocarcinoma cell line) and was related to activation of the NF-kB 
pathway128. TGF-p increased expression led to the transformation of A549 cells from 
epithelial to a mesenchymal phenotype128.
1.1,2.5 MIPl-a and MIPl-p
MIP-la (aka CCL3) and MIPl-p (aka CCL4) are highly homologous and bind to 
CCR5 receptors, existent in T cells, natural killer cells (NK), dendritic cells and 
monocytes. Similarly, RANTES also binds to CCR5. HIV virus is known to be a ligand 
for CCR5, thus these three chemokines are important in the impairment of HIV virus 
replication. MIP-la and MIPl-p are produced by macrophages, epithelial cells 
(including pneumocytes), lymphocytes and platelets. They are chemoattractants for 
monocytes and a vast array of inflammatory cells, including T cells, NK cells and 
dendritic cells. They have been associated with lymphocytic migration to the nasal 
mucosa and their expression is particularly significant in the nasal and bronchial 
epithelium of influenza infected mice. Activation of CCR5 enhances CD8+ T cell 
responses to tumours, via regulation of T helper cells (Th)/CD4+T cells129. Activation of 
CCR5 also mediates the egress of thymic regulatory T cells (Treg)130. Additionally, 
MIPl-a binds to CCR3 and CCR1 receptors and MIPl-p binds to CCR8 receptors131. T 
helper 1 (Thl) cells exhibit CCR5 receptors whilst T helper 2 (Th2) cells exhibit CCR3 
and CCR8 receptors132.
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MIPl-a is thought to have a more efficient chemoattractant/activating capacity for 
B and Thl cells, the latter leading to an increment in IFN-y, It has also been associated 
with increased cytotoxicity of CD8+ T cells in mucosal (nasal, vaginal) and immune 
(serum extracted) murine cells. It has long been implicated in host immune response to 
viruses in the lung. In equine herpesvirus type 1 (EHV-1) infection of mice with BL/6 
background, MIPl-a was found to decrease viral replication, enhance lymphocyte 
migration and the pneumonia observed. In rabies infection an increase in MIPl-a is 
seen associated with an increase in dendritic and B cells133,134, This results in a increase 
in neutralizing antibodies at the site of inoculation, lymph nodes and in the blood and 
less extensive pathological changes in the brain133, 134. In RSV infection, MIPl-a 
expression by macrophages and CD8+T cells is increased. The impairment of MIPl-a 
expression in RSV infection, leads to a decrease in T cell recruitment but does not have 
an effect on NK cell kinetics135.
1.1.2.6 Interleukin 10
Interleukin 10 (IL-10) belongs to the IL-10 cytokine family, which is thought to 
have developed prior to the adaptive immune system response and is related to the IFN 
family. It is of major importance in epithelial maintenance and its main actions aim at 
dampening inflammation by inhibiting expression of other pro-inflammatory cytokines 
and inducing a response towards healing136. IL-10 binds to IL-10R1 and IL-10R2. IL- 
10R1 is mainly present in leucocytes and IL-10R2 in cells from epithelial cell rich 
tissues137. It is one of the main cytokines produced by B cells, Th2 lymphocytes and 
alternatively activated macrophages and one of its effects is suppression of Thl cytokine 
expression138. Upon TGF-p and IL-6 presence, IL-10 expression in Treg cells (Thl 7) is 
induced via extracellular signal-regulated kinases (ERK) activation and the transcription 
factor, cMAF139. The MAPK/ERK pathway is a cell membrane-nucleus communication 
system. It is activated upon surface receptor binding. This is followed by sequential 
phosphorylation of cellular proteins and ultimately affects DNA by for example 
regulation of protein secretion. ERK activation of IL-10 expression occurs to lesser 
extent in Thl cells alongside IFN-y production. The expression of IL-10 in Thl cells is 
probably a self-regulating process which acts to decrease the inflammatory changes 
induced by the other pro-inflammatory cytokines produced by these cells138,14°.
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1.1.3 Nitric oxide
Nitric oxide (NO) is an endogenous nitrogen-based free radical. NO is cytotoxic 
and cytostatic via its interaction with oxygen radicals. NO is the product of nitric oxide 
synthase (NOS). There are three main types of NOS, namely iNOS (inducible), nNOS 
(neuronal) and eNOS (endothelial). iNOS is not expressed in cells under normal 
physiological conditions, but only when there is an inflammatory stimulus141. Whereas 
nNOS and eNOS are constitutively expressed. iNOS and nNOS are both present in 
soluble forms whilst eNOS is membrane bound. Furthermore, these enzymes differ in 
their function, eNOS and nNOS function is dependent on Ca2+ concentrations and is 
intermittent, whilst iNOS function is Ca2+ independent and persistently active141 once the 
enzyme is expressed. iNOS is known to be expressed in macrophages, dendritic cells, 
endothelial cells, epithelial cells and neutrophils142, CBA/J mice infected intranasally 
with HSV-1 developed severe pneumonia. However, when these mice were treated with 
NG-monomethyl-l-arginine, a NOS inhibitor, the severity of the pneumonia was very 
much decreased. This decrease in severity of pathological changes in the presence of 
NOS inhibitor occurred despite the viral titres being 17 times higher in lung tissue. 
These findings indicate that the severe pneumonia seen with HSV-1 infection was not a 
direct effect of the virus but of NO produced as a result of the viral infection 143. The 
induction of NOS is thought to be by PKR, which is activated by the virus intermediate 
replication stage of dsRNA144.
There are two pathways of macrophage activation, classical and alternative. 
Classical activation of macrophages (Ml) occurs mostly upon stimulation by Thl 
cytokines (mainly IFN-y, IL-6, IL-12 and TNF-a)145, 146. Ml express iNOS which 
converts arginine into NO. On the contrary, alternative activation of macrophages (M2) 
occurs mostly upon stimulation by Th2 CKs (mainly IL-13 and IL-4)145,146. M2 express 
arginase which also uses arginine as a substrate and converts it into urea and 
ornithidine. Urea and omithidine will produce polyamines and proline which induce 
proliferation and collagen production respectively. The CKs produced by Ml 
macrophages inhibit M2 macrophage proliferation, and vice versa, by blocking the 
specific arginine metabolism at the translational level145*148.
Migration of macrophages to affected tissues occurs generally within the first 24 
hours of the intitial incident146.
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1.1.4 Summary of signalling pathways
A summary of the main cellular pathways referred to throughout this thesis is 
represented in Figure 1.2.
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Figure 1.2 Schematic representation of cellular signalling pathways referred to 
throughout this thesis.
Signalling pathways are extremely complex and in this representation, for purpose of clarity, 
not all effects are shown. Abbreviations: ERK - extracellular signal-regulated kinase; FasR - 
Fas receptor; FADD - Fas receptor associated death domain; IL-6 - interleukin-6; JNK 
mediators and/ - c-Jun N-terminal kinase; MAPK - mitogen-activated protein kinases; RIP1 
- receptor interaction protein; TNFa, tumour necrosis factor a; TNF-R - tumour necrosis 
factor receptor; IL1R - interleukin 1 receptor; TLR: Toll like receptor; IRAK: interleukin-1 
receptor-associated kinase 4; p53 - tumour protein 53; Bcl-2 - B cell lymphoma protein; 
STAT - signal transducer and activator of transcription Jak -Janus kinase; PKA - protein 
kinase A; RTK - receptor tyrosine kinase; GPCR - G-protein coupled receptors; CK - 
Chemokines; Ras - rat sarcoma protein; MAPK - microtubule-associated protein kinase; 
MKK - a.k.a. MAP3K, MAP kinase kinase kinase; IRF - Interferon regulatory factors; 
IKKe - IkB kinase; TBK - TANK binding kinase
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1.2 Herpesviruses 
1.2.1 Taxonomy
Since 1966, the taxonomy of viruses has been established by the International 
Committee on Taxonomy of Viruses (ICTY)11. Viruses are classified by the use of the 
hierarchical levels of Order, Family, Subfamily, Genus, and Species11. These divisions 
are made based predominantly on the morphology of viruses149 and thus indicate their 
evolutionary relationships. The Herpesvirales order includes three families: the 
Herpesviridae, the Alloherpesviridae and the Malacoherpesviridae (Table 1.2)150. The 
current nomenclature uses the family or subfamily of the host that the virus infects and 
the order it was found in such family or subfamily. Sequence homology between the 
different families of viruses consists of a common gene, encoding a putative ATPase 
subunit of a DNA-packaging terminase1 ^151,152.
Order
Herpesvirales
Family
Herpesviridae
-mammals, birds and reptiles-
Alloherpesviridae 
-fish and amphibians-
Malacoherpesviridae 
-invertebrates: oysters-
Table 1.2 Taxons of the Herpesvirales order and their host range 150
1.2.2 The Herpesviridae family
Herpesviridae infect a broad spectrum of species including mammals, birds and 
reptiles. Members of the Herpesviridae family show a high degree of sequence 
conservation14'17. Even when sequence conservation is not present it has been found that 
there is often conservation of viral protein interaction and/or their role in the different 
viral species . Viruses within the Herpesviridae family share the same basic 
morphology and structures: genome, nucleocapsid, tegument and envelope16,149,15°. The 
genome consists of double stranded DNA (dsDNA) and is 120 to 230 kilobases in size 
154. It encodes 70 to 170 open reading frames, this being for most enzymes and genes
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needed for viral replication and viral evasion of the immune system154. The structure of 
the genome in herpesviruses allows the division of these into six groups based on the 
presence and location of repeat sequences (Table 1.3). The capsid is icosahedral and is 
composed of 162 capsomers enclosing the genome154. It integrates four structural 
proteins: the major capsid protein, triplex-1 protein, triplex-2 protein and a small capsid 
protein155. The tegument is a layer of proteinaceous material surrounding the capsid. 
MHV-68 is the virus of interest in this study and will be further discussed ahead. The 
tegument in MHV-68 has unique features when compared to the other herpesviruses. In 
MHV-68, the tegument consists of an outer layer that does not completely encircle the 
inner layer (Figure 1.3)156. This feature enables contact between the inner layer and the 
envelope156. The morphology of the outer layer could account for the different 
morphologies of virions encountered 156. The envelope in herpesviruses is the outermost 
layer and forms a lipid bilayer made up of viral encoded glycoprotein spikes and host­
cell derived lipids16,149,15°. The glycoprotein spikes are involved in multiple functions 
including virus attachment, fusion and entry. The tegument and envelope protect the 
DNA from nucleolytic or chemical attack by the host16,149, 150,155. Herpesviridae share 
biological properties such as the ability to remain latent in the host cell, this can occur 
when viral DNA covalently ligates to the host DNA and is maintained as episomal DNA 
. The virus, whilst incorporated into the host DNA, utilises the hosts cellular 
machinery for its own replication157. In latent replication only a subset of the viral 
genome is expressed16,149. Latency allows virus survival in successively dividing cells 
whilst maintaining its ability to fully replicate upon reactivation4,149,15°. Full replication 
with production of infectious virions results in cell lysis16, 149. Viruses in this family 
have a very narrow host range and in the case of the mammal infecting 
gammaherpesvirus, are thought to have developed in parallel with their host18. These 
viruses are highly adapted to their host and generally only exert mild pathological 
changes except in the very young, foetuses, immunosuppressed or aberrant hosts150. 
Some of these viruses are widespread such as the Epstein Barr virus (EBV) which 
infects approximately 90% of the human population12.
The herpesvirus family is further classified into four subfamilies, alpha, beta, 
gamma (Table 1.3) and one unassigned species150. Disease expression amongst 
subfamilies is highly variable, mainly due to the different cell specificity and replication 
rates of these viruses2.
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Group Terminal repeat sequences Example
A Identical terminal repeats at either end of genome EHV-2
B Terminal repeats that repeat several times within
the genome
MHV-68
C Terminal repeats that repeat several times and
additional internal repeat sequences throughout
genome
EBV
D Terminal repeat which is inverted and repeated
within the genome
VZV
E Terminal repeats are inverted and positioned
adjacently on either end
HSV
F No terminal repeats TSHV
Table 1.3 Herpesvirus group divisions based on the presence and location of genomic 
terminal repeats.
Outer tegument 
** Inner tegument
Capsid 
* Genome
Figure 1.3 Schematic representation of the MHV-68 virion.
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Alphaherpesvirinae
• lltovirus
•Gallic! herpesvirus 1 
•Psittacid herpesvirus 1
• Mardivirus
•Columbid herpesvirus 1 
•Gallid herpesvirus 2 
•Gallid herpesvirus 3 
•Meleagrid herpesvirus 1
• Simplexvirus
•Ateline herpesvirus 1 
•Bovine herpesvirus 2 
•Cercopithecine herpesvirus 2 
•Human herpesvirus 1 
(HSV-l)
•Human herpesvirus 2 
(HSV-2)
•Macacine herpesvirus 1 
•Macropolid herpesvirus 1 
•Macropolid herpesvirus 2 
•Papiine herpesvirus 2 
•Saimiriine herpesvirus 1
• Varicellovirus
•Bovine herpesvirus 1 
•Bovine herpesvirus 5 
•Bubaline herpesvirus 1 
•Canid herpesvirus 1 
•Caprine herpesvirus 1 
•Cercopithecine herpesvirus 9 
•Cervid herpesvirus 1 
•Cervid herpesvirus 2 
•Equid herpesvirus 1 
•Equid herpesvirus 3 
•Equid herpesvirus 4 
•Equid herpesvirus 8 
•Equid herpesvirus 9 
•Felid herpesvirus 1 
•Human herpesvirus 3 
•Phocid herpesvirus 1 
•Suid herpesvirus 1
• Unassigned 
•Chelonid herpesvirus 5 
•Chelonid herpesvirus 5
Betaherpesvirinae
•Cytomegalovirus 
•Cercopithecine herpesvirus 5 
•Human herpesvirus 5 (CMV) 
•Macacine herpesvirus 3 
•Panine herpesvirus 2
• Muromegalovirus 
•Murid herpesvirus 1 
•Murid herpesvirus 2
•Proboscivirus 
•Elephantid herpesvirus 1
•Roseolovirus 
•Human herpesvirus 6 
•Human herpesvirus 7
•Unassigned 
•Caviid herpesvirus 2 
•Suid herpesvirus 1 
•Tupaiid herpesvirus 1
Gammaherpesvirirnae
• Lymphocryptovirus
•Callitrichine herpesvirus 3 
•Cercopithecine herpesvirus 
14
•Gorilline herpesvirus 1 
•Human herpesvirus 4 (EBV) 
•Macacine herpesvirus 4 
•Panine herpesvirus 1 
•Papiine herpesvirus 1 
•Pongine herpesvirus 2
• Macavirus
•Acelaphine herpesvirus 1 
•Acelaphine herpesvirus 2 
•Bovine herpesvirus 6 
•Caprine herpesvirus 2 
•Hippotragine herpesvirus 1 
•Ovine herpesvirus 2 
•Suid herpesvirus 3 
•Suid herpesvirus 4 
•Suid herpesvirus 5
• Percavirus
•Equid herpesvirus 2 
•Equid herpesvirus 5 
•Mustelid herpesvirus 1
• Rhadinovirus
•Ateline herpesvirus 2 
•Ateline herpesvirus 3 
•Bovine herpesvirus 4 
•Human herpesvirus 8 (KSHV) 
•Macacine herpesvirus 5 
•Murid herpesvirus 4 
(MHV-68)
•Saimiriine herpesvirus 2
• Unassigned
•Equid herpesvirus 7 
•Phocid herpesvirus 2 
•Sanguinine herpesvirus 1
Table 1.4 Herpesviridae sub-families with respective genuses and species .
Species acronyms are occasionally shown in brackets. MHV-68, the virus of interest in this 
study, is highlighted in bold.
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1.2.2.1 Alphaherpesviruses
Alphaherpesviruses have the widest host range of animal species and cell types of 
the Herpesviridae family150. The hosts include humans, various ungulate and avian 
species, seals and turtles. Alphaherpesviruses are characterized by a short replication 
cycle, between 16 and 18 h4, which leads to early cell death and high infectivity158. The 
target host cells are mostly nerves and the spread of the virus infection occurs via 
intraxonal transmission4. Latency is established predominantly in sensory ganglia149,159, 
160. Herpes simplex-1 (HSV-1), HSV-2 and Varicella-Zoster virus (VZV) are examples 
of this subfamily.
1.2.2.2 Betaherpesvirus
Betaherpesviruses are more host specific than alphaherpesviruses150 but are still 
capable of infecting a variety of cell types4. They are characterized by a longer 
replication cycle than alphaherpesvirus. CMV replication usually takes between 48 and 
72 hours4. This longer replication time leads to cell death later than in 
alphaherpesvimses, being several days post-infection159’161. Latency can be established 
in various tissues, including secretory glands, lymphoreticular tissues and kidneys16,149. 
Similarly to gammaherpesvimses, reactivation occurs when immunosuppression is 
present16. Cytomegalovirus (CMV) and Human Herpes virus- 6 (HHV-6) are examples 
of this sub-family15'17.
1.2.2.3 Gammaherpesvirus
Gammaherpesviruses are the most host specific of all the three sub-families and 
are subdivided into four genera. These genera include: the yl-herpesviruses 
(lymphocryptoviruses), which affects only primates and the y2-herpesviruses 
(rhadinoviruses) which are known to have a wider host range of mammal species18. The 
Macavims and Percavirus (artiodactyls, perissodactil and carnivore viruses) exhibit an 
internal structure which resembles the lymhocriptovirus clade162. MHV-68, the virus of 
interest in this study belongs to the y2-herpesviruses subfamily. Despite rodent and 
primate y2-gammaherpesvirus being thought to have diverged in evolutionary terms 
approximately 60 million years ago163 sequence homology is quite considerable. MHV- 
68 genome possesses 80 open reading frames (ORFs) and these are often homologous 
with those of other gammaherpesvirus such as KSHV, EBV and Herpesvirus Saimiiri
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(HVS) (Figure 1.4). Homologous genes most frequently encode for factors related to 
viral replication or structural components of the virion particle2, ,63. Non homologous 
genes normally are related to latency establishment and/or transformation of infected 
cells163. MHV-68 exhibits genes unique to its sequence in the left end of the genome 
consisting of eight vtRNA-like genes and Ml to Ml 1 genes164. Ml gene is the gene of 
interest in this thesis. Unlike other gammaherpesviruses, MHV-68 can be easily 
replicated in vitro thus facilitating research into its function ’ .
HVS mmn
KSHV
EBV
K2-7,S2,S70,S16)
K1 K8
4 11 17 50 52-69 72-75 SliUllll
LMP1.2 BILF1
BARF1 BILF2
BALF1\:
[ebnai]
BZLF1.BZLF2
EBNA3a-c
gp350/220
BLLF2 BFRF3
II I 1 I I I_______ I_______ I___ I__________I______ I_______I---------- 1-------- 1----------- 1---------- 1----------1—
10 30 50 70 90 110 130 150 170 kb
Figure 1.4 Alignment of HVS, MHV-68, KSHV and EBV genomes
Taken from163.
In the HVS genome, attribution of ORF numbers is based on their sequential position. In the 
remaining genomes attribution of ORF numbers is based on collinear and
nucleotide/fiinctional homology of these and the HVS genome. Conserved sequences are 
shown in black boxes. Unique genes are shown in the white boxes and in this figure MHV- 
68 is represented by yHV68.
Gammaherpesviruses are characterized by an initial lytic phase of high 
replication. This is followed, in immunocompetent animals, by a latent phase of 
continuous and low level replication mainly in lymphoid tissue159, 160, 165. In latency 
there is tethering of the viral genome to the hosts chromosome, with only a subset of 
genes being transcribed. During latency intermittent reactivation with low level lytic 
replication also occurs. In the presence of an immunosuppression episode, lytic
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1 ^ 1 *7 1 i f’f\replication is reinitiated 5 3 . It is not fully understood why some cells enter
latency rather than the lytic cycle but it is suspected to be due to failure in the
expression of immediate early transcribed (IE) genes166, hi MHV-68, ORF 73 is an IE
gene essential to reactivation but not to lytic replication. ORF 73 encodes for latency
associated nuclear antigen (LANA) which is involved in viral episome maintenance
during latent replication in MHV-68, HVS and KSHV. In KSHY and MHV-68 LANA
proteins bind to viral genome terminal repeats, tethering the viral genome to the host
mitotic chromosomes, enabling viral persistence in daughter cells167'170, LANA proteins
also inhibit the activation and propagation of cellular tumour-suppressing protein,
p53171. p53 is a DNA-binding protein that regulates DNA transcription of various
genes172. Normally, in the presence of DNA errors p53 expression is increased and can
induce either cellular repair or apoptosis172. In herpesvirus infections such as VZV and
MFIV-68 infection, p53 enhances viral lytic gene expression instead of being a cellular
regulator . The presence of LANA proteins and their inhibitory effect on p53,
decreases cellular injury and enables latent virus maintenance171. LANA proteins also
target pRb, oncogenic p-catenin and c-Myc pathways as alternative ways of promoting
the survival of infected cells174'178. In order to halt viral lytic transcription, LANA
proteins inhibit the transcription of RTA179. RTA is encoded by ORF 50 and induces
lytic replication 180, 18 J. Contrary to LANA, RTA does not exert a negative effect on
LANA expression and instead binds to the ORF 73 promoter and induces LANA
expression182. RTA induces expression of different genes by binding to their promoter,
M3 in MHV-68 being one of these . RTA location in the viral genome and its function
as viral lytic replication inducer is common between gammaherpesviruses163, 184. In
EBV infection besides RTA as a viral transactivators, there is also ZTA. In EBV lytic
replication the reactivation process results from the interaction between RTA and 
ZTA185-189.
1.2.2.3.1 Gammaherpesvirus and oncogenesis
Some gammaherpesviruses are associated with oncogenic transformation and 
lymphoid cells are the main cell types to show such change18,159,160,165,190,191.
Oncogenic transformation of B cells has been seen associated with EBV infection 
and occurs both in vitro and in vivo. Infected humans develop in a small percentage of 
cases, Burkitt’s lymphoma160. The oncogenic potential in EBV infection, has been
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related in part to Epstein Barr nuclear antigen l(EBNAl) which binds to the latency 
associated origin of replication, oriP18. EBY has also been associated with carcinomas 
such as nasopharyngeal carcinoma192.
KSHV infection of immunosupressed human patients has been associated with 
Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL) and multicentric 
Castleman’s disease (MCD)193. KS is a spindle cell neoplasm with significant 
neoangiogenesis as a feature. KS can present in four different clinical forms, classic, 
endemic. Iatrogenic or AIDS associated. In the case of classic KS, it occurs most 
frequently in elderly men from Mediterranean and Eastern European countries. The 
endemic form is mostly seen in African children. This suggests that a genetic 
predisposition or local infectious agent increases the likelihood of developing KS . In 
PEL, the neoplastic cells are B cells exhibiting the cluster of differentiation 30 (CD30) 
and CD138 indicating that expansion of these cells occurred at a late stage of cellular 
differentiation ’ ‘ . MCD is characterised by a multicentric lymphoid and vascular
proliferation mostly in germinal centres of lymphoid tissue . In KSHV, the gene 
product of K13, vFLIP has been linked to apoptosis resistance in B cells. Resistance to 
apoptosis often predisposes to uncontrolled cell growth and likely contributes to the 
lymphoproliferative disorder. This resistance to apoptosis was indicated as being 
through enhanced expression of RelB, a subunit of NF-kB. vFLIP also led to inhibition 
of c-Myc and p27 rise following blockage of anti-IgM. C-Myc and p27, are known 
growth arrest and apoptosis inducers199.
HVS infects New World primates and leads to T cell proliferation200 that can be 
occasionally fatal . Oncogenic potential has been related in part to HVS tyrosine 
kinase-interacting protein (Tip) both in vitro and in vivo. Evidence suggests Tip induced 
transformation of T-cell is through Tip activity on signal transducer and activator of 
transcription 6 interleukin 4 induced (STAT6)202. STAT 6 is an inducer of Th2 cell 
polarization203,204.
1.2.2.3.2 Gammaherpesvirus and pulmonary fibrosis
Idiopathic pulmonary fibrosis (IFF) is a condition seen in humans and is 
characterized by progressive and irreversible interstitial fibrosis in the lung. IFF is 
frequently accompanied by arterial hypertension due to thickening of arterial walls 
207. The aetiology of IFF has not fully been determined but herpesviruses, in particular
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EBV to lesser extent KSHV and the betaherpesvims HHV-7 and HHV-5 are often 
detected in the lungs of IFF patients208"210. Equine nodular fibrosis is a uncommon entity 
described in horses which features extensive interstitial fibrosis in a nodular to 
coalescing pattern. There have been several reports associating equid herpesvirus 5 
(EHV-5) with equine nodular fibrosis211, 212. MHV-68 infection has been used as a 
laboratory model to study pathogenesis of IFF since similar lesions are observed in the 
chronic infection of CD l208 or IFNyR"7" mice209, 210. In human patients with IFF and 
MHV-68 infected CD1 and IFNyR"7' mice with evident interstitial fibrosis, there is an 
increase in the expression of the pro-fibrotic cytokine, TGF-p208,210,213. When IFNyR'7' 
mice were infected with a MHV-68 virus expressing a mutant dominant inhibitor of the 
NFkB signaling pathway, in latent infection there was a decrease in viral load and 
absence of vasculitis and fibrosis. This was seen together with a decrease in the 
expression of integrin <xvp6, a transmembrane receptor associated with TGF-p 
activation and decrease in the expression of arginase, an enzyme used as a marker for 
alternative activation of macrophages210. Alternative activation of macrophages with no 
change to classical activation of macrophage was also related to splenic fibrosis in the 
chronic MHV-68 infection of IFN-y R'7' mice209. Alternative activation of macrophages 
occurs mainly upon stimulation by Th2 CKs145, 146. Additionally in MHV-68 infection 
of IFN-y R'7’ mice if CD4+ T cells and CD8+ T cells are extracted prior to infection, 
there is no onset of the fibrosis, indicating the role of these cells in the induction of 
fibrosis214'216.
1.2.2.3.3 Gammaherpesvirus and neurotropism
Gammaherpesviruses are generally lymphotropic but viruses such as EBV and 
KSHV have been detected in the brains of both asymptomatic and immunosuppressed 
humans217"225. EBV infection is only occasionally accompanied by neurological 
disease ’ . However, neurologic complications are often the cause of death in
humans with infectious mononucleosis, a syndrome of EBV infection * . Viral
replication in the brain has been recognized but it is not certain if this is restricted to the 
infiltrating lymphocytes ’ . EBV associated neuropathogenesis has been related to
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immune-mediated mechanisms resulting in demyelination of white matter rather than 
effects on the gray matter as commonly observed in typically neurotropic viruses229.
Meningitis following intranasal MHV-68 infection has been described in BALB/c 
mice newborn or with a deletion in type-I interferon receptor gene . MHV-68 is 
able to persist in the central nervous system (CNS) during the infection of laboratory 
mouse strains232. In 4-5 weeks and 9-10 weeks old BALB/c infected intracerebrally 
with MHV-68, lytic replication was detected in astrocytes and to lesser extent in 
neuronal and glial cells227. The highest mortality was observed in 4-5 weeks old mice 
and the authors hypothesised this to be related to a higher increase in the expression of 
TNF-a, IL-lp and IL-6 in this age group. The literature available suggests that MHV-68 
shows neurotropism despite the absence of obvious neuropathogenesis in 
immunocompetent animals.
1.2.3 Cell infection
Most of the literature available on herpesvirus entry, assembly and egress has 
been obtained through the study of Herpes simplex virus (HSV) infection233.
1.2.3.1 Binding to the cell surface
Like most viruses, the first step in the herpesvirus infection is binding to the cell 
surface14, I5, 17. Binding occurs mainly by ligation of viral envelope glycoproteins to 
heparan sulphate on the cell surface234. However, this process is non-essential and in 
some cases reversible16,149. Binding potentiates infectivity by concentrating virions on 
the cell surface and so enables better access of the virions to cell entry receptors16,149.
Following binding, the virus enters the cell either by endocytic vesicles or by 
fusion with the plasma membrane. Fusion leads to loss of the envelope, making this 
ligation irreversible16,149 In Varicella Zoster virus (VZV) infection the mechanism of 
viral entry is dependent on the targeted host cell, being through endocytosis in 
endothelial and epithelial cells235,236 and through membrane fusion in fibroblasts236. In 
Herpesviridae binding to the cell surface is mainly mediated by the core fusion 
machinery: Glycoprotein B (gB), gH and gL " which is conserved throughout the 
family240. However other glycoproteins have been identified as viral ligands, including 
gD in HSV-1 241,242 and gp42 in EBV243 explaining in part the different cell and tissue 
tropism159, 16°. In the case of EBV, the glycoproteins used for binding to cells lead to
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their sequestration and so the produced virions will not express them. Consequently, 
virions produced by infected B cells infect epithelial cells more readily and virions
0*30 OA'Xproduced by infected epithelial cells infect B lymphocytes more efficiently ’
1.2.3.2 Virus entry into the cell
During the fusion process, there is loss of the virion envelope and exposure of the 
tegument proteins. The released proteins are known to interfere with cellular 
mechanisms at various levels, either by priming the host cell for synthesis of viral 
components (VP 16 in HSV-1), virion-host shut off (SOX in KSHV) or immediate-early 
gene transactivators244'246. In KSHV the release of proteins includes RTA with its 
expression being detected at 2 h post infection (p.i.)247-249. The progression of 
replication into latent or lytic cycle is dependent on the proteins present.
1.2.3.3 Viral assembly
Once inside the cell, the virus translocates to the nucleus within microtubules ’ 
251 and then enters through nuclear pores4, releasing the capsid which remains 
perinuclear. When virus particles are intranuclear, viral genome replication is initiated 
either as a subset (latent replication) or completely (lytic replication).
During lytic replication, gene transcription and consequent protein synthesis 
occurs in a staggered manner. Consequently, genes are classified as immediate early 
(IE) or a, early (E) or p and late (L) or y149,16°. IE genes are the first to be expressed in 
lytic replication and generally correspond to genes modulating the cellular machinery 
for viral replication and activating transcription of downstream genes149, 154. Such genes, 
in KSHV and MHV-68, include ORF 50 encoding for RTA. E gene products are related 
to DNA replication and control cellular activities84,149,154. In KSHV, E protein is vIL-6 
that induces B cell proliferation as does the human IL-6. Also in KSHV, Kaposin an 
early gene, has been identified as inducing cellular transformation252,253. L proteins are 
related to production of structural components149, 154. Genome replication occurs in the 
nucleus and results in formation of concatemeric molecules that need to be assembled 
into a unit-length genome. This process is mediated by a dodecameric portal complex 
(pUL6)244. The capsid proteins are synthesised and released in the cytoplasm. In order 
for the capsid to be packed with the viral DNA, the proteins have to migrate to the
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nucleus where they assemble into preformed capsids254. The packed capsid then 
acquires an initial layer of tegument while in the nucleus149.
1.2.3.4 Viral egress
Viral egress is thought to be by sequential de-envelopment and re-envelopment as 
the viral particles travel through the cell (Figure 1.5). The primary envelopment occurs 
at the inner nuclear membrane. However, this envelope is lost once the virus 
translocates into the cytoplasm, through the outer nuclear membrane (de- 
envelopment)149, 244. Secondary envelopment is thought to occur when viral particles 
bud into Golgi-apparatus derived vesicles that afterwards fuse with the extracellular 
membrane and release the virus into the extracellular matrix244,255. This is supported by 
the finding that there are differences in morphology and protein composition between 
enveloped virions that present perinuclearly (immature virions) or extracellularly 
(mature virions) 244,255.
Figure 1.5 Schematic representation of viral egress.
1) Empty capsid in the nucleus. 2) Filled capsid (capsid and genome) as it fuses with the 
inner nuclear membrane (primary envelopment). 3) Primarily enveloped virus as it migrates 
between inner and outer leaflet of nuclear membrane. 4) Loss of primary envelopment as 
virus translocates into the cytoplasm, through the outer nuclear membrane (de­
envelopment). 5) Secondary envelopment when viral particles bud into Golgi-apparatus. 6) 
Enveloped and tegumented viral particles migrating through Golgi apparatus. 7) Enveloped
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viral particles fuse with the extracellular membrane. 8) Release of virion into extracellular 
space
1.3 MHV-68
To date, several acronyms are used to refer to the MHV-68 virus, including 
murine gammaherpesvirus, murine gammaherpesvirus type 4 strain 68, 
gammaherpesvirus 68 and Murid herpesvirus type 4150.
MHV-68 is a natural pathogen of free living rodents19’21. It was first isolated in 
Slovakia, from My odes glareolus, the bank vole, and Apodemus flavicollis, yellow­
necked field mice captured in Slovakia during a study on the ecology of arboviruses20, 
. Along with MHV-68, four more murid herpesviruses were isolated (strains 60, 72, 76 
and 78). An epidemiological study in the UK revealed Apodemus sylvaticus, the wood 
mouse, as the natural host of MHV-6819, Contrary to what was found in Slovakia, 
MHV-68 infection was not detected in bank voles in the UK256. Further serological and 
molecular studies have led to the conclusion that MHV-68 does not naturally infect 
free-living Mus muscitlus164.
The natural route of infection of MHV-68 is thought to be intranasal28 although 
neonatal transmission is also suspected257. A recent study using luciferase imaging 
reported sexual transmission of MHV-68 in BALB/c mice. In this study genital 
excretion and latent infection by MHV-68 was detected at the external border of the 
vagina in females that had been infected intranasally. The viral excretion was dependent 
on oestrogen levels and efficiently infected males following intercourse. However this 
excretion site did not lead to horizontal of other females nor vertical transmission to 
offspring. In the males, vims was seen to replicate in the penis epithelium and corpus 
cavemosum prior to viral seeding of local lymph nodes and spleen .
Experimental studies are performed mainly by using the intranasal route28,170,215, 
. Intrap eritoneal, subcutaneous, intravenous and oral routes of infection are also used 
in infection studies but less frequently256, 260'263. Like other gammaherpesvimses 
MHV-68 is capable of establishing latent replication in the infected host (Figure 1.6).
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Figure 1.6 Schematic representation of MHV-68 replication.
MHV-68 binds to the host cell heparan sulphate proteoglycans, which occurs 
initially through gB/gL or gp70240, 264. This results in the displacement of the viral 
glycoprotein gpl50 and further heparan-sulphate independent binding264,265. Cell entry 
occurs through endocytic vesicles and release of the encapsulated viral particle into the 
cytoplasm by membrane fusion266 261.
1.3.1 MHV-68 pathogenesis based on the laboratory mouse model
Following intranasal infection, high level viral lytic replication occurs in the 
pulmonary epithelium and mononuclear cells, mainly in macrophages (Figure 1.7). 
During acute replication there is an acute interstitial pneumonia. The pneumonia is 
characterised by a moderate to severe increase in interstitial cellularity due to moderate 
to severe infiltration by macrophages and lymphocytes, and there is abundant necrotic 
debris accumulation. Peribronchiolar and perivascular cuffing is also seen during acute 
infection which is mainly T cell dominated154. The pneumonia is usually cleared around 
day 10 p.i. but latently infected cells can still be detected by in situ hybridization after 
this period269.
Through lymphatic drainage, the virus spreads further to the local lymph nodes, 
the mediastinal lymph nodes. Once in the mediastinal lymph nodes, MHV-68 infects B
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lymphocytes, macrophages and dendritic cells[34]. MHV-68 haematogenous spread 
also occurs during acute infection and virus can be detected in this phase in adrenal 
glands and heart25,270,271.
Next, further dissemination of infectious virus occurs in the spleen. As in the 
lymph node, infection of lymphocytes, macrophages and dendritic cells occurs in the 
spleen270,272'276, Secondary splenic and peripheral mononucleosis develops 276, similar 
to what occurs in EBV277. By the second to third week following infection, there is a 
transient splenomegaly and adenopathy, associated with a peak in latently infectious 
cells278. In general, after 28 days splenomegaly is no longer observed154. The virus then 
remains latent mostly in B cells of germinal centres and upon an immunosuppressive 
episode, reactivation occurs with initiation of lytic replication (Figure 1.7). The 
reactivation mechanism is not fully determined. Studies have found however that the 
immediate-early gene transcription necessary for reactivation is triggered by hypoxia 
and chemicals such as phorbol esters and sodium butyrate can induce it .
If an intraperitoneal route of infection is used there is a different cellular tropism. 
Lytic infection that follows the intraperitoneal route is established mostly in B cells, 
while latent infection is observed mostly in macrophages256.
32
Chapter 1 Introduction
Figure 1.7 Schematic representation of MHV-68 acute replication following intranasal 
infection.
•#
c-v
1. Following intranasal infection, 
high level viral lytic replication 
occurs in the pulmonary 
epithelium and mononuclear 
cells, mainly in macrophages. 
During this stage of acute 
replication there is an acute 
interstitial pneumonia.
2. Through lymphatic drainage, the 
virus spreads to mediastinal 
lymph nodes where MHV-68 
infects B lymphocytes, 
macrophages and dendritic cells.
3. Further dissemination of 
infectious virus occurs to the 
spleen with infection of 
lymphocytes, macrophages and 
dendritic cells. Secondary splenic 
and peripheral mononucleosis 
develops and there is a transient 
splenomegaly and adenopathy.
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1.3,2 Inflammatory response to infection
During acute infection, the pulmonary inflammatory infiltrate is initially mainly 
composed of macrophages. Macrophages are most numerous at day 3 p.i.164. After this 
time there is an increase in the number of CD8+ T cells (cytotoxic) which are highest in 
number at day 7 p.i.164,2681276. CD8+ T cell dominance is very closely related to the time 
when virus titres are highest in the lung (between day 5 and 7 p.i.)154. After the initial 
peak there is a gradual decrease in the presence of CD8+ T cells and expansion of these 
cells ceases by day 21 p.i. The decrease in CD8+ T cells is thought to be secondary to 
MHV-68 induced interference in MHC class I antigen presentation. Expression of K3, a 
MHV-68 early lytic protein, leads to the ubiquination of MHC class I proteins4042 and 
the transporter associated with antigen processing (TAP)42, 43 in infected cells. As a 
result of ubiquination, proteins are degraded through a proteosome-dependent 
mechanism. K3 also inhibits the expression of endogenous p53 in lytically infected 
cells. The decrease in CD8+ T cells is accompanied by a decrease in production of Bcl-2 
and IL-2, similar to what occurs during EBV infection and other viral infections. Bcl-2 
is necessary to prevent apoptosis and IL-2 is necessary for rapid expansion of CD8+ T 
cells when reinfection occurs.
In latent replication only a subset of genes are expressed including latency 
associated proteins. Latent replication is detected mainly in B cells and to a lesser extent 
in T cells, pulmonary epithelial cells, macrophages and dendritic cells. The latently
OnCl 7RRinfected cells are present in the spleen, lung, bone marrow and peritoneum ’
There is proliferation of B cells which is mainly CD4+ T cell mediated and leads to 
mononucleosis25,256,268,289. The B cells prime cytotoxic CD8+ T cell to respond to the 
latency associated proteins164. CD8+ T cells moderate latent infection but do not 
completely clear it ’ ’ . Latently infected mice exhibit antigen-specific CD 8+ T
cells with enhanced antiviral potential and a more rapid turnover. This has been related 
to low level sporadic antigenic stimulation during latent infection that does not cause 
severe deficits in the effector population. Expansion of CD8+ T cells however is 
maintained after day 21 p.i. in infected animals with the non-persistent MHV-68 ORE 
73 mutant virus . This indicates that the switch to latent replication is what triggers 
CD8+ T cells contraction.
34
Chapter 1 Introduction
In long term latency (after two months), the virus is foimd almost exclusively in B 
cells germinal centres (GC)270,275. B cells in GC can develop into memory B cells which 
have a long term survival and circulate systemically, ensuring viral long term survival 
and spread164.
1.3.3 MHV-68 and proliferation of lymphoreticular tissue
BALE [32 microglobulin deficient (p2m'/') mice developed atypical lymphoid 
hyperplasia (ALH) 6 to 12 months following intraperitoneal infection with MHV-6 8261. 
ALH was observed to consist of the abnormal expansion of plasmacytic CD138+ cells 
which preceded B cell lymphomas261. In ALH lesions, not all cells showed vtRNA 
expression indicating infection of all cells is not necessary for lesion development260,261, 
ALH development was related to v-cyclin, Mil (encoding v-Bcl-2) and Ml gene had a 
positive effect on inducing ALH on the contrary to ORF 74. This cell dominance is also 
observed in 35% of polymorphic post transplant lymphoproliferative disorder (PTLD) 
cases in humans292.
1.3.4 Wood mouse versus laboratory mouse strain infection
Most of the studies into the pathogenesis of MHV-68 have been undertaken using 
laboratory mice strains derived from Mus musculus . However, these studies may not 
necessarily represent what occurs during infection in the natural host. Notably, there 
have been few MHV-68 infection studies performed to date in natural hosts, such as the 
wood mouse (Apodemus sylvaticus)m. There are distinct differences in the MHV-68 
infection profile in the wood mouse and laboratory mice strains derived from Mus 
musculus such as the BALB/c mouse. In the wood mouse, there is less lytic replication 
but latency is more efficiently established5. Also, the infiltrate seen in the lung 
following infection is macrophage dominated. Furthermore, the lymphocytic infiltration 
is less intense and there is an increase in B cells and induced bronchial associated 
lymphoid tissue (iBALT ) formation154. The detection of vtRNA in B cells indicates 
latent replication occurs in these cells154. iBALT is structurally similar to secondary 
follicles in lymphoid tissues and is associated with inflammation/infection294. iBALT 
has been shown to be the main site where cells latently infected with MHV-68 reside in 
the lung of the wood mouse[2,3]. In BALB/c mice, MHV-68 infection is not associated
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with iBALT formation and the infiltrate seen in the lung shows a higher predominance 
of T cells5.
1.4 The protein of interest - MHV-68 Ml protein
The Ml gene is positioned between 2023 and 3282 base pairs of the MHV-68 
genome . Previous work found that Ml gene encodes a secreted protein . Little is 
known regarding the contribution of Ml in MHV-68 pathogenesis.
Genetically, Ml presents 25% homology (Figure 1.8) with MHV-68 M3 and M4 
gene, which encodes the abundant secretion of a chemokine binding protein81,163,269'295. 
Evidence suggests that the Ml protein shares functional similarities with the 
chemokine-binding proteins resulting from the closely related genes, M3 and M49, If 
M3 expression is inhibited in MHV-68 infection of wood mice, iBALT formation is no 
longer observed. Furthermore in the absence of M3 instead of a lymphocytic response 
which is B cell dominated, there is a relative increase in T cells5, 9. Quantification of 
Ml, M2, M3 and M4 expression in the lung of infected wood mice at day 7, 10,12 and 
14 p.i found Ml to be the protein with highest expression at 7 days p.i. (Figure 1.9)9 . 
This time also coincided with when Ml mRNA expression was highest9. At day 7 and 
day 14 p.i.. Ml was transcribed at a higher levels in wood mice than in BALB/c mice, 
the difference being most at day 7 p.i, [Hughes, DJ, unpublished] (Figure 1.10).
Ml also shares homology with poxvirus seipin (serine protease inhibitors) 
proteins163. However, the Ml sequence lacks the critical domains/residues for serpin 
activity.
Intranasal infection of inbred laboratory mice with vtRNAs and Ml gene knock­
out virus, found that in vitro replication and in vivo latency was still maintained8,296. 
This showed that Ml is not essential for latency establishment. In C57BL/6J- 
RagltmlMom infected intraperitoneally with MHV-68 with lacZ insert disrupting Ml 
ORF found Ml suppressed reactivation. Mice infected with the viral mutants had a 
fivefold increase in reactivation efficiency7. Ml suppression of viral reactivation occurs 
through activation of Vp4+ CD8+ T cells. Vp4+ CD8+ T cells resist functional 
exhaustion and consequently there is long term secretion of IFN-y6. These cells also 
secrete TNF-a and IL-2 in vitro191. The notion that Ml effect on reactivation is 
mediated through IFN-y increase is supported by the maintenance of Vp4+ CD8+T cell 
activation but not of Ml suppressive effect on reactivation in the infection of IFNyR'7'
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mice. Additionally, in the infection of IFNyR'^mice there are more extensive 
pathological changes including severe inflammation and fibrosis of several organs. 
Further studies in C57BL/6J using recombinant viruses with a deletion or a stop 
insertion in the Ml gene found persistent viral replication in the lungs during chronic 
infection. However this was not observed in all mice studied suggesting that viral 
replication occurs in a interrupted manner and not continuously297. Ml mediated 
activation of Vp4+ CDS’1- T cells, is not to a feature in MHV-68 infection of BALB/c 
mice297. The different effect of Ml on the activation of VP4+ CD8+ T cells is possibly 
related to the different genetic backgroimd of the mouse strains studied and different 
immune responses inherent to the host including bias in CD4+ T cell polarization. 
C57BL/6 have been described has having a Thl dominated response whilst BALB/c 
mice have a Th2 dominated response298"301.
During chronic infection of both C57BL/6 and BALB/c mice, impairment of Ml 
secretion led to an increase in latently infected IgD" B cells present in the spleen297. Ml 
effect in decreasing the presence of latently infected cells in chronic infection was 
hypothesized as a protective measure employed by the virus to avoid further 
pathological changes in the host such as lymphoproliferation.
In MHV-68 infection of IFNR'7" mice in there is extensive fibrosis in the lung at 2 
weeks p.i. and in mediastinal lymph nodes and spleen at 3 weeks p.i. The most severe 
fibrosis is seen at the peak of latent infection in the tissues described. If CD4* and 
CD8+cells were extracted prior to infection, there was no onset of the fibrosis214'216, 
indicating the role of these cells in the induction of fibrosis. The splenic fibrosis was 
related to alternative activation of macrophages with no change to classical activation of 
macrophages209. Taken together the IFN R'7' mice studies could suggest that Ml could 
modulate activation of macrophages and be involved in induction of fibrosis in 
laboratory mice strains.
1.5 This thesis
The aim of the present work is to determine the effect of Ml expression in MHV- 
68 infection. For this, in vitro and in vivo studies were performed using vMlstop virus 
and its genetically repaired counterpart, vMlrev virus. vMlstop virus is an MHV-68 
virus with an in-ffame stop codon in the Ml locus. The stop codon impairs expression 
of Ml without exerting interference with the remaining genome. The objective was to
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ascertain the influence of Ml in MHV-68 infection through comparison of infection in 
the presence or absence of Ml expression.
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Figure 1.9 Expression of A/7, M2, M3, M4 and ORF 50 in the woodmouse lung at day 
7,10,12 and 14 post intranasal infection with MHV-68.
Taken from9
Quantification performed by qRT-PCR. ORF50 assessed as a general reference for lytic-cycle 
gene expression. The copy numbers of individual viral-gene RNAs (as cDNAs) were 
normalized to those for cellular RPL8. Error bars represent the standard error of the mean 
from three wood mice per time point. Analysis of expression from the M1-M4 locus of 
infected wood mice. Ml was the protein with highest expression at 7 days p.i. and this was the 
timepoint when M1 transcript expression was the highest of all examined timepoints.
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Figure 1.10 Ml expression in the woodmouse and BALB/c mouse at day 7 and day 14 
post intranasal infection with MHV-68.
Quantification was performed by qRT-PCR. The copy numbers of individual viral-gene RNAs 
(as cDNAs) were normalized to those for cellular RPL8. Error bars represent the standard 
error of the mean from three wood mice pier time point. At day 7 and day 14 p.i., Ml was 
transcribed at a higher level in wood mice than in BALB/c mice, the difference being most at 
day 7 p.i.
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2. Materials and methods
2.1 Cell culture
The cell lines used in this study were BHK-21, ctpSVl, NIH 3T3 and MH-S. 
Baby hamster kidney cells (BHK-21) clone 13 is a cell line derived from the kidney 
cells of one day old hamsters302, ctpSVl, is a fibroblast transformed cell line derived 
from IFN-apR-/-129/Sv303 mouse embryos (Stewart JP, unpublished). NIH3T3 is a 
fibroblast cell line derived from the SV40 transformation of Swiss mouse embryo 
cells304. The MH-S alveolar macrophage cell line was obtained from ATCC, UK (CRL- 
2019). This cell line is an alveolar macrophage cell line derived by SV40 transformation 
of adherent macrophages from a BALB/c mouse. Alveolar macrophage morphology and 
phagocytic capacity is maintained. They are adherent, esterase positive and peroxidase 
negative. Lipopolysaccharide (LPS) treatment stimulates IL-1 production. The cells are 
capable of suppressing the in vitro plaque forming cell (PFC) response in a cell dose- 
dependent manner 305.
Cells were routinely grown in 75cm2 and 175cm2 vented tissue culture flasks 
(Iwaki) and 25 ml of growth medium. The growth medium varied with cell type (Table 
2.1). For passaging, the growth medium was discarded and the monolayer was washed 
three times with 5 mis of sterile PBS at 37°C. Cells were then incubated at 37°C with 5 
mis of 2.5% (v/v) trypsin (Gibco) and 0.02% (w/v) versene (Lonza) solution until they 
detached from the bottom of the flask, usually after 2 to 5 minutes. Then 5 mis of 
growth medium was added to the flask and vigorously pipetted to produce an even 
suspension. The cell suspension was centrifuged at 500 g for 3 min and the pellet was 
resuspended in 5 mis of growth medium. To assess the concentration of cells, 10 pi of 
the cell suspension was mixed with 90 pi of 0.04% (w/v) Trypan Blue (Sigma). The 
mixture was mixed vigorously and the concentration of cells determined by counting the 
cells present in 10 pi in a haematocytometer. Cells not stained by Trypan Blue were 
interpreted as having an intact cellular membrane and thus were deemed viable. During 
routine cellular passage, 1 ml of the resuspended cell pellet was placed into new flasks 
containing 20 ml of growth medium. The cells were grown at 37°C in an atmosphere of 
5% carbon dioxide until they reached subconfluency.
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Cell line BHK-21 apSVl NIH3T3 MH-S
Medium l,J GMEM DMEM DMEM RPMI
Calf serum 10% (v/v)
newborn
10% (v/v)
foetal
10% (v/v)
foetal
10% (v/v) foetal
L-glutamine ,3J 2mM 2mM 2mM 2mM
P/S 141 100 i.u/ml 100 i.u/ml 100 i.u/ml 100 i.u/ml
Tryptose phosphate
broth 1,1
10% (v/v)
Hepes llJ - - - lOmM
2-mercaptoethanol|5J - - - 0.05 mM
Sodium pyruvate ,IJ - - - ImM
Table 2.1 Growth media formulations used for the BHK-21, aflSYT, NIH3T3 and MH-S 
cell lines.
Abbreviations: GMEM: Glasgow minimal essential medium; DMEM: Dulbecco's Modified 
Eagles Medium; RPMI: Roswell Park Memorial Institute Medium; P/S: penicillin-streptomycin. 
[1]: Lonza; [2]: (Biowest); [3]: Invitrogen Life Technologies; [4]: Invitrogen Life Technologies; 
[5]: Sigma Aldrich; i.u.: international units
2.2 Virological techniques
2.2.1 The viruses
2.2.1.1 vMlstop and vMlrev viruses
The recombinant MHV-68 deficient in the Ml function [Ml knock-out virus 
(vMlstop)] and the marker rescue virus (vMlrev) were a kind gift from Dr B.M. Dutia 
(University of Edinburgh). The aim of the construction of the vMlstop virus was to 
insert a stop codon and diagnostic restriction site close to the start codon of Ml ORE at 
position 2023.
Two PCR fragments were prepared with stop/Hpal site at the 3’ and 5’ ends 
respectively. They were then combined and amplification of DNA was performed in a 
second PCR to create a mutant PCR fragment (Figure 2.1). The 5’ PCR product has a 
StuI site at the 5’end, while the 3’ product has a BsaBI site at the 3’end. The mutant 
fragments were cloned into MHV-68 HindE clone (106-626Int) using StuI and BsaBI. 
The HindE fragment mutant was then subcloned into the pST76K_SR shuttle vector. 
The shuttle vector was ultimately transformed into DH10B containing MHV-68 BAC 
and mutants were selected by PCR. Primers used in PCR reactions are shown in Figure
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2.2. Virus stocks were produced by transfection of BAC DNA into BHK-21 cells. BAC 
sequences were excised from the reconstituted virus by passage through mouse NIH3T3 
cells expressing ere recombinase306.
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M1 StopforA: CAG TC GCT CTC AG
MlStoprevA3: GCC AG
Hpal
C I AC' ACG TTA ACY ACCi CC1 GCA TGG TCG
CCG CTG CTC
MlStopforB2
Hpal
GCG TAG TTA ACG TGT AC |: TGG CCA CCT TAT GCC
TTC
M1 StoprevB GAG ATC CA C GT
Figure 2.2 Primers used in the construction of the vMlstop virus. 
Boxed areas are representative of restriction digest sites
2.2.1.1.1 Verification of deletion in the vMlstop virus stocks
In order to confirm the state of deletion in the various virus prepared stocks, viral 
DNA was extracted from the virus stocks and PCR was performed using Ml primers. 
The reaction mix consisted of: 0.5 pM forward and reverse primers (MWG Biotech), 
0.25mM dATP, dTTP, dCTP and dGTP (GE Healthcare), 1.5 mM Mg Cl2, 20 mM Tris- 
HC1 (pH 8.4), 50 mM KC1 (Invitrogen Life Technologies) and diH2G to a final volume 
of 50pl. To the reaction mix, lOpl of the virus stock was added followed by 2pg of 
Proteinase K (Invitrogen Life Technologies). The mixture was then incubated at 55°C 
for 20 minutes. To deactivate the Proteinase K, there was a further incubation at 95°C 
for 10 minutes. To this mixture was added 1 U of Taq DNA Polymerase Platinum and 
RT-PCR was performed using a previously described protocol (Section 2.2.2). PCR 
products were then analysed by gel electrophoresis to determine the size of the PCR 
products.
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2.2.1.2 LHagfp
LHagfp vims was a kind gift from Dr B.M. Dutia (University of Edinburgh). 
LliAgfp virus is a MHV-68 virus which was constructed by co-transfection of MHV-68 
viral DNA with DNA containing a human cytomegalovirus (HCMV) immediate-early 
promoter-driven green fluorescent protein cassette (CMV-GFP) into BHK cells215.
2.2.1.3 MHV-68
MHV-68 working stocks were constituted of sub-master stocks of MHV-68 clone 
g2.425.
2.2.2 Preparation of virus stocks
On the day prior to infection, 106 apSVl cells per flask were seeded onto 150 cm2 
flasks. The cells were infected with virus at a multiplicity of infection of 0.05 PFU/cell. 
The inoculum volume was 5 ml per flask. Infected cells were then incubated for 1.5 
horns at 37° C. After this period, 25 ml of medium (formula mentioned in section 2,1) 
was added per flask. Infected cells were observed daily and incubated at 37° C for four 
to six days, until 100% cytopathic effect (CPE) was seen.
Cells were harvested and a pellet was obtained by centrifugation at 1000 g at 4° C 
for 20 minutes. The supernatant was removed and all the following steps were 
performed on ice. The lowest possible volume of PBS was used to resuspend the pellet 
present in one centrifuge tube and the solution was then transferred to the next 
centrifuge tube and so forth until all pellets were resuspended. Then the total volume 
resulting from the pellet resuspension was introduced into a previously cooled douncer. 
The contents were crushed using the dounce homogeniser (to assure breakage of cell 
walls and release of intracellular viral particles). The crushed mixture was then 
centrifuged at 2000 g at 4° C for 20 minutes. The supernatant solution was then 
removed and kept in a separate centrifuge tube. The remaining pellet was resuspended 
in the smallest volume possible (one to two ml) of PBS solution. The solution was 
transferred once again into the douncer and crushing of contents was repeated. 
Centrifugation of resuspension solution was performed at 2000 g at 4° C for 20 minutes. 
Finally, the supernatant was removed, mixed with the previously separated supernatant 
and distributed into cryovials to be stored at -80°C.
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2.2.3 Virus stock titration
Titration was performed using 6-welled plates (Iwaki). On the day prior to 
infection, plates were seeded with 106NIH3T3 cells per plate. Serial 10-fold dilutions of 
the virus preparation were performed to obtain 10 ' to 10u dilutions in 1 ml of media. 
Each diluted virus preparation was then introduced into the respective well. Infected cell 
plates were incubated for one hour at 37°C. After the incubation period, the inoculum 
was removed and 4 ml of medium was introduced. Infected cell plates were then 
incubated for four days at 37°C.
After four days, the cells were fixed by introduction of 4% (v/v) formal saline for 
30 minutes into each well. After fixation, infected cells were stained with 0.1% (w/v) 
toluidine blue for 30 min or overnight if solution old or reused. Once dried, cell plates 
were analyzed under the microscope for viral plaques (Figure 2.3).
Figure 2.3 Plaque forming unit in NIH3T3 cells infected with MHV-68.
Magnification: 40 x 0.45
2.2.4 Multi-step growth curve
The multi-step growth curve was performed using 24-welled plates (Iwaki). On 
the day prior to infection, 24 well cell plates were seeded with 1x106NIH3T3 cells per 
plate. Cells were infected using a multiplicity of infection (MOI) of 0.01 PFU/cell in 
250pl of media per well and incubated for 1 hour at 37 °C. To calculate the MOI, cells 
were considered to have divided at least once overnight. After this, an inoculum was 
removed and 1 ml per well of citrate buffer (135 mM NaCl, 10 mM KC1, 40 mM citric 
acid (pH 3.0))307 was introduced for one minute to kill any unbound virus. Cells were 
then washed three times with DMEM medium with 10% (v/v) calf serum (Biowest),
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2mM L- glutamine (Invitrogen Life Technologies) and 100 i.u/ml P/S (Invitrogen Life 
Technologies). Cells were incubated in 1 ml of DMEM at 37 °C. A baseline sample was 
taken at 0 hours by scraping cells and removing the medium completely and cell/virus 
mixture. Five more samples were taken at six hour intervals. Then four more samples 
were taken at 24 hour intervals. Samples were frozen at -80 °C until being titrated. Prior 
to titration (Section 2.2.3) samples were freeze-thawed three times (to cause cell 
breakage and release of virus particles) and centrifuged at 2000 g for five minutes.
2.2.5 One-step growth curve
One-step growth curves were performed using 24-welled plates (Iwaki). On the 
day prior to infection, 2xl06NIH3T3 cells per plate were used when NIH3T3 cells were 
employed. However, 4xl06NIH3T3 cells per plate were utilised when MH-S cells were 
used. NIH3T3 cells were infected at an MOI of 5 and MH-S cells were infected at an 
MOI of 10. The infection protocol was identical as mentioned for the multi-step growth 
curve (Section 2.2.4) apart from the incubation time and media used when the study was 
performed in MH-S cells. In MH-S cells, the incubation with the inoculum was for two 
hours and the media used was RPMI with 10% (v/v) foetal calf serum (Biowest), 2mM 
L-glutamine (Invitrogen Life Technologies), 100 i.u/ml P /S (Invitrogen Life 
Technologies), lOmM Hepes (Lonza), 0.05 mM2-mercaptoethanol (Sigma Aldrich) and 
ImM sodium pyruvate (Lonza).
The samples corresponding to 0 hours were taken at this time point by scraping 
cells and removing the medium completely and cell/virus mixture. Six more samples 
were taken at four hour intervals. Then, two samples were taken at six hour intervals. 
Finally, three more samples were taken at 12 hour intervals.
Samples were stored at -80C until titration of virus stock was performed following 
a protocol described in Section 2,2.3.
2.2.6 Preparation of cell pellets for transmission electron microscopy
Infected cell pellets were produced by seeding 75 cm2 flasks (Iwaki) at an MOI of 
5 PFU/cell. After 48 hours, cells were detached by trypsinisation and a pellet was 
obtained by centrifugation at 800 g for five minutes. The pellet was resuspended in 
2.5% (v/v) glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) and centrifuged
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at 800 g for three minutes (reagents: TAAB Laboratories). The resulting pellet was 
resuspended in the fixative 4% (v/v) paraformaldehyde and 2.5% (v/v/) glutaraldehyde 
in 0.1 M sodium cacodylate buffer) and kept at -4° C imtil further processing.
Further processing consisted of washing of the pellets with 0.1M sodium 
cacodylate buffer and fixation in 1 % (v/v) osmium tetroxide for 90 minutes. A second 
wash using distilled water was performed. The pellets were then stained en bloc with 
2% (v/v) uranyl acetate in 0.69% (v/v) maleic acid for 90 minutes, dehydrated in 
incrementing concentrations of ethanol (50, 70, 90, 100%) (v/v) and finally in 100% 
(v/v) acetone. Next the pellets were infiltrated in epoxy at incrementing concentrations 
of resimacetone (25:75, 50:50, 75:25) (w/v). This was performed for 10 minutes, two 
times, at each concentration and finally pellets were infiltrated in 100% epoxy resin (3 x 
10 minutes) resin in acetone. Pellets were added to embedding capsules and left 
overnight in fresh resin at 60 °C to polymerise. In ordinary preparations of samples for 
ultrastructural examination, the next step consisted of the processing of semi-thin 
sections (0.5 pm). Semi-thin sections were cut using an ultramicrotome (Reichert-Jung 
Ultracut) with a diamond knife (Diatome Ltd.) and stained with 0,1 % (w/v) toluidine 
blue to enable examination by light microscopy and selection of areas of interest. 
However, the infected cell pellets were too small and friable. Following embedding, the 
next processing step was the production of ultrathin sections (60 nm) for ultrastructural 
examination. Ultrathin sections were cut using a diamond knife, mounted on copper 
grids, stained with Reynold’s lead citrate. Ultrastructural examination was performed on 
a H600 transmission electron microscope (Hitachi) and on a FBI EM208S transmission 
electron microscope (Philips).
2.2.7 Extraction of genomic DNA from virus stocks
100 pi of virus preparation was added to 100 pi of PBS. To enable digestion, 20 
pi of proteinase K was added along with 200 pi of lysis buffer (DNeasy Blood & Tissue 
Kit, Qiagen). The solution was then mixed by agitation on a vortex for 15 seconds and 
centrifuged at 20,000 g for 15 seconds, before being incubated in a water bath at 56°C 
for 10 minutes. To stop the digestion, 230 pi of molecular grade ethanol (Bhd) was 
added, the solution was mixed by agitation on a vortex for 15 seconds and centrifuged at 
10,000 g for 10 seconds. The final mixture was then placed in a spin column and 
centrifuged at 8000 g for one minute. Wash buffer AW1 (500pl) was added to the
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column that was respim at 8000 g for one minute. Buffer AW2 (500j.il) was also added 
to the column and was respim at 11,000 g for three minutes. The spin column was then 
cleared by an extra spin at 14,000 g for one minute. The DNA was eluted in 60j.il of 
Buffer AE, which was added to the column, left at room temperature for ten minutes 
and then centrifuged at 6000 g for one minute. The flowthrough was stored at -20oC 
until further use.
2.2.8 Optimisation of MH-S cell line infection
On the day prior to infection, cells were seeded 12 hours prior to infection in 24 
well plates, at increasing cellular densities ranging from 106 to 4 x 106 cells per well. 
LHAgfp virus was diluted in 200 pi of inoculum as to have a MOI of 1, 5 or 10 PFU/cell 
and incubated for a period of one, two or three hours. Plates were then washed with PBS 
or not washed with PBS and RPMI media was added to have 1 ml of media overlaying 
cells. Fluorescence was measured to ascertain the percentage of cells infected. NIH3T3 
and MH-S cell infection experiments were performed in parallel since NIH3T3 cells are 
more permissive to MHV-68 in vitro infection and so were a positive control of 
infection.
2.3 In vivo studies 
2.3.1 Infection of mice
All wood mice used in these studies were from a laboratory-bred colony 
maintained at the Leahurst campus, School of Veterinary Science, University of 
Liverpool308, 309 under semi-barrier conditions. The colony was created by J. Clarke in 
1995 and mice were descendents from captive-bred colonies from the Department of 
Zoology, University of Oxford. Introduction of animals from the wild was done 
intermittently. Mice were tested (see appendix 1 - Figure 5,1) for the major infections of 
laboratory rodents (Harlan United Kingdom Technical Services, Loughborough, United 
Kingdom) and tested negative for these infections. MHV-68 infection has not been 
detected in this colony by either serology or PCR analysis19. BALB/c mice were 
purchased from Bantin and Kingman (Hull, United Kingdom),
Animals were anesthetized with isoflurane and infected intranasally with the virus 
solution (40 pi) which contained 4x 105 PFU diluted in sterile phosphate-buffered saline
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(PBS). For each time point studied, three animals were infected. The timepoints studied 
were day 3, 7, 14 and 28 p.L. Animals were culled according to local and national 
schedule I requirements and all procedures were carried out in compliance with the 
Animal Scientific Procedures Act (1986).
2.3.2 Collection of tissue samples
Wood mice were humanely euthanized by cervical dislocation after sedation and 
anaesthesia with isofluorane. Spleen and lungs with trachea, thymus, mediastinal and 
bronchial lymph nodes and brain were collected. Half of the spleen and the left lung 
lobe were introduced separately into cryovials (Nunc), immersed in liquid nitrogen and 
then stored at -80°C. A longitudinal third of the right middle and accessory lung lobes 
and approximately a third of the distal 6th of the right distal lung lobe were immersed in 
Optimal Cutting Temperature (OCT) embedding medium (Raymond A Lamb 
Laboratory supplies) within an aluminium foil tube that was then frozen in isopentane 
cooled in a bath of liquid nitrogen, (see Figure 2.4 for location of lobes). A longitudinal 
third of the right middle and accessory lung lobes, approximately a third of the distal 6th 
of the right distal lung lobe and part of the mediastinal and bronchial lymph nodes were 
collected and immersed in 4% (v/v) PFA + 2.5% (v/v) glutamine in 0.1M sodium 
cacodylate buffer for examination by transmission electron microscopy. The remaining 
lung, thymus, meadiastinal and bronchial lymph nodes, spleen and brain were 
immediately immersed in 4% (v/v) paraformaldehyde. In a separate pot and after 
opening of the skull and removal of the skin, the remaining animal tissues were also 
immersed in 4% (v/v) paraformaldehyde.
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Figure 2.4 Wood mouse lung.
Abbreviations: R: rostral; D: distal; LL: left lung lobe; RC: right caudal lung lobe; RM: right 
middle lung lobe; AL: Accessory lung lobe; RCr: right cranial lung lobe
2.3.3 Preparation of tissues for histological examination
Lung, thymus, mediastinal, bronchial lymph nodes, spleen and brain were 
collected from study animals and fixed overnight in 4% (w/v) buffered 
paraformaldehyde (pH 7.4). On the day following sampling, tissues were routinely 
embedded in paraffin wax. Sections (3-5 pm) were prepared and placed on glass slides. 
In the case of the nasal cavity, on the day following sampling the unskinned nasal cavity 
was cut sequentially using a diamond saw into sections (3-5 pm) and left in 10% (w/v) 
EDTA solution (pH7.4), for one week prior to embedding in paraffin.
For histopathological examination purposes, the tissues were laid on plain glass 
slides (ColourSlides, Solmedia Laboratory Supplies). Paraffin embedded sections used 
for immunohistology examination and in situ hybridisation were laid on adhesive- 
coated glass slides (Polysine TM, VWR International). Sections were dewaxed by 
immersion in xylene for 10 minutes. Rehydration of samples was then performed by 
incubation for three minutes, twice in isopropanol and once in 96% (v/v) ethanol. 
Dewaxed sections were stained with haematoxylin-eosin (HE).
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2.3,4 Cryosectioning
Tissue embedded in OCT was sectioned into 4-8 pm sections using a Leica 
CM1900UV cryostat with the cryochamber at -30°C. The cut sections were mounted on 
adhesive coated slides (Polysine TM, VWR International). Sections were allowed to dry 
on the slides at room temperature for 10 minutes. Ice cold acetone was applied to the 
sections and they were allowed to dry at 4°C. Tissues were then stored at -80DC until 
further processed.
2.3.5 Immimohistology
Immunohistology was performed by the Histology Laboratory, Veterinary 
Laboratory Services, School of Veterinary Science, University of Liverpool.
Detection of CD4 and CDS antigens was performed on frozen tissue sections 
fixed in acetone. Detection of the remaining antigens was performed on tissue sections 
embedded in paraffin and fixed in 4 % (v/v) paraformaldehyde. The detection method of 
choice was the peroxidase antiperoxidase method (PAP) technique 3I0.
2.3.5.1 Immunohistology of acetone fixed sections
Acetone fixed sections were thawed for two hours at room temperature. For the 
purpose of endogenous peroxidase inactivation, sections were incubated in methanol 
with 0.5 % (v/v) H2O2 at room temperature (Perhydrol 30 %, Fisher Scientific), for 15 
minutes. Sections were then washed in Tris-Buffered Saline (TBS) for 5 minutes and 
placed in coverplates in Sequenza racks (Thermo Shandon). See Section 2.3.5.2 for 
details of further processing.
2.3.5.2 Immunohistology of paraffin embedded sections
Paraffin embedded sections were dewaxed by immersion in xylene for 10 
minutes. Tissue sections were rehydrated by sequentially immersing the sections twice 
in 100 % (v/v) ethanol for three minutes and then once in 96 % (v/v) ethanol for three 
minutes. For the purpose of endogenous peroxidase inactivation, sections were 
incubated in methanol with 0.5 % (v/v) diH202 at room temperature (Perhydrol 30 %, 
Fisher Scientific), for 30 minutes. The sections were washed twice in TBS. What 
follows is the description of the protocol for MHV-68 detection. However, there were 
some variations to this method depending on the used antibodies (see Table 2.3). Pre-
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treatment was performed by incubation in lOmM citrate buffer (0.9 % (v/v) 0.1 M citric 
acid, 1 % (v/v) 0.1M sodium acetate (pH 6.0) for 25 to 30 minutes at 97 °C.
For the remainder of the experiment, slides were placed in coverplates in 
Sequenza racks (Thermo Shandon). Tissues were washed with TBS (pH 7.4). In order to 
block non-specific binding by the anti-serum, tissues were incubated with 50 % (v/v) 
swine serum in TBS for 10 minutes at room temperature. This was followed by 
incubation with primary antibody diluted in 20 % (v/v) swine serum in TBS for 15 to 18 
horns at 4 °C (see Table 2.3). The tissues were then washed with TBS and incubated 
with 1:100 dilution of swine antirabbit IgG in 20 % (v/v) swine serum (Stratech 
Scientific Ltd., Vector Laboratories, Peterborough) in TBS for 30 minutes at room 
temperature. A second wash was done using TBS alone. The tissues were then 
incubated with 1:100 PAP-rabbit (Stratech Scientific Ltd.) in TBS at room temperature 
for 30 minutes. Slides were then washed in TBS and removed from the coverplates. 
Finally, tissues were incubated with 3,3'-diaminobenzidine tetrahydrochloride (DAB, 
Sigma-Aldrich Co. Ltd.) and 0.01 % (v/v) diH202 in 0.1 M imidazole buffer (0.1 M 
imidazole, 0.1 M HC1 (pH 7.1)) at room temperature for 10 minutes and washed three 
times with TBS and once with distilled water.
In order to increase the contrast between tissue sections and to aid visual 
examination, counterstaining with Papanicolaou’s special haematoxylin was performed. 
In all experiments, a positive and a negative control were included as to assess 
specificity and sensitivity of the reactions and validate the experiment.
2.3.6 Preparation of tissues for transmission electron microscopy
See section 2.2.7 for details of processing.
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Antigen Pre­
treatment
Blocking Primary
antibody
Secondary
antibody
Detection
method
MuHV-4 * Citrate 
buffer 
pH 6.0
50 % (v/v) 
swine 
serum in 
TBS
PAb rabbit 
anti-MHV- 
68 at 1:2000
Swine anti­
rabbit IgG 
1:100(1]
PAP; Rabbit 
1:100 
[1]
Lysozyme 
(macrophage 
s, and DCs)
Protease 50 % (v/v) 
swine 
serum in 
TBS
PAb rabbit 
anti-human 
lysozyme 
1:800(1]
Swine anti­
rabbit
1:100(1]
PAP; Rabbit 
1:100 
[1]
CD45R 
(B cells)
Citrate 
buffer 
pH 6.0
Undiluted
horse
serum
MAb rat 
anti-mouse 
(B220-Ly5) 
1:1000 (31
Biotinylated 
rabbit anti-rat 
IgG 1:100 
[2]
ABC [2]
CD3*
(T cells)
Protease 50 % (v/v) 
swine 
serum in 
TBS
PAb human 
anti-CD3 
Pre-di luted 
[1]
Swine anti- 
rabbit IgG 
1:100(1]
PAP; Rabbit 
1:100(1]
TNF-a
(Cytokine)
None Undiluted
rabbit
serum
PAb goat 
anti-mouse- 
TNF-a [4]
Rabbit anti­
goat IgG
1:100 [2]
ABC [2]
CD4
(helper T 
cells)
None Undiluted
horse
serum
MAb rat 
anti-mouse 
CD4 [3] 
diluted in
10% rabbit 
serum &
2.5% mouse 
serum)
Rabbit anti-rat 
IgG
1:100 [2]
ABC [2]
CDS
(cytotoxic
T cells)
None Undiluted
horse
serum
MAb rat 
anti-mouse 
CD4 [3] 
diluted in
10% rabbit 
serum &
2.5% mouse
serum
Rabbit anti-rat 
IgG
1:100 [2]
ABC
[2]
SP-C
(typell
pneumocytes)
None 20% (v/v) 
swine 
serum in 
TBST
PoAb rabbit 
anti SP-C [4] 
1:50
Swine anti­
rabbit [1]
1:100
PAP Rabbit 
[5] 1:250
IFN-y Citrate 
buffer 
pH 6.0
Goat
Serum
PAb rabbit 
Polyclonal 
[4] 1:100
Goat anti
Rabbit 1:100 
[2]
ABC
[2]
Table 2.2 Specific treatments used in immunohistology.
MAb:Monoclonal antibody; PAb: Polyclonal antibody; [1]: Dako; [2]: Vector Laboratories; 
[3]: Southern Biotech; [4]: Santa Cruz Biotech; [5]: Covance
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2.4 Molecular biology techniques
2.4.1 Extraction of genomic DNA from tissues
Lung and splenic tissue (25 mg) from infected mice, was cut into small fragments 
and placed in a 2 ml centrifuge tube with 180 pi of ATL buffer (DNAeasy Qiagen kit, 
Qiagen). Proteinase K (20pl) was then added to the mixture and was mixed by agitation 
on a vortex mixer. The sample was then incubated overnight in a water bath at 56 °C to 
enable frill digestion. The next day, the mixture was centrifuged in a fast spin cycle at 
20,000 g and then 200 pi of AL buffer (Qiagen) was added. The solution was mixed by 
pulse-vortexing for 15 seconds and incubated for 10 minutes in a water bath at 70 °C. 
Next, 200pl of molecular grade ethanol (Bhd) was added and mixed by pulse vortexing, 
followed by fast spin centrifugation at 20,000 g. The mixture was then placed in a spin 
column and centrifuged at 6000 g for one minute. Buffer AW1 (500pl) (Qiagen) was 
added to the column that was centrifuged at 6000 g for 1 minute. Buffer AW2 (500pl) 
(Qiagen) was then added to the column that was respun at 6000 g for one minute. 
Finally, 200pl of buffer AE (Qiagen) was added and the tube was left at room 
temperature for ten minutes before being centrifuged at 6000 g for one minute. The 
flowthrough was stored at -20°C until further use.
2.4.2 Reverse transcriptase PCR (RT- PCR)
All RT-PCR and quantitative PCR (qPCR) reaction mixtures were prepared in a 
“PCR clean room” in a Captair Bio hood® (Erlab) with ultraviolet light. All used 
plastics and equipment were treated by UV light radiation for a minimum of 10 minutes 
prior to the experiment being performed to remove any residual nucleic acids.
DNA concentration was measured using a Nano drop (Thermo scientific) 
spectrophotometer and 200 ng was diluted in 8 pi of distilled water (ditLO). In all 
experiments a test sample was included where instead of DNA, the equivalent volume 
of water was used in order to assess if there was contamination of reaction mix or water.
The RT-PCR reaction was performed in a Thermo Hybaid MBS thermo cycler 
(Thermo Electron Corporation). Reactions were performed in 0.2 ml thin walled tubes 
(Bioplastics). The reaction mix was composed of: 0.5 pM forward and reverse primers, 
0.25mM dATP, dTTP, dCTP and dGTP (GE Healthcare), 1.5 mM Mg C12, 20 mM 
Tris-HCl (pH 8.4), 50 mM KC1, 1 U of Platinum Taq DNA Polymerase (Invitrogen Life 
Technologies), 20 pg/ml of acetylated BSA (Promega), 0.15% (v/v) Triton X-100 and 
diH20 to make up the final volume to 12 pi.
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The cycling parameters used were 94 °C for 90 seconds; followed by the 
annealing step for 20 seconds, which was dependent on the primer set chosen (Table 
2.3); and 72 °C for 2 minutes. Cycles were repeated 35 times. There was a final 
extension period at 72 °C for 7 minutes and samples were maintained at 4°C.
2.4.3 Quantitative polymerase chain reaction (qPCR)
Amplification of DNA for qPCR was performed in an Opticon Monitor 2 (bio­
rad) real-time PCR machine. The qPCR reaction mix was composed of: 0,5 pM forward 
and reverse primers, 0.25mM dATP, dTTP, dCTP and dGTP (GE Healthcare), 1.5 mM 
Mg C12, 20 mM Tris-HCl (pH 8.4), 50 mM KC1 and 1 U of Platinum Taq DNA 
Polymerase (Invitrogen Life Technologies), 20 pg/ml of Acetylated BSA (Promega), 
0,15% (v/v) Triton X-100, 0.5x Sybr Green (Lamb Bioscience) and diH20 to a final 
volume of 12 pi. DNA concentration of samples to be tested was detennined as 
described in Section 2.4.1. In all experiments a test sample was included where instead 
of DNA, the equivalent volume of water was used in order to assess if there was 
contamination of reaction mix or water.
The cycling parameters used were: a hot start at 94 °C for 10 minutes followed by 
either 35 or 40 cycles of amplification. The cycling parameters used were dependent on 
the experiment type. Where the target DNA was found to be higher, as in viral genomic 
DNA experiments, 35 cycles of amplification were performed. Where the target DNA 
was found to be lower, as in the quantification of cytokine expression, 40 cycles of 
amplification were performed.
The amplification cycles consisted of a DNA denaturation step at 94 °C for 10 
seconds followed by an annealing step. The annealing temperature chosen was 
dependent on the primer sets used (Table 2.3). The annealing temperature was 
maintained for 20 seconds and followed by an extension period at 72 °C for 15 seconds. 
A step at 75 °C for 1 second was included to melt off possible primer-dimers, before the 
plate was read. At the end a melting curve analysis was performed between 65 °C and 
95 °C with 0.2 °C increments every one second.
Where necessary, primer optimization was performed using the thermal gradient 
feature in the PCR machine to evaluate which was the optimal annealing temperature. 
The protocol used was decided based on the lowest cycle threshold (Ct) value obtained 
in the quantification curve, without evidence of primer-dimer formation in the tested 
sample. The latter was confirmed by checking the size of the PCR product by agar gel
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electrophoresis. This was especially important because the used primers for cytokine 
expression studies were designed against laboratory mouse strain sequence data. Even 
though in the wood mouse, the species studied, a high degree of similarity is assumed, it 
was necessary to confirm this. Primer specificity was confirmed by gel electrophoresis 
of qPCR products
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Primer set Sequence Annealing
temperature
Product
size
L89
(MWG
Biotech)
F: 5’- CAGTGAATATCGGCAATGTnTG-3'
R: 5’- TTCACTCGAGTCTTCTTGGTCTC-3'
60 *C 163 bp
L8 intv*
(Sigma
Aldrich)
F: 5’- ACAGAGCCGTTGTTGGTGTTGT-S'
R: 5’- CAGTTCCTCTTTGCCTTGTACT-3'
60 *C 100 bp
gpl509 (MWG
Biotech)
F: 5’CTACTTCTTCATCGGACGCT-3'
R: 5’CGGGATCTGTCGGACTGT-3'
60 ’C 159 bp
ORF 73 F: 5 ’-ATGGCTGCTGGTTTGTTGAAGC -3'
R: 5’- CCACATCCCCACCGACTAC -3
60 #C 88 bp
Ml* (MWG 
Biotech)
F: 5’-TTGTAAGGGTACTCTCATCACC -3'
R: 5’- TAGAGGCGCAGCTGTAGATG -3'
60 *C 1726
bp
Ml
(MWG
Biotech)
F: 5’-GACTGCCCTTGTCACTTTTC-3'
F: 5’-CCAGGTAAGAGATCCTGTGT-3'
60 °C 127 bp
TNF-a (Sigma 
Aldrich)
F: 5’-CAC CAC CAT CAA GGA CTC A A3'
R: 5’-GAC AGA GGC AAC CTG ACC AC-3'
60 *C 100 bp
IFN-y3"
(Sigma
Aldrich)
F: 5’- TAGCTCTGAGACAATGAACGCTAC -3'
R: 5’- GTGATTCAATGACGCTTATGTTGT -3'
62 *C 302 bp
IL-1031^
(Sigma
Aldrich)
F: 5’- TTTAAGGGTTACTTGGGTTGC-3'
R: 5’- TCAAATGCTCCTTGATTTCTG-3'
60 *C 120bp
MIPl-a313
(Sigma
Aldrich)
F: 5'-GCCCTTGCTGTTCTTCTCTGT-3' 
R:5'-GGCAATCAGTTCCAGGTCAGT—3'
60 *C 258 bp
MIPl-p514
(Sigma
Aldrich)
F: 5'-CCTGACCAAAAGAGGCAGAc-3'
R: 5'-GAGGAGGCCTCTCCTGAAGT—3'
60 *C 134 bp
Arginase I146
(Sigma
Aldrich)
F: 5' -TTGCGAGACGTAGACCCTGG-3'
R: 5'- C A A AGCTC AGGTG AATCGGC-3'
60 *C 160 bp
iNOS146
(Sigma
Aldrich)
F: 5 ' -GCCACCAACAATGGCAACA—3'
R: 5 ' -CGTACCGGATGAGCTGTGAATT-3 '
60 *C 103 bp
TGF-p3 2
(Sigma
Aldrich)
F: 5’- TCAGCTCCACAGAGAAGAACTG -3
R: 5’- AAGTTGGCATGGTAGCCCTTG -3’
60 *C 106 bp
Rantes3 5
(Sigma
Aldrich)
F: 5'-AAGATCTCTGCAGCTGCCCTC-3'
R: 5'-TTGAACCCACTTCTTCTGTGG—3'
65 *C 243 bp
Table 2.3 List of used primers in PCR reactions
Footnotes: * refers to primers only used in RT-PCR reactions; **refers to sequence of 
ribosomal protein mRNA, but these primers do not contain the intron sequences to enable 
specificity towards cDNA yielded from RNA and not genomic DNA.
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2.4.3.1 Establishment of qPCR standard for assessment of viral load
To assess viral load, PCR-amplification of vgpl50, a viral glycoprotein, was 
performed. To normalize the input DNA between different samples, amplification of 
RPL8, a ribosomal protein, was performed within the same experiment.
To quantify the DNA amplified, serial dilutions (from 10 to 10 copy numbers) of 
known plasmid concentrations containing the genes of interest were performed. The 
plasmid concentration was assessed by the measurement of the absorbance using a 
nano drop and the known molecular weight of the plasmid plus gene insert using the 
equation on Figure 2.5
Molecular weight (Da)=:(bp of plasmid + insert)(330 Da x 2 nucleotide per bp)
Molecular weight of 1 Copy number =
Molecular weight in Daltons 
Avogrado's number
Avogrado's number = 6.02214199 x 1023
Concentration of plasmid (copies/pl) =
Absorbance (g/pl)
molecular weight of 1 copy number
Figure 2.5 Equation used to calculate the plasmid concentration
Avogadro’s number represents the number of protons present in one mole and 330 Da is the 
weight in Daltons of a single nucleotide.
2.4.3.2 Analysis of qPCR results
Analysis of the qPCR results was based on the fluorescence measured at each 
cycle. In the case of the samples of known concentrations, these measurements enabled 
the construction of standard curves.
In order to assess whether the standard curves were acceptable, a straight line was 
drawn crossing the curves Ct values (threshold line) at a point where the magnitude of 
the signal is higher than the background and increases exponentially (Figure 2.6 A).
Using the Ct value and the base 10 logarithm of the initial copy numbers, a 
straight line was automatically plotted, which is the standard graph plot (Figure 2.6 B). 
In order to further verify the correct positioning of the Ct line, the y and the r values
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yielded from this plot were used. Y represents the line equation: y = mx+b where m is 
the slope and b the y-intercept and it should be close to -0.3 when perfect doubling has 
occurred. On the other hand, r (square of correlation coefficient), indicates the 
proximity of the data points to the regression line and it should be close to 1, optimally 
greater than 0.990.
Melting curve analysis (Figure 2.7) was also performed on all reactions, including 
test reactions, and examined for abnormal peaks indicative of primer-dimer complex 
formation. Also, melting temperatures were examined and were accepted only if they 
were in the region of 86° for RPL8 and 82° for gpl 50 primed reactions.
The efficiency of qPCR reactions was also monitored. Efficiencies were accepted 
when equal or greater than 70%, the optimal being 100%. DNA quantification of test 
samples was based on a comparison of their Ct values and those of the standard curves.
To ensure that the copy number retrieved for the target gene referred to the same 
DNA loaded into the reaction, the housekeeping gene values were used as calibrators of 
input DNA. The correction value was determined by dividing by the lowest copy 
number of the reference gene. All the values obtained for the gene of interest were then 
divided by the corresponding correction value.
When standard curves were not available analysis of qPCR results was performed 
using the Pfaffl equation316 represented in the Figure 2.8.
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A B
Figure 2.6 Left: Example of a gplSO standard curves.
A: Fluorescence curves of plasmids at different concentrations. The dilutions of plasmid used 
were sequential tenfold dilutions from 103(red line in A) until 108 (light blue line in A) ; 
Threshold represented by dashed line; B: Standard curve line equation with r2 value on top. Y 
axis represents fluorescence measured and X axis represents cycle numbers
Figure 2.7 Melting curve of the standards represented in Figure 2.6. Y axis represents 
fluorescence measured and X axis represents temperature in °C.
(£ target geneY cp (control-sample)
Ratio =-------------------------------------------------
(F reference geneY CP (control~samPle)
Figure 2.8 Pfafl equation.
Footnotes: (E) refers to mean of reaction efficiencies in samples examined
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2.4,4 Agarose gel electrophoresis
Agarose gels were prepared by adding 0,8 g of molecular biology grade agarose 
(Invitrogen Life Technologies) to 100 mis of TAE buffer (40 mM Tris base, 20 mM 
Glacial Acetic acid, 1 mM EDTA) and microwaving at medium power for 10 minutes. 
This was cooled to 55 °C in a water bath and 0.0lx ethidium bromide added before 
pouring into an electrophoresis system gel tank. The gel was allowed to set at room 
temperature. TAE buffer was added to the tank until it covered the gel by a few mm. 
Each amplification product (10j.il) was mixed with 1 jxl of loading dye (50% (v/v) 
glycerol, 100 mM Tris-HCl, 10 mM EDTA, 0.02% (w/v) Orange G dye). A 1Kb Plus® 
DNA ladder (Invitrogen Life Technologies) was also loaded to enable the determination 
of PCR product size. The gel was run at approximately 5-7 V/cm. The run was stopped 
after migration of at least 5 cm had occurred. The gel was then visualized on a UV 
transilluminator (BioRad) at a wavelength of 302 mn. Images were recorded using 
GeneSnap software (Syngene). Specificity of the product was also determined by 
evaluating band yields per product lane.
2.4.4.1 Agarose gel electrophoresis of RNA
When gel electrophoresis was performed on RNA samples, denaturation of RNA 
was performed by incubating it at 65°C for 5 minutes. Also, 1.8ml of 37% (v/v) 
formaldehyde (to degrade secondary structures) was added per 100ml of 1% (w/v) 
agarose gel. The running buffer used was 1 x MOPS (3-(N-morpholino) 
propanesulfonic acid) buffer as it has a neutral pH and RNA is more susceptible to 
alkali cleavage than DNA. 200 T|g RNA was mixed with 5x RNA loading buffer and 
loaded into the respective electrophoresis gel lane. Amplification product was mixed 
with loading dye (50% v/v glycerol, 100 mM Tris-HCl, 10 mM EDTA, 0.02% (w/v) 
Orange G dye) and loaded onto a 0.8 % (w/v) agarose gel with 0.1 pg/ml of ethidium 
bromide (Sigma). A Kb Plus® DNA ladder (Invitrogen) was also loaded within the 
same experiment. Electrophoresis was performed on a horizontal tank containing 
MOPs, Gel electrophoresis ran at approximately 5-7 V/cm and was stopped after 
migration of at least 5 cm had occurred. The gel was then visualized on a UV 
transilluminator (Figure 2.9). RNA integrity was assessed by the clear demarcation of 
the 28S and 18S ribosomal RNA (rRNA) bands. Optimally the first should be twice as 
strong as the second, as 18S is more labile, if this is not the case or these are smeared, it
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is representative of RNA degradation. The molecular size of the reaction products were 
estimated by comparison with the ladder. Specificity of product was also determined by 
evaluating band yields per product lane.
|
►
*
B
Lane 1 Lane 2 Lane 3
Figure 2.9 Agarose gel electrophoresis showing intact and degraded RNA.
Lane 1 was loaded with Kb Plus® DNA ladder. Lanes 2 and 3 were loaded with 2 pg of total 
RNA. Lane 2 shows intact RNA which exhibits two well demarcated bands, corresponding to 
the 18S rRNA (A) and 28S rRNA (B). Lane 3 shows degraded RNA, which appears as a lower 
molecular weight smear.
2.4.5 Synthesis of DIG-labelled probes for RNA in situ hybridisation
Template DNA (plasmid with inserted sequence of interest) was incubated at 37°C 
for two hours with endonucleases with activity upstream and downstream from the 
sequence of interest (see Table 2.4). Notably, the incubation temperature for Smal 
digest was 25 °C and not 37 °C as the other enzymes.
The sequence of interest consisted of the entire Ml or M3 ORF amplified from 
MHV-68 DNA and cloned into pCRII (Invitrogen)9 or transcripts to the MHV-68 
vtRNA genes 1-4 within plasmid pEH1.4269.
Digests were performed in a total volume of 100 pi, using 10 pi of DNA, 10 pi of 
the appropriate enzyme (10U), 10 pi of the recommended enzyme buffer and 70 pi of 
diH20.
65
Chapter 2 Materials and Methods
Gene Vector Enzyme for sense
probe
Enzyme for anti- sense
probe
MHV-68 vtRNA
1.4
pBluescript EcoRI (Biolabs) Hindlll (Roche)
sPLUNC pBluescript Smal* (Biolabs) EcoRV (Biolabs)
Ml per II TOPO EcoRV (Biolabs) BamHl (Biolabs)
M3 per II TOPO EcoRV (Biolabs) BamHl (Biolabs)
Table 2.4 Restriction digest enzymes used to cut template DNAs used in the synthesis 
of vtRNA, sPLUNC, Ml and M3 RNA probes.
Footnotes:* incubation temperature for Smal digest was 25 °C and not 37 °C as the other 
enzymes.
To test if the correct sequence was obtained, agarose gel electrophoresis was 
performed. The linear templates were then transcribed into a DIG-labelled RNA probe 
using the DIG RNA labelling kit (Roche). To remove the DNA template, RNase-ffee 
DNase I (Roche) was added to the solution and incubated for 15 minutes at 37°C. This 
was followed by a phenol-chloroform extraction. In order to produce short riboprobes, 
alkaline hydrolysis was initiated. 5 pi of 0.4M sodium bicarbonate (Sigma) was added 
and incubated at 60°C for the time value (T) obtained using the equation in Figure 2.10. 
The reaction was stopped by neutralization with 5pl of 3M ammonium acetate (Sigma) 
and followed by ethanol precipitation.
Li - Lf 
K x Li x Lf
Figure 2.10 Formula used for calculation of incubation time for hydrolysis 
K is 0.11 Kb/min; Li: initial length of the fragment (Kb); Lf desired final length (Kb).
Probes were produced and labelled RNA probes, including a positive control 
(Roche) were tested by dot-blot using Hybond H+ (Amersham Bioscience) membrane. 
Serial dilutions of the riboprobes were applied to the membrane and then fixed through 
the use of UV Stratalinker (Stratagene). The membrane was incubated twice for five 
minutes in Buffer 1 (0.1 M maleic acid, 0.15 M NaCl) and once for 30 minutes in
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Buffer 2 (Buffer 1 with 0.1% (v/v) casein blocking agent). The membrane was then 
incubated for an hour with a 1:5000 dilution of the antibody (alkaline phosphatase 
conjugated anti-DIG fab fragments (Roche) in Buffer 2). Next, the membrane was 
incubated for five minutes in Buffer 1 with 0.3% (v/v) Tween 20 and for five minutes in 
Buffer 3 (0.1M Tris-HCl, 0.1M NaCl, 50mM MgCla). Finally, the membrane was left in 
the dark in colour solution (45 pi of NBT (Sigma), 35pl of BCIP (Sigma), 10 ml of 
Buffer 3) until a positive reaction (colour change).
2.4.5.1 RNA In situ hybridisation (RNA-ISH)
RNA In situ hybridisation was performed following a protocol previously 
described317.
2.4.5.1.1 Paraffin embedding of tissue samples
See section 2.5.3.
2.4.5.1.2 Proteolysis and post-fixation
Deparaffinization and re-hydration of samples was performed by sequential 
incubation of slides for 5 min in xylene (twice), 98% (v/v) alcohol (twice), 70% (v/v) 
alcohol and distilled water with 0.1% (v/v) DEPC (diethyl pyrocarbonate). An extra 
incubation in water with DEPC was performed for one minute followed by a wash in 
PBS for 5 minutes. Slides were incubated twice for 20 minutes in 0.2M HC1. This step 
was followed by incubation at 50 °C in 2x saline-sodium citrate buffer (SSC) and 5mM 
EDTA. Proteolysis was performed using 5 pi of proteinase K diluted in a 60 ml solution 
of distilled water containing 0.1% (v/v) DEPC, 1ml of 1M Tris and 1ml of 0.1M CaC^. 
Slides were incubated in this solution for 15 minutes. Fixation of the slides was 
performed by incubation for 5 minutes in 0.2% (v/v) glycine-PBS solution followed by 
incubation for 4 minutes in 4% (v/v) paraformaldehyde and finally one minute 
incubation in lx PBS and 5mM MgCl2.
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2.4.5.1.3 Acetylation
Acetylation was performed by incubation of slides for 10 minutes in 0,25% (v/v) 
acetic anhydride and 0.1M triethanolamine solution. This was followed by two washes 
for one minute and one wash for 15 minutes with PBS.
2.4.5.1.4 Pre-hybridisation and hybridization of riboprobes
Prehybridisation was performed by incubation of slides at 52 °C for at least 1 hour 
in a solution composed of 49.5 ml of prehybridisation buffer, 0.5 ml of 10 mg/ml 
ssDNA and 1ml of RNA. The prehybridisation buffer was prepared as a master stock 
containing: 450 ml of 20x SSC, 675ml of 100% deionized formamide, 150 ml of 50x 
Denharts solution and 210 ml of distilled water with 0.1% (v/v) DEPC-treated dit^O.
Hybridisation was performed by overnight incubation in a moist chamber at 37 
°C. The hybridization mixture volume was calculated so as to ensure the availability of 
30 to 40pl of mix per tissue section. The buffer was prepared as a master stock with: 16 
ml of 100% formamide, 8 ml of 20x hybridization salts, 3.2ml of 50x Denharts solution, 
400pl 20U/ml heparine solution and 320pl of 10% (v/v) Triton X-100. Before 
application on to the samples, the buffer was prewarmed to 52 °C and 18pi of 250pg/ml 
of RNA, 20pi of lOmg/ml ssDNA, 0.5 to Ipl of RNA probe was added per 698pl of 
buffer. Samples were then covered with the hydrophobe surface of gel bond and the 
extremities of the bond fixed to the slide through the use of fixo-gum gel (Marabu).
2.4.5.1.5 Detection of hybridized riboprobes
Slides were washed by sequential incubation twice in 6xSSC, 45% (v/v) 
formamide at 42 °C for 15 min then twice in 2xSSC for 5 min and finally twice in 
0,2xSSC for 15 min. Next, a one minute wash with Buffer 1 (lOOmM Tris and lOOmM 
NaCl) was performed. This was followed by equilibration of the samples for 30 minutes 
in a solution of 1.2 ml of neutral sheep serum and 1.8 ml of 10% (v/v) Triton X-100 in 
60ml of Buffer 1. Dilution of the antibody was performed by adding 15 pi of anti- 
digoxinenin antibody, 3 Ipl of neutral sheep serum and 94 pi of 10% (v/v) Triton X-100 
to 3 ml of buffer 1. Incubation with antibody was then performed for two hours in a 
moist chamber. After incubation, slides were washed twice for 15 minutes in Buffer 1 
and once for two minutes in Buffer 3 (lOOmM Tris, lOOmM NaCl, 50mM Mg Ck).
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Finally, samples were stained overnight by incubation in the dark (length of time 
dependent on speed of staining reaction) with 60 ml of Buffer 3 containing 150pi of 
NBT, 120pi of X-phosphate and 30 mg of levamisole. The staining reaction was 
stopped by washing the slides for 10 minutes in Buffer 4 (lOmM Tris and ImM EOT A) 
followed by a five minute wash in distilled water. Counter staining of samples was 
performed by incubation for 10 seconds with Papanicolau’s haematoxylin solution. To 
remove all stain residues, slides were left in running water for five minutes. A coverslip 
was then placed on samples after application of one drop of warmed glycer-gel.
In the case of the Ml riboprobe, Ml RNA-ISH was also performed on one tissue 
section from a vMl stop-infected animal to assess if the synthesised riboprobe was 
specific for the Ml sequence. vMlstop virus has been designed to inhibit Ml 
expression. As expected, the experiment using Ml riboprobe in vMlstop-infected 
animals yielded no reaction. In all experiments both anti-sense (complimentary 
sequence) and sense (homologue sequence) riboprobes were used in order to control for 
nonspecific reactions and so assess sensitivity and specificity of reactions.
2.4.6 Transformation of plasmid
Plasmid (5 pi) was added to a vial of competent Escherichia coli bacteria (XL1 
Blue Stratagene), the mixture was mixed and then placed on ice for 30 minutes. The 
solution was heat-shocked at 42 °C for 60 seconds and then incubated on ice for five 
minutes. Next, the mixture was added to 800 pi of Luria-Bertani (LB) medium (1 % 
(w/v) tryptone, 0.5 % (w/v) yeast extract, 1 % (w/v) NaCl) with 50 pl/ml ampicillin and 
placed on a orbital shaker at 200 rpm, for 45 minutes. A 100 pi sample was spread on 
the surface of a 1% (w/v) LB with 50 pl/ml ampicillin agar plate (Sigma-Aldrich). The 
rest of this LB culture was centrifuged at 2000 g for five minutes and the pellet was 
resuspended in 100 pi LB medium and spread onto another LB with 50 pl/ml ampicillin 
agar plate. LB agar plates were incubated at 37 °C overnight. The next day, individual 
colonies were cultured using 10 ml LB medium containing 50 pg/ml ampicillin and 
incubated at 37 °C in an orbital shaker at 200 rpm overnight.
2.4.7 Plasmid purification
For plasmid purification, the QIAGEN Plasmid Maxi Kit (Qiagen) was used. The 
10 ml LB medium starter culture (containing plasmid transformed bacterial culture) was 
added to 400 ml LB medium containing 50 pg/ml ampicillin in a two litre Erlemneyer
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flask and incubated at 37 °C in an orbital shaker at 200 rpm overnight. The next day, the 
culture was centrifuged at 6000 g for 10 minutes at 4 °C. The pellet was resuspended in 
10 ml buffer PI (50 mM Tris-Cl [pH 8.0], 10 mM EDTA, lOOpg/ml RNase A). Lysis of 
bacteria was induced by addition of 10 ml of buffer P2 (200 mM NaOH, 1 % [w/v] SDS 
and incubating it for five minutes at room temperature. Then 10 ml of neutralisation 
buffer; buffer P3 (3 M potassium acetate [pH 5.5]) was added and the mixture was 
incubated on ice for 20 minutes. This was followed by centrifugation at 20,000 g for 30 
minutes at 4 °C. The supernatant containing the DNA was collected and centrifuged 
once more at 20,000 g for 15 minutes at 4 °C The supernatant was then added to an 
equilibrated QIAGEN-tip 500 (10 ml buffer QBT (750 mM NaCl,50 mM MOPS (pH 
7.0), 15 % (v/v) isopropanol, 0.15 % (v/v) Triton X-100) and was filtered by gravity 
flow. The tip was washed twice with 30 ml of buffer QC (1 M NaCl, 50 mM MOPS 
(pH 7.0), 15 % (v/v) isopropanol). DNA was then eluted using 15 ml buffer QF (1.25 M 
NaCl, 50 mM Tris-Cl (pH 8.5), 15 % (v/v) isopropanol). Isopropanol (10.5 ml Sigma) 
was added to the eluate and the mixture centrifuged at 15,000 g for 30 min at 4 °C and 
the supernatant was removed. The pellet was washed with 5 mis of 70 % (v/v) ethanol 
and centrifuged again at 15,000 g for 10 minutes. After removal of supernatant, the 
pellet was air dried and the DNA dissolved in 500 pi TE buffer (pH 8.0). The yield of 
DNA was calculated using the Nanodrop (Thermo Scientific).
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3. Results
71
Chapter 3 Results
3.1 Analysis of Ml expression in a natural host and on a artificial host
Ml RNA in situ hybridization (RNA-ISH) was performed to determine and compare 
the extent and sites of Ml transcription. Ml is the protein of interest in this study. Viruses 
are highly adapted to their host150 and gammaherpesviruses are thought to have developed 
in parallel with their host18. In the wild, MHV-68, a gammaherpesvirus has been found to 
infect the wood mouse (Apodemus sylvaticus)5,19,293 but not the mouse (Mus Musculus)293, 
. Laboratory mouse strains such as BALB/c mice are derived from Mus Muscidus. The 
hypothesis tested was that the transcription of Ml would be different in a natural and in an 
artificial host.
Lung, the main site of acute infection; and the spleen, the main site of latent infection, 
were examined for Ml expression. The times chosen, were representative of acute infection 
(day 3, 5, 7, 10 p.i) and latent infection (day 14, 28 and 40 p.i).
3.1.1 Day 3 
Wood mice
At day 3 p.i. in the lung of wood mice, expression of Ml was detected in occasional 
airway epithelial cells, interstitial macrophages and alveolar epithelial cells (type I 
pneumocytes) (Figure 3.1). In the spleen, expression of Ml occurred in a few lymphocytes 
scattered in follicles and disseminated in the red pulp. In the red pulp, Ml transcripts were 
also observed in disseminated macrophages and megakaryocytes (Figure 3.1).
BALB/c mice
At day 3 p.i. Ml expression was also monitored in the lung and spleen of BALB/c 
mice. In the lung of BALB/c mice, Ml mRNA was detected in scattered both alveolar 
epithelial cells (type I pneumocytes) and scattered interstitial macrophages. Furthermore, 
expression was also noted in the lungs in slender cells lining vessels (endothelial cells) and 
intravascular lymphocytes attached to endothelial surface (rolling) or in the pulmonary 
interstitium adjacent to vessels (Figure 3.2). In the spleen, Ml mRNA was detected in 
lymphocytes and macrophages within follicles and in the red pulp in close proximity to 
follicles (Figure 3.2).
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Figure 3.1 Wood mouse, day 3 p.i. Lung and spleen. MlmRNA expression.
A. Lung MlmRNA expression in airway epithelial cells (full arrow head with square tip), in 
macrophages (full arrow) and type I pneumocytes (full arrow head with round tip); B-D. Spleen 
Ml mRNA expression in lymphocytes (dashed arrows) in the red pulp (B, C) and in follicles 
(D). In the splenic red pulp (B, C), expression is also seen in macrophages (full arrow) and 
megakaryocytes (full arrow head with square tip). RNA-ISH, NBT/BC1P, Papanicolaou’s 
haematoxylin counterstain. Bars: A,B,C= 25|im; D= 100pm
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Figure 3.2 BALB/c mouse, day 3 p.i. MlmRNA expression.
A,B- Lung MlmRNA expression in the lungs in scattered interstitial macrophages (full arrow), 
lymphocytes (dashed arrows), type I pneumocytes (full arrow head with round tip) endothelial 
cells (dashed arrow with round tip); C. Spleen Ml mRNA expression in lymphocytes in the red 
pulp (dashed arrow) and in follicles (dashed arrow with square tip). RNA-ISH, NBT/BCIP, 
Papanicolaou’s haematoxylin counterstain. Bars= SOpm.
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3.1.2 Day 5 
Wood mice
At day 5 p.i. in the lung of wood mice. Ml transcripts were detected in airway 
epithelial cells (bronchiolar, bronchial and tracheal), intravascular rolling lymphocytes 
(migrating), alveolar epithelial cells (type I and type II pneumocytes) interstitial 
macrophages and lymphocytes. Notably, the overall number of cells in the lungs that 
expressed the Ml transcript was greatly increased by day 5 compared to the day 3 
timepoint (Figure 3.3 A-C). Furthermore, in the spleen (Figure 3.3 D), Ml expression was 
observed in numerous lymphocytes in germinal centres, in the periphery of follicles and to 
lesser extent in the red pulp. In the red pulp. Ml expression was also detected in 
disseminated macrophages and megakaryocytes. This pattern of expression in the red pulp 
was similar to what was observed on day 3 p.i.
BALB/c mice
At day 5 p.i. in the lung of BALB/c mice, expression of Ml was inconspicuous. In 
the spleen, a few lymphocytes within splenic follicles were found to exhibit Ml mRNA 
(Figure 3.4).
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Figure 3.3 Wood mouse, day 5 p.i. Lung MlmRNA expression.
A-C: Lung, MlmRNA expression in airway epithelial cells (full arrow), round intravascular 
lymphocytes (dashed arrow with round tip), pneumocytes (dashed arrow with square tip), 
interstitial macrophages (full arrow with square tip) and interstitial lymphocytes (dashed arrow). 
C: Spleen, Ml mRNA expression in lymphocytes in germinal centres (dashed arrow with round 
tip), in the periphery of follicles and red pulp (dashed arrow). In the red pulp Ml expression was 
also seen in disseminated macrophages (full arrow) and megakaryocytes (full arrow with round 
tip). RNA-ISH, NBT/BCIP, Papanicolaou’s haematoxylin counterstain. Bars: A= 50pm; B=25 
pm; C= 250pm; D= 100pm
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Figure 3.4 BALB/c mouse, day 5 p.i. Spleen MlmRNA expression.
MlmRNA expression in few lymphocytes (arrow) within splenic follicles. RNA-ISH, 
NBT/BC1P, Papanicolaou’s haematoxylin counterstain. Scale bar= 25pm.
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3.1.3 Day?
Wood mice
At day 7 p.i. in the lungs of wood mice, Ml expression was seen in airway 
(bronchiolar, bronchial and tracheal - Figure 3.5 A) and alveolar epithelial cells (type I and 
type II pneumocytes) (Figure 3.5 C, D). Ml expression was highest in type II pneumocytes 
which were often binucleated. In the lungs, Ml expression was also observed in 
lymphocytes in the iBALT, pulmonary interstitium and rolling within vessels. Macrophages 
in the pulmonary interstitium and lining, or desquamated into the alveoli, also contained 
Ml transcripts (Figure 3.5 C). Satellite cells surrounding neuronal bodies in 
parabronchiolar ganglia expressed Ml transcript (Figure 3.6). Parabronchiolar ganglia were 
not present in all sections and this is likely related to their small size. As a result, the 
expression of Ml transcripts in these cells at earlier timepoints could not be ruled out.
In the spleen at day 7 p.i. there was little difference in the pattern of Ml transcript 
expression compared to day 5 p.i. Numerous lymphocytes in the germinal centres, in the 
periphery of follicles and to a lesser extent in the red pulp were noted as exhibiting Ml 
mRNA. Ml transcript expression was also noted in macrophages and megakaryocytes 
present in the splenic red pulp.
BALB/c mice
In the lung of BALB/c mice at day 7 p.i. Ml mRNA expression was restricted to 
scattered type I pneumocytes (Figure 3.7 A). In the spleen of infected BALB/c mice. Ml 
mRNA was detected in numerous lymphocytes within follicles (Figure 3.7, Panel B) and 
very rarely in the red pulp.
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Figure 3.5 Wood mouse, day 7 p.i. Trachea and lung , MlmRNA expression.
A. Trachea, Ml mRNA expression in numerous ciliated (arrow) tracheal epithelial cells. B-D, 
Lung MlmRNA expression in lymphocytes in iBALT (full arrow in B), alveolar desquamated 
macrophages (dashed arrows with round tip in C), type II pneumocytes, (full arrow with round 
tip in C and D), including multinucleated pneumocytes (dashed arrow head with round tip in D), 
RNA-ISH, NBT/BCIP, Papanicolaou’s haematoxylin counterstain. Bars: A, C, D= 25pm; B= 
50pm; E=50 pm
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Figure 3.6 Wood mouse, day 7 p.i. Bronchus and adjacent ganglia, MlmRNA expression. 
Ml mRNA expression in ciliated bronchial epithelial cells (dashed arrow), and satellite cells 
surrounding neuronal bodies (full arrow) in parabronchiolar ganglia. RNA-ISH, NBT/BCIP, 
Papanicolaou’s haematoxylin counterstain. Bar= 25pm
Figure 3.7 BALB/c mouse, day 7 p.i. Lung and spleen, Ml mRNA expression.
A. Lung, Ml mRNA expression in type I pneumocytes (arrow). B. Spleen, Ml mRNA 
expression numerous lymphocytes within follicles and very rarely in the red pulp. RNA-ISH, 
NBT/BCIP, Papanicolaou’s haematoxylin counterstain. Bars: A= 25 pm; B= 100 pm
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3.1.4 Day 10 
Wood mice
In the lung of wood mice, expression of Ml mRNA was observed in the same type of 
cells on day 10 p,i, as described on day 7 p.i. These were airway (tracheal, bronchial and 
bronchiolar) epithelial cells, type I and type II pneumocytes. Expression in type II 
pneumocytes was more frequent than in type I pneumocytes. Within the lung, Ml transcript 
expression was also detected in lymphocytes in the iBALT, pulmonary interstitium and 
intravascularly but adjacent to the endothelium (rolling/migrating). Macrophages in 
pulmonary interstitium and lining/desquamated into the alveoli also exhibited Ml 
transcripts.
In the spleen, there was also little difference in the pattern of Ml expression at day 10 
p.i. from that described at day 5 and day 7 p.i. Numerous lymphocytes in the germinal 
centres, in the periphery of follicles and to a lesser extent in the red pulp were observed to 
contain Ml mRNA. Macrophages and megakaryocytes present in the splenic red pulp were 
also seen to exhibit Ml transcript expression.
BALB/c mice
By day 10 p.i. in the lung of the BALB/c mouse, Ml mRNA expression was 
inconspicuous. Similarly to the findings on day 7 p.i. Ml mRNA expression was present in 
lymphocytes in splenic follicles and very rarely in the red pulp.
3.1.5 Day 14 
Wood mice
By day 14 p.i. Ml mRNA expression in the lung of wood mice was detected mostly 
in airway (tracheal, bronchial and bronchiolar) epithelial cells, occasional type I and type II 
pneumocytes, lymphocytes within the iBALT and pulmonary interstitium. There was a 
marked decrease in the number of cells that expressed Ml transcripts in comparison to 
previous timepoints (Figure 3.8 A). The pattern of Ml expression in satellite cells 
surrounding neuronal bodies in parabronchiolar ganglia was similar to what was observed 
at day 7 p.i in that these on day 14 p.i. also expressed Ml mRNA. To a lesser extent than
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that which was seen at day 10 p.i., at day 14 p.i., macrophages in pulmonary interstitium 
and lining/desquamated into the alveoli, also exhibited, Ml transcripts.
Within the spleen, numerous lymphocytes in the germinal centres and in the 
periphery of follicles, to a lesser extent in the red pulp, exhibited Ml mRNA. Macrophages 
and megakaryocytes present in the splenic red pulp expressed Ml. At this time, cells in the 
splenic red pulp, mostly macrophages and lymphocytes, exhibiting Ml expression were 
more numerous than those seen in previous timepoints (Figure 3.8 B).
BALB/c mice
By day 14 p.i, in the lung of the BALB/c mouse, Ml mRNA expression was 
restricted to occasional lymphocytes in close proximity to bronchioles and/or vessels 
(Figure 3.9 A).
In the spleen, Ml expression was detected in lymphocytes within follicles (Figure 3.9 
B). The pattern of Ml transcript expression was similar to what was observed at earlier 
timepoints.
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Figure 3.8 Wood mouse, day 14 p.i. Lung and spleen, MlmRNA expression.
A. Lung, Ml mRNA expression mostly in airway (dashed arrow) and lymphocytes within the 
iBALT. (full arrow).B, Splenic red pulp, overall frequency of cells, mostly macrophages, 
exhibiting Ml expression increased when compared to previous timepoints. RNA-ISH, 
NBT/BCIP, Papanicolaou’s haematoxylin counterstain. Bars: A= 250 pm; B= 25 pm
Figure 3.9 BALB/c mouse, day 14 p.i. Lung and spleen, MlmRNA expression.
A. Lung, Ml mRNA expression restricted to occasional lymphocytes in close proximity to 
vessel (full arrow); B. Spleen, Ml expression within follicles (dashed arrow). RNA-ISH, 
NBT/BCIP, Papanicolaou’s haematoxylin counterstain. Bars: A= 25 pm; B= 100 pm
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3.1.6 Day 28
3.1.6.1 Wood mice
At day 28 p.i similarly to day 14 p.i, in the lung of the wood mouse, Ml mRNA 
expression was observed mostly in airway (tracheal and bronchial) epithelial cells, 
occasional type I and type II pneumocytes, lymphocytes within the iBALT and pulmonary 
interstitium (Figure 3.10 A,B). Likewise, as described for day 14 p.i. occasional 
macrophages in pulmonary interstitium and lining, or desquamated into the alveoli, also 
exhibited, Ml transcripts.
In the spleen, Ml expression was seen in lymphocytes within follicles. Numerous 
lymphocytes in the germinal centres and in the periphery of follicles, to a lesser extent in 
the red pulp were seen to exhibit Ml mRNA. Macrophages and megakaryocytes present in 
the splenic red pulp were also seen to exhibit Ml expression. Similarly to day 14 p.i. the 
overall frequency of cells that exhibited Ml expression in the splenic red pulp, 
macrophages, lymphocytes and megakaryocytes, were increased when compared to day 3 
and day 7 p.i (Figure 3.10 C).
3.1.6.2 BALB/cmice
BALB/c mice culled at day 28 were not included in this experiment.
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Figure 3.10 Wood mouse, day 28 p.i. Trachea, lung and spleen, MlmRNA expression.
A. Trachea, MlmRNA expression in ciliated tracheal epithelial cells (arrow) B. Lung, Ml 
mRNA expression mostly in airway (dashed arrow), alveolar epithelial cells (arrow with round 
tip) and lymphocytes within the iBALT. (full arrow). C, Splenic red pulp, overall frequency of 
cells, similarly to day 14 p.i. exhibiting increased expression when compared to day 3 and day 7 
p.i. Arrow highlighting megakaryocytes showing presence of Ml transcript. Ml RNA ISH, 
NBT/BCIP, Papanicolaou’s haematoxylin counterstain. Bars: A,C= 25 pm; B= 50 pm
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3.1.7 Day 40
3.1.7.1 Wood mouse
At day 40 p.i, in the lung of the wood mouse, Ml mRNA expression was seen in very 
occasional lymphocytes present within iBALT (Figure 3.11 A) and within interstitium. Ml 
expression was lower at this time point than observed at earlier timepoints in infected 
lungs.
In the spleen, Ml expression was detected in lymphocytes within follicles and to a 
lesser extent in red pulp (Figure 3.11 B).
3.1.7.2 BALB/c mouse
At day 40 p.i, in the lung of the BALB/c mouse, Ml mRNA expression was seen in 
in close proximity to bronchioles and/or vessels. This pattern of expression was consistent 
with the pattern of expression exhibited at previous timepoints.
In the spleen Ml mRNA expression was inconspicuous.
3.1,8 Summary of Ml transcript expression analysis in the wood mouse and BALB/c 
mouse over a 40 day timecourse by RNA-ISH.
The findings of Ml transcript expression analysis by RNA-ISH in the lung and spleen 
of the wood mouse and BALB/c mouse are summarized in Table 3.1 and 
Table 3.2.
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Figure 3.11 Wood mouse, day 40 p.i. Lung and spleen, MlmRNA expression.
A. Ml mRNA expression in occasional lymphocytes within the iBALT. (arrow).B, Spleen, Ml 
expression within follicles (arrow). In the red pulp, overall frequency of cells, exhibits 
decreased Ml expression when compared to day 14 and day 28 p.i. RNA-1SH, NBT/BCIP, 
Papanicolaou’s haematoxylin counterstain. Bars= 25 pm
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Days
p.i.
Lung of 
wood mouse
Lung of
BALB/c mouse
3 Airway epithelial cells (+)
Type I pneumocytes (+)
Macrophages, interstitial (+)
Endothelial cells (+)
Type I pneumocytes (+)
Macrophages, interstitial (+)
Lymphocytes rolling (+) perivascular (+)
5 Airway epithelial cells (++)
Type I pneumocytes (++)
Type II pneumocytes (++) 
Macrophages, interstitially (++) 
Lymphocytes rolling/perivascular (+)
Inconspicuous
7 Airway epithelial cells (++)
Type I pneumocytes (++)
Type II pneumocytes (++) 
Macrophages: interstitially (++) & 
desquamated (-H-)
Lymphocytes: rolling/perivascular 
(+)iBALT (+) & interstitial (+)
Type I pneumocytes (occasional)
10 Airway epithelial cells (++)
Type I pneumocytes (+)
Type II pneumocytes (++) 
Macrophages: interstitially (++) & 
desquamated (++)
Lymphocytes: rolling/perivascular 
(+), iBALT (+)& interstitial (+)
Inconspicuous
14 Airway epithelial cells (+)
Type I pneumocytes (+)
Type II pneumocytes (+) 
Macrophages: interstitially (+) & 
desquamated (+)
Lymphocytes: rolling/perivascular 
(++), iBALT (++) & interstitial (+)
Lymphocytes
peribronchiolar/perivascular (+)
28
Airway epithelial cells (+)
Type I pneumocytes (+)
Type II pneumocytes (+) 
Macrophages: interstitially (+) & 
desquamated (+)
Lymphocytes: rolling/perivascular 
(++); iBALT (++) & interstitial (+)
Not included in the experiment
40 Lymphocytes in iBALT (+) Lymphocytes
peribronchiolar/perivascular (+)
Table 3.1 Summary of the pattern of Ml transcript expression in the lung of wood mice and 
BALB/c mice over a 40 day timecourse following MHV-68 infection.
Semiquantitative parameters used to represent number of cells exhibiting Ml transcript expression:
+ (scattered cells); ++ (moderate number of cells); +++ (numerous cells)
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Days
P-i-
Spleen of
Wood mouse
Spleen of
BALB/c mouse
3 Lymphocytes in follicles (+) 
and red pulp (+)
Macrophages in red pulp(+) 
Megakaryocytes in red 
pulp(+)
Lymphocytes in follicles (+) 
and red pulp(+)
Macrophages in follicles (+) 
and red pulp (+)
5 Lymphocytes in follicles 
(+++) and red pulp (++) 
Macrophages in red pulp 
(++)
Megakaryocytes in red 
pulp(+)
Lymphocytes in follicles (+) 
and red pulp(+)
7 Lymphocytes in follicles 
(++) and red pulp (++) 
Macrophages in red pulp 
(++)
Megakaryocytes in red 
pulp(+)
Lymphocytes in follicles (++) 
and red pulp (rarely)
10 Lymphocytes in follicles 
(++) and red pulp (++) 
Macrophages in red pulp 
(++)
Megakaryocytes in red 
pulp(+)
Lymphocytes in follicles (+) 
and red pulp (rarely)
14 Lymphocytes in follicles 
(++) and red pulp (++) 
Macrophages in red pulp 
(+++)
Megakaryocytes in red 
pulp(+++)
Lymphocytes in follicles (+) 
and red pulp (rarely)
28 Lymphocytes in follicles 
(++) and red pulp (++) 
Macrophages in red pulp 
(+++)
Megakaryocytes in red 
pulp(+++)
Not included in the experiment
40 Lymphocytes: follicles (+) 
and red pulp (rare)
Inconspicuous
Table 3.2 Summary of Ml transcript expression analysis in the spleen of wood mice and 
BALB/c mice over a 40 day timecourse after MHV-68 infection.
Semiquantitative parameters used to represent number of cells exhibiting Ml transcript 
expression: + (scattered cells); ++ (moderate numbers of cells); +++ (numerous cells).
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3.2 In vivo studies on the effect of Ml expression on MHV-68 infection in a natural 
host
In order to determine the effect of Ml expression in MHV-68 infection of a natural 
host, the wood mouse, in vivo experiments were performed using vMlstop virus and its 
genetically repaired counterpart, vMlrev virus. vMlstop virus is an MHV-68 virus with an 
in-frame stop codon in the Ml locus which impairs expression of the Ml. The hypothesis 
tested was that the presence or absence of Ml transcription would lead to different MHV- 
68 induced pathogenesis and/or virus replication. The lung, the main site of acute MHV-68 
infection, and the spleen, the main site of latent MHV-68 infection, were examined for 
morphological changes, viral gene transcripts, viral load, presence of viral antigen and 
cytokine expression. The chosen timepoints following infection were representative of 
acute infection (day 3 p.i. and 7 p.i.) and latent infection (day 14 p.i. and 28 p.i.).
3.2.1 Airways and lung
3.2.1.1 Mock infected wood mice. Histological, immunohistological and ultrastructural 
examination
Wood mice instilled intranasally using PBS (mock infected) served as negative 
controls to determine any potential effects of the infection protocol. Accordingly, the 
examination of this group of mice served to identify normal structure and baseline 
leukocyte numbers. The morphology of the lower airways and lung are similar to that of 
laboratory mice strains. The lower airways are represented by bronchi and bronchioles 
(Figure 3.12) lined by pseudostratified and columnar ciliated epithelium and Clara cells 
with microvilli on their apical surface. The alveoli are lined by two specialised epithelial 
cells: pneumocytes type I and pneumocytes type II, Pneumocytes are connected to each 
other by the zona adherens. Occasionally, the alveolar lining/space contains macrophages 
that have migrated from the interstitium into the alveolar space, these communicate with 
other cells through filopodia. Macrophages can also be discerned by the presence of 
lysosomes. The interstitium is mostly composed of connective tissue with a low number of 
leukocytes, mainly T and B cells, fewer macrophages embedded in an intensely vascular 
meshwork (Figure 3.13).
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Figure 3.12 Wood mouse, mock infected. Lung, histology and ultrastructure.
Lower airways: bronchi and bronchioles (a) lined by columnar cells with cilia on apical surface 
(o) and Clara cells with microvilli on apical surface (n). Alveoli lined by type I pneumocytes (b) 
and type II pneumocytes (c), connected by zona adherens (f). Occasionally, the alveolar 
lining/space exhibited macrophages that migrated from the interstitium (j, gap in alveolar 
epithelium with macrophage (i) migrating from the interstitium), Macrophages exhibited 
lysosomes (m) and contacted with other cells through filopodia (1). A: Haematoxilin & eosin 
(H&E) stained section; B: Toluidine blue (TB) semithin section; C-H: Electron microscopy 
(EM); Scale bars A,B= 100 pm
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Figure 3.13 Wood mouse, mock infected, lung. Immunohistology for T cells (CD3- 
positive), B cells (CD45R-positive) macrophages (lysozyme-positive) and type II 
pneumocytes (SP-C-positive).
The interstitium was composed of connective tissue with scarce leukocytes, mainly B cells (arrow 
in A); T cells (arrowheads in B) and fewer macrophages (arrowheads in C), embedded in a 
vascular meshwork. Macrophages were also seen lining the alveoli (dashed arrows in C). Type II 
pneumocytes (arrowheads in D; alveolar macrophages) were observed most frequently in the 
angles of alveoli and occupied a small proportion of the alveolar lining surface. PAP method 
(CD3, SP-C, lysozyme); ABC method (CD45R), Papanicolaou’s heamatoxylin counterstain. 
Bars = 25 pm
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3.2.1.2 Inflammatory response in wood mice following vMlstop and vMlrev infection 
3.2.1.2.1 The lower airways
The morphological changes seen in the lower airways following infection with 
vMlrev and vMlstop were similar. At day 3 p.i., the lower airways (bronchi and 
bronchioles) showed a mild to moderate increase in cellularity, leading to protrusion of the 
epithelium into the lumina. Cells lining the airways were mostly columnar and ciliated. 
Also they showed mild to moderate anisocytosis and mild anisokaryosis (mild respiratory 
epithelium hyperplasia) (Figure 3.14). Furthermore, these cells also showed various 
degenerative changes such as extensive mitochondrial swelling, hyperchromatic and 
shrunken nuclei (Figure 3.15).
At day 7 p.i., the epithelial hyperplasia was more intense than at day 3 p.i. and 
bronchiolar lumina often contained apoptotic/necrotic cells. Occasionally bronchioles 
exhibited vacuolated macrophages and/or multinucleated cells amongst the cellular debris 
in the lumina.
At day 14 p.i. and day 28 p.i., the bronchial/bronchiolar epithelium appeared 
unaltered apart from a few desquamated and apoptotic cells.
93
Chapter 3 Results
Figure 3.14 Wood mouse, vMlstop and vMlrev infected, day 3 p.i. Histology of 
bronchiolar epithelium.
Bronchiolar epithelial cells were observed protruding into the alveolar lumen and showed mild 
to moderate anisocytosis and mild anisokaryosis. These cells were mostly ciliated (arrows in C 
and D). A, B: TB stained semithin sections; C, D: H&E stained sections. Bars: A,B= 25|im; C, 
D=10 pm
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Figure 3.15 Wood mouse, vMlrev infected, day 3 p.i Ultrastructure of bronchiolar 
epithelium.
The bronchiolar epithelium was hyperplastic and was comprised of scattered degenerate cells 
but did not contain identifiable viral particles. Bronchiolar epithelial cells showed extensive 
mitochondrial swelling (full arrow) and/or extensive degenerative changes (dashed arrows) were 
noted. EM
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Figure 3.16 Wood mouse, vMlstop and vMlrev infected, day 7 p.i Histology of 
bronchiolar epithelium.
A,B: Overview of bronchioles; C,D: Close up of bronchiolar epithelial cells. Bronchiolar lumina 
with numerous apoptotic/necrotic cells (A, B). Ciliated epithelial cells (arrows) were observed 
protruding into the alveolar lumen and showed moderate anisocytosis and anisokaryosis. H&E 
stained sections. Bars= A,B= 25pm; C,D=10 pm
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3.2.1.2.2 The lung 
3.2.1.2.2.1 Day 3
Infection with vMlstop and vMlrev led to an increase in the overall cellularity in the 
lung. At day 3 in the vMlrev infected wood mouse, the increase in cellularity was 
multifocal and mild (Figure 3.17A) and was mostly due to a mild increase in macrophages 
infiltrating the interstitium and/or lining alveoli and mild type II pneumocyte hyperplasia 
(Figure 3.18B). However in the vMlstop infected mice there was a multifocal moderate to 
severe increase in cellularity. These made air spaces inconspicuous where the changes were 
most severe (Figure 3.17B). In the vMlstop infected mice the increase in cellularity 
occurred in the alveolar lining due to mild to moderate type II pneumocyte hyperplasia 
(Figure 3.18 and Figure 3.19) and the presence of foamy macrophages, associated with type 
I pneumocyte necrosis. Type II pneumocytes were occasionally binucleated. In the 
interstitium there was mild to moderate interstitial infiltration by lymphocytes and 
macrophages (Figure 3.18 and Figure 3.19). In vMlstop infected mice there was also a 
more frequent and pronounced formation of induced bronchial associated lymphoid tissue 
(iBALT) which was minimal in vMlrev infected mice (Figure 3.17).
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Figure 3.17 Wood mouse. vMlrev and vMlstop infected, day 3 p.i. Histology of lung.
A: vMlrev infected wood mouse; B: vMlstop infected wood mouse. An increased cellularity in 
the lung following infection was observed. In the vMlrev infected wood mouse the increase in 
cellularity was mild and multifocal. In the vMlstop infected wood mouse, this increase was 
more intense with infection leading to multifocal to a focally extensive, moderate to severe 
increase in cellularity. Furthermore in vMlstop infected woodmice, iBALT (arrows) formation 
was more frequent and pronounced. H&E stained sections. Bars= 250 pm
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Figure 3.18 Wood mouse. Mock, vMlrev and vMlstop infected, day 3 p.i. Histology of 
lung.
A. Mock infected; B: vMlrev infected; C. vMlstop infected, in an area where increased 
cellularity was not severe to enable clearer observation of the cell types involved. Both 
infections led to an increase in macrophages (arrow with square tip) infiltrating the interstitium 
and/or lining alveoli. These macrophages were often highly vacuolated (activated). There was 
also type II pneumocyte hyperplasia, (arrow with round tip). Type II pneumocytes showed 
moderate anisocytosis and anisokaryosis and were occasionally binucleated (dashed arrow with 
TB stained semithin sections. Bars= 25 pm
99
Chapter 3 Results
Figure 3.19 Wood mouse, vMlstop infected, day 3 p.i. Histology and im mu nohistology of 
area with severely increased cellularity.
A: H&E stained; Immunohistology using T cell (B), macrophage (C) pneumocyte type II (D), 
markers. The immunohistology confirmed that the foci of increased cellularity were due to 
disseminated T cells (arrow with square tip), macrophages (arrow with round tip) and type II 
pneumocytes (dashed arrows). A-D: Corresponding areas in the lung section. Necrotic debris 
(full arrow) was also seen amongst inflammatory infiltrate. PAP method Papanicolaou’s 
haematoxylin counterstain. Bars= 25pm
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The ultrastructural examination of vMlstop infected wood mice lung at day 3 p.i, 
revealed that type I pneumocytes showed more extensive cytoplasmic oedema and 
basement membrane reduplication, a degenerative change preceding cell death (Figure 
3.21). Also when vMlstop infected animals were compared to mock-infected animals, it 
was observed that lamellar bodies were more numerous per cell and larger in size in type II 
pneumocytes (Figure 3.21, Figure 3.22). This indicated that type II pneumocytes were 
actively producing more surfactant. Another feature unique to the vMlstop infected wood 
mice was that cells frequently exhibited intracytoplasmic lipid droplets (Figure 3.21). The 
droplets were often numerous and occasionally compressed the nucleus effacing cellular 
architecture and thus preventing accurate cell type identification. The majority of cells 
appeared to be alveolar and/or interstitial macrophages. This feature was also observed in 
the macrophages infected in vitro with the vMlstop virus (see Section 3.3.2). The lipid 
vacuoles were also present extracellularly (likely cells that had degenerated and lost their 
membranes).
In vMlrev infected wood mice the ultrastructural examination of lung at day 3 p.i 
revealed the presence of glycogen lakes in the interstitium (Figure 3.22 A), which was not 
observed in vMlstop infected animals. The presence of binucleated type II pneumocytes 
was not associated with the presence of viral particles (Figure 3.22 B). This finding 
indicates the binucleation to represent a type II pneumocyte hyperplasia stage as part of 
regeneration process in the lung rather than being a change induced by viral infection.
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Figure 3.20 Wood mouse, vMlstop infected, day 3 p.i. Ultrastructure.
A,B represent same figure but in B, cells have been outlined using the colour coding (orange: 
macrophage; yellow: pneumocyte type II; brown: pneumocyte type I; blue: intertitium, red: 
endothelium; green: intravascular cell. Overview of alveolar wall showing a hyperplastic type II 
pneumocyte. These contained abundant lamellar bodies and an extremely rugged apical 
cytoplasmic membrane. Within the interstitium there were macrophages with abundant lipid in 
the cytoplasm.
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Figure 3.21 Wood mouse, vMlstop infected, day 3 p.i. Ultrastructure.
A,B represent the same figure but in B, the cells have been outlined using the colour coding 
(orange: macrophage; brown: pneumocyte type I; blue: intertitium. There is also cross 
referencing of equivalent areas between images using unicase letters. Close up of the interstitial 
macrophage surrounded by type I pneumocytes; I: Lipid vacuoles occupy most of the cytoplasm 
and compress nucleus; II: lipid in cytoplasm (c) and within the interstitium (d); III: Extensive 
basement membrane reduplication, a degenerative change preceding cell death in a type I 
pneumocyte cytoplasm underlying macrophage; IV: Close up of type I pneumocyte with 
circular structure resembling size and shape of a viral particle ~155r|m that appears to be being 
enveloped; V: Close up of zona adherens between neighbouring type I pneumocytes; VI: 
Roughly circular structure within alveolar space and attached to cytoplasmic membrane of type 
I pneumocyte which has the approximate shape to a viral particle ~130x200 qm;
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Figure 3.22 Wood mouse, vMlrev infected, day 3 p.i. Ultrastructure.
A: Type II pneumocytes in vMlrev infected mice were observed to have fewer lamellar bodies 
(dashed arrow) than in vMlstop infected mice (Figure 3.21). Large glycogen lakes (arrows) 
were also noted in the interstititium.; B: Binucleated type II pneumocyte (arrow) without 
evidence of active viral replication. EM
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3,2.1.2.2.2 Day?
By day 7 p.i., there was further increased cellularity when compared to day 3 p.i in 
both vMlrev and vMlstop infected mice. In vMlrev infected mice, the increased cellularity 
exhibited a more diffuse pattern. However, in the vMlstop infected mice there was a 
multifocal pattern (Figure 3.23 C, D). This distribution was also obvious at the macroscopic 
level (Figure 3.23 A, B). In the vMlstop infected animals, despite the multifocal pattern, 
the changes observed were more intense and included necrotic foci with fibrinous centres 
(Figure 3.24), a more intense type II pneumocyte hyperplasia (Figure 3.24) and 
macrophage infiltration. Type II pneumocytes often showed mitotic figures and were 
occasionally binucleated. In the vMlstop infected animals there was also more frequent, 
occasionally larger, better demarcated iBALT (Figure 3.23, Figure 3.24) and rare syncytia 
formation (Figure 3.24). Within the alveolar space, in either infection desquamated 
macrophages were frequently observed.
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Figure 3.23 Wood mouse, vMlstop and vMlrev infected, day 7 p.i. Macroscopic 
appearance and histology of lung.
A-D: macroscopic appearance; C, D represent same images as A,B respectively but dashed lines 
have been drawn to highlight consolidation areas; E, F:, HE stained sections Bars= 250pm; A, 
C, E: vMlrev, focally extensive areas of consolidation (A) correlated with focally extensive 
areas of increased cellularity(C); B, D, F: vMlstop, multifocal pattern consolidation (B) 
correlated with multifocal areas of increased cellularity (D). Arrows in E, F highlight iBALT.
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Figure 3.24 Wood mouse, vMlstop infected, day 7 p.i. Lung. Histology and 
immunohistology.
A,B: Foci of necrotic debris (arrow with round tip) and fibrin deposition (full arrow), 
surrounded mainly by macrophages (dashed arrow); C,D:. Close up of area of severely 
increased cellularity. Cells showed severe anisocytosis and anisokaryosis, frequent mitotic 
figures (arrow in A) and were occasionally binucleated (arrow in B); E,F: Close up of an 
alveoli with moderate type II pneumocyte (arrows) hyperplasia; D: Immunohistology confirmed 
cells showing severe anisocytosis and anisokaryosis and binucleated cells (dashed arrow) to be 
type II pneumocytes (full arrow); E: iBALT surrounding an artery; F: syncytial cell (arrow) 
within alveolar lining. A, B, C, D, E: H&E stained sections. F: Immunohistology using marker 
for type II pneumocyte (PAP method, Papanicolaou’s haematoxylin counterstain); G,H: 
Semithin TB stained sections; Bars= A= 20pm; B, C,D, F,G= 25 pm; H=100 pm
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Figure 3.25 Wood mouse, vMlstop and vMlrev infected, day 7 p.i. Lung. 
Immunohistology using marker for type II pneumocytes, B and T cells.
A,C, E: vMlrev; B,D,F: vMlstop infected wood mice. A,B: Immunohistology using marker for 
Type 11 pneumocytes; C,E and D,F: corresponding areas in the lung sections. C,D: 
Immunohistology using marker for T cells; E, F: Immunohistology using marker for B cells. B 
cells in iBALT (arrows) form larger and better demarcated clusters (follicles) in vMlstop 
infected animals. In either infections, iBALT is composed mostly by B cells. PAP method (T 
cell marker); ABC method (B cell marker), Papanicolaou’s haematoxylin counterstain 
Papanicolaou’s haematoxylin counterstain. Bars= A,B= 25 pm; C-F= 100 pm
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3.2.1.2.2.3 Day 14
In comparison to previous timepoints, at day 14 p.i. the overall cellularity was 
markedly reduced but there was very little difference between animals infected with either 
virus (Figure 3.26). As in the mock infected mice, the alveoli were mainly lined by type I 
pneumocytes and type II pneumocytes were rarer (Figure 3.27). The septae were mildly to 
moderately and diffusely expanded due to infiltration of the interstitium mainly by 
macrophages and to a lesser extent B cells and T cells; the macrophage infiltration being 
more intense in this location than at previous timepoints (Figure 3.27). In the vMlrev 
infected animals, when compared to day 7 p.i, the iBALT seen surrounding 
bronchi/bronchioles and medium size vessels was more frequent and better demarcated 
(Figure 3.26). In both infections, the iBALT was still composed mainly of B cells, but at 
this time point also contained a high number of T cells (Figure 3.28).
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Figure 3.26 Wood mouse, vMlstop and vMlrev infected, day 14 p.i. Lung macroscopic 
appearance and histology of lung.
A, B: macroscopic appearance; C-E:, HE stained sections. A, C: lung of vMlrev infected wood 
mouse; B, D: lung of vMlstop infected wood mouse. There was little difference between 
infections. Macroscopically, lungs appear unaltered. Compared to previous timepoints the 
overall cellularity was markedly reduced. In the vMlrev infected wood mouse, when compared 
to day 7 p.i., the iBALT (arrows in B,C) was more frequent and better demarcated and more 
pronounced. Bars= C,D=250|im;
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Figure 4.27 Wood mouse, vMlstop and vMlrev infected, day 14 p.i. Immunohistology 
using marker for type II pneumocytes, epithelial cells, macrophages.
A, C, E: corresponding areas in the lung of vMlrev; B, D, F: corresponding areas in the lung of 
vMlstop infected. Immuhistology using markers for type II pneumocytes (A,B), epithelial cells 
(C, D). macrophages (E,F). Slender cells lining alveoli, not positive when using type II 
pneumocyte marker, interpreted as type I pneumocytes. There is little difference between the 
infections. However, when compared to day 7 p.i, at day 14 p.i., in both infections, in the 
alveolar lining, type II pneumocytes were much decreased in numbers whilst type I 
pneumocytes were much increased and were the majority of cells present. Furthermore, when 
compared to day 7 p.i, the interstitium, at day 14 p.i. showed increased infiltration by 
macrophages. PAP method Papanicolaou’s haematoxylin counterstain. Bars=100 pm
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Figure 3.28 Wood mouse, vMlstop and vMlrev infected, day 14 p.i. Lung 
immunohistology using marker for T and B cells.
A, C: corresponding areas in the lung of vMlrev; B, D: corresponding areas in the lung of 
vMlstop infected. Immuhistology using markers for T cells (A,B) and B cells (C,D). Arrows 
highlight iBALT surrounding arteries and bronchioles. There is little difference between 
infections. However when compared to day 7 p.i, at day 14 p.i. the proportion of T cells in the 
iBALT, in relation to B cells was increased. PAP method Papanicolaou’s haematoxylin 
counterstain B cell marker: ABC method Papanicolaou’s haematoxylin counterstain. Bars= 
100pm
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3.2.1.2.2.4 Day 28
At day 28 p.i, histologically there was very little difference between the overall 
cellularity in the lungs of animals infected with either virus (Figure 3.29). At day 28 p.i., 
the most significant difference between the vMlstop and vMlrev infection was the 
presence of more frequent and pronounced iBALT surrounding bronchi/bronchioles and 
medium sized vessels in the vMlstop infected mice. iBALT was mostly composed of B 
cells, but also contained numerous T cells as seen in day 14 p.i (Figure 3.29). When 
compared to mock infected wood mice, in the vMlrev infected mice in the interstitium, 
there was still a mild infiltration by macrophages (Figure 3.30). The presence of type II 
pneumocytes in the alveolar lining, in either infection was similar to that seen in mock 
infected wood mice.
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Figure 3.29 Wood mouse, vMlstop and vMlrev infected, day 28 p.i. Lung. Histology and 
immunohistology using marker for T and B cells.
A,C,E: corresponding areas in the lung of vMlrev infected animal; B,D,F: corresponding areas 
in the lung of vMlstop infected animal. A,B: HE stained sections; C,D: Immunohistology using 
marker for T cells; E,F: Immunohistology using marker for B cells. On histology there is little 
difference between infections but immunohistology confirmed iBALT (arrows) being more 
pronounced in the vMlstop infection. A, B: HE stained sections. PAP method (T cell marker); 
ABC method (B cell marker) Papanicolaou’s haematoxylin counterstain. Bars= lOOpm
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Figure 3.30 Wood mouse, vMlstop and vMlrev infected, day 28 p.i. Lung. Histology and 
immunohistology using marker for macrophages and type II pneumocytes.
A, C: corresponding areas in the lungs of vMlrev infected animal; B, D: corresponding areas in 
the lungs of vMlstop infected animal. A, B: HE stained sections; C, D: Immunohistology using 
marker for macrophages; E, F: Immunohistology using marker Type II pneumocytes. On 
histology there is little difference between infections but immunohistology confirmed mild 
interstitial infiltration by macrophages in the vMlrev infected wood mice. Type II pneumocytes 
presence in alveolar lining, in either infections however was similar to that seen in mock 
infected wood mice. A, B: HE stained sections. C-F: PAP method Papanicolaou’s haematoxylin 
counterstain. Bars= 25 pm
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3.2.1.3 Viral load in the nasal cavity and lung following vMlstop and vMlrev 
infection
Viral load was measured in order to assess MHV-68 replication. The tissues 
examined were, nasal cavity, the route of infection in this experiment and the lung the main 
site of MHV-68 acute infection. The hypothesis tested was that in the natural host, the 
presence or absence of Ml transcription would lead to changes in MHV-68 replication.
The viral load in the nasal cavity was assessed at day 3 and day 7 p.i., times 
representative of acute infection. The viral load was highest in vMlstop and vMlrev 
infection at day 3 p.i and decreased by day 7 p.i (Figure 3.31]. However, the statistical 
analysis using an unpaired t test did not reveal a significant difference (P>0.05), this is 
likely due to high biological variability per infection.
In the lung, viral load was determined at day 3 and 7 p.i (times representative of acute 
infection) and day 14 and 28 p.i. (times representative of latent infection). Similarly to that 
seen in the nasal cavity, viral load was highest at day 3 p.i and decreased thereafter. 
Differences in viral load between viral infections were statistically significant at day 14 and 
28 p.i (Figure 3.31). At day 14 p.i vMlstop infected animals showed more than a tenfold 
less of viral load when compared to vMlrev infected animals. At day 28 p.i. in vMlstop 
infected animals, the viral load observed at day 14 p.i remained approximately the same. 
On the other hand, at day 28 p.i in vMlrev infected mice, there was a greater decrease in 
viral load of approximately a hundredfold when compared to the values on day 14 p.i. 
Within the vMlrev infection there was a significant decrease in the viral load between day 
7 and day 14 p.i. and between day 14 and day 28 p.i.
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A
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Figure 3.31 Wood mouse, vMIstop and vMIrev infected. Viral load in nasal cavity and 
lung tissue.
A and B are representations of viral load determined by 2 separate real time PCR experiments, 
using genomic DNA extracted from nasal cavity tissue (A) and lung (B) of wood mice infected 
with vMIrev and vMIstop virus. n=3 per virus per time point. Error bars represent SEM and 
significant differences were determined by an unpaired t test (*p<0.05, **p<0.01). In the nasal 
cavity, there were no significant statistical differences detected at day 3 and 7 p.i. In the lung the 
time when viral load was highest in either infections was at 3 d.p.i and it decreased thereafter. 
Differences in viral load between viruses were statistically significant at day 14 and 28 p.i. 
vMIstop infected animals showed more than a tenfold less of viral load at day 14 p.i when 
compared to vMIrev infected animals. The viral load observed at day 14 p.i remained 
approximately the same at day 28 p.i. in vMIstop infected animals. On the contrary, in vMIrev 
infected mice, at day 28 p.i there was a great decrease in viral load of approximately a 
hundredfold when compared to the values on day 14 p.i.
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3.2.1.4 Presence of viral antigen in the nasal cavity and lung
Immunohistology was performed using anti-MHV-68 antibody. The antibody used is 
a rabbit polyclonal anti-MHV-68 serum raised against infected RK-13 cells and with 
specificity for structural proteins and thus is an indicator of lytic infection.
In the nasal cavity, no viral antigen was detected at any time. In the lungs, at day 3 
p.i., in both infections, lytic infection was shown in mainly type I pneumocytes and to a 
much lesser extent type II pneumocytes. At day 7, in both infections, the overall presence 
of viral antigen was reduced. However lytic infection was still shown in type I and type II 
pneumocytes as seen in day 3 p.i. and was also seen in macrophages (Figure 3.32). In both 
infections the increased cellularity did not correlate with the amount of antigen detected 
and on the contrary the majority of cells seen in the areas of increased cellularity, did not 
exhibit the presence of viral antigen. Viral antigen was more frequently seen in areas where 
pathological changes were less severe.
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Figure 3.32 Wood mouse, vMlstop and vMlrev infected, day 3 and 7 p.i. Lung. 
Immunohistology for demonstration of viral antigen.
A, C: vMlrev infected animals; B, D vMlstop infected animals. A,B: day 3 p.i.; C,D: day 7 p.i.; 
Cells bearing antigen include pneumocytes type I (full arrows); pneumocytes type II (arrow 
with round tip) ; macrophages (dashed arrow). At day 3 p.i, in both infections, lytic infection 
was shown in mainly type I pneumocytes and to a much lesser extent type II pneumocytes. In 
the vMlstop infected animals the majority of cells seen in the areas of increased cellularity (B), 
did not exhibit the presence of viral antigen. At day 7, in both infections, the presence of viral 
antigen was reduced. However lytic infection was shown in macrophages, type I and type II 
pneumocytes (Figure 3.32). In both infections the majority of cells seen in the areas of increased 
cellularity, did not exhibit the presence of viral antigen. PAP method Papanicolaou’s 
haematoxylin counterstain Bars= 25pm
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3.2.1.5 Viral gene expression in latently infected cells in the lung
RNA-m situ hybridisation was performed using a vtRNA riboprobe on sections from 
the nasal cavity and lung. vtRNA refers to vtRNA-like sequence elements located at the 
extreme 5 'end of the genome, which are known to be expressed both in lytic and latent 
replication. If vtRNA transcript is detected and not associated with viral antigen, it is 
assumed that it represents latent infection. Tissues examined were from wood mice culled 
at day 3, 7, 14 and 28 p.i. with either vMlrev or vMlstop MHV-68. In the nasal cavity, no 
vtRNA transcripts were detected at any time.
At day 3 p.i, in the lung of wood mice infected with either vMlrev and vMlstop 
virus, vtRNA was detected in lymphocytes within the iBALT, intravascularly and 
occasionally in the interstitium. However, this was less intense and less frequent in the 
vMlstop infected animals (Figure 3.33).
At day 7 p.i. vtRNA transcripts were detected equally in both infections in 
lymphocytes within the iBALT, intravascularly and occasionally in the interstitium (Figure 
3.33). Furthermore, at day 7, in the lung of vMlstop infected animals vtRNA was also 
detected in type II pneumocytes in the alveolar lining and in macrophages in the 
interstitium and desquamated into the alveolar space (Figure 3.35).
The samples examined from day 14 and day 28 p.i. showed tRNA transcripts in 
lymphocytes in the iBALT.
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Figure 3.33 Wood mouse, vMlstop and vMlrev infected, day 3 p.i. Lung. RNA-ISH using 
vtRNA riboprobe.
A,C: vMlrev infected wood mice; B: vMlstop infected wood mice. Transcription of vtRNA 
detected in lymphocytes in peribronchiolar/perivascular areas (arrow), intravascularly (dashed 
arrow) and occasionally within the alveolar wall (arrow with round tip). This is most frequently 
seen in the vMlrev infected animals. RNA-ISH, NBT/BCIP, Papanicolaou’s haematoxylin 
counterstain. Scale bars 50 pm
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Figure 3.34 Wood mouse vMlrev infected, day 7 p.i. Lung. RNA-ISH using vtRNA 
riboprobe and immunohistology using marker for T and B cells.
A,B,C: Represent sequential sections of same area. A: RNA-ISH using vtRNA riboprobe. 
vtRNA transcripts in lymphocytes clustered within the iBALT (arrows with round tip), single 
lymphocytes intravascular (dashed arrow) and lymphocytes adjacent to endothelial surface, 
rolling (full arrow); B: Immunohistology using marker for T. The cells observed to show 
vtRNA transcripts are not T cells; C: Immunohistology using marker for B cells. Cells observed 
to exhibit vtRNA transcripts are B cells: lymphocytes clustered within the iBALT (arrow with 
round tip), single lymphocytes intravascular (dashed arrow) and lymphocytes adjacent to 
endothelial surface, rolling (full arrow). RNA-ISH, NBT/BCIP, Papanicolaou’s haematoxylin 
counterstain. PAP method (T cell marker); ABC method (B cell marker), Papanicolaou’s 
haematoxylin counterstain; Bars=25 pm
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Figure 3.35 Wood mouse, vMlstop infected, day 7 p.i. Lung RNA-ISH using vtRNA 
riboprobe.
vtRNA positive lymphocytes (full arrows) within the iBALT, intravascular and in adjacent 
alveoli. In the interstitium (A,B,D) and desquamated into alveoli (E) vtRNA positive cells 
(arrows with round tip) larger than lymphocytes consistent with macrophages are seen. Also 
occasional cells lining alveoli, consistent with type II pneumocytes were positive for 
vtRNA(arrow with square tip in C). RNA ISH, NBT/BCIP, Papanicolaou’s haematoxylin 
counterstain. Bars: A,B,C= 25 pm; D=50 pm
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3.2.1.6 Ultrastructural study of viral replication in the lung
Electron microscopy was used to examine viral replication in situ. Active viral 
replication was only seen in vMlrev infected animals at day 3 p.i. The cells where 
replication was observed showed extensive degenerative changes when replication was 
highly active (Figure 3.36 - Figure 3.38). These cells were identified to be type II 
pneumocytes due to the presence of lamellar bodies and/or the intercellular junctions, zona 
adherens. The nuclei of these cells were swollen and exhibited peripheralization of the 
chromatin leading to a thick electron dense area adjacent to the inner nuclear membrane. 
The remaining nucleus exhibited lake like areas where the chromatin was mildly denser and 
where the “viral factories” were seen (Figure 3.37). “Viral factories” consisted of areas 
where empty and packed capsids measuring 73-76 r|m were most numerous and often 
clustered. The space between the inner and outer leaflet of the nuclear membrane was 
irregularly expanded and the profile of the latter showed wide “corrugations”. In the 
cytoplasm the viral particles were within membrane bound tubules consistent with a 
swollen Golgi apparatus and were bigger than those seen in the nucleus. There were two 
types of viral particle, those with several circular demarcations and those which were 
completely electron dense with no identifiable structure. The inner circular demarcation 
was of the same size as the ones seen in the nucleus thus likely represents the capsid, the 
middle demarcation ~115-126r|m in diameter likely represents the primary envelope and 
the outer demarcation, ~ 168-172rim likely represents the secondary envelope. The 
cytoplasmic viral particles were occasionally surrounded or adjacent to abundant electron 
dense material, possibly tegument related. The cytoplasmic organelles including Golgi and 
mitochondria were frequently expanded with the mitochondrial cristae profile being 
effaced.
3.2.1.7 Summary of morphological and immunohistological findings in the lung.
The findings in the lung of wood mice infected with vMlstop and vMlrev are 
summarized in Table 3.3.
124
Chapter 3 Results
Figure 3.36 Wood mouse, vMlrev infected, day 3 p.i. Lung Ultrastructure.
A,B - Overview of the alveolar architecture. B represents the same image as A but with the cells 
outlined using the following colour code: macrophage (orange), pneumocyte type II (yellow), 
pnemocyte type I (brown, in the top right comer of the picture); endothelium (red); intravascular 
cell (green) and interstitium (blue). In the alveolar lining, there is a type II pneumocyte showing 
active viral replication (full arrow in B). The interstitium is severely expanded due to necrotic 
debris and cellular infiltration. Within the interstitium there are cellular processes with 
numerous fully formed viral particles (dashed arrow in B).
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Figure 3.37 Wood mouse, vMlrev infected, day 3 p.i. Lung Ultrastructure of viral 
particles.
A,B- Close up of the type II pneumocyte highlighted with full arrow in Figure 3.36 B, showing 
the viral particles at the different locations. Intranuclear distribution of chromatin and 
effacement of cytoplasmic organelles; B,C: represent the same image but in B circular 
demarcations of the viral particles outlined using the following colour code as to facilitate the 
discerning of the different structures. Dashed blue: empty capsid; Blue: packed capsid; Yellow: 
primary envelope; Red: secondary envelope;
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Figure 3.38 Wood mouse vMlrev infected, day 3 p.i. Lung. Ultrastucture.
A: Type II pneumocyte with intranuclear structures consistent with fully formed viral particles 
(~170 r|m - arrows) but showing no evidence of active viral replication. There is a virion in the 
adjacent extracellular space (arrowhead). B: Area of increased interstitial cellularity composed 
mostly of hyperplastic and active type 11 pneumocytes, macrophages and not identifiable 
degenerating cells. There is a cell in the centre showing active viral replication (white arrow). In 
the cytoplasm of the central cell there are numerous lamellar bodies indicating this to be a type 
II pneumocyte (dashed white arrow). A,B: lamellar bodies highlighted by dashed arrows.
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Days
p.i.
Lung of vMlstop
Infected wood mouse
Lung of vMlrev 
infected wood mouse
3 MF > cellularity (++/+++)
>Type II pneumocytes (+/++)
Macrophages often containing lipid: 
interstitial (+/++); alveolar (+/++) 
Lymphocytes, interstitial (+/++)
More frequent iBALT (+) 
vAg: type I & type II pneumocytes 
vtRNA: lymphocytes - iBALT, 
intravascular and interstitial (+)
Viral load peak
MF increase in cellularity (+)
> Type II pneumocytes (+)
Viral factories: type II pneumocytes: 
Macrophages: interstitial (+); alveolar 
(+)
Lymphocytes, interstitial (+)
Minimal iBALT (+) 
vAg: type I & type II pneumocytes 
vtRNA: lymphocytes - iBALT, 
intravascular and interstitial (+/++) 
Viral load peak
7 MF increase in cellularity (++/+++) 
Type II pneumocytes 
hyperplasia(++/+++)
Type I pneumocyte necrosis (+/++)
MF fibrino-necrotic foci
Macrophages: interstitial (++); alveolar 
(++/+)
Lymphocytes, interstitial (+/++)
More frequent iBALT (+)
vAg: type I and type II pneumocytes
and macrophages - more frequent in
less altered areas
vtRNA: lymphocytes - iBALT,
intravascular and interstitial; type II
pneumocytes; macrophages
D increase in cellularity (++/+++)
Type II pneumocytes 
hyperplasia(++/+)
Type I pneumocyte necrosis (+/++)
Macrophages: interstitial (+/++); 
alveolar (+/+++)
Lymphocytes, interstitial (+/++) 
iBALT (+)
vAg: type I and type II pneumocytes 
and macrophages - more frequent in 
less altered areas 
vtRNA: lymphocytes - iBALT, 
intravascular and interstitial
14 MF increase in cellularity (+)
Type II pneumocytes hyperplasia(+) 
Macrophages: interstitial (++/+++); 
alveolar (+)
Lymphocytes, interstitial (+/++) 
iBALT (++)
vtRNA: lymphocytes - iBALT 
< viral load than d7 p.i. & vMlrev at 
day 14 p.i.
MF increase in cellularity (+)
Type II pneumocytes hyperplasia(+) 
Macrophages: interstitial (++/+++); 
alveolar (+)
Lymphocytes, interstitial (+/++) 
iBALT (++)
vtRNA: lymphocytes - iBALT 
< viral load compared to day 7 p.i.
28 iBALT (++)
vtRNA: lymphocytes — iBALT
Viral load similar to day 14 p.i.
iBALT (+)
vtRNA: lymphocytes - iBALT 
< viral load compared to day 14 p.i.
Table 3.3 Summary of main findings in the lung of wood mice over a 28 day timecourse 
following vMlstop or vMlrev infection.
Semiquantitative parameters used to represent number of cells: + (scattered cells); ++ (moderate 
number of cells); +++ (numerous cells); MF: multifocal; D: diffuse; vAg: viral antigen; <: 
significant decrease;
>: significant increase;
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3.2.1.8 Cytokine expression in the lung and airways following infection of the 
woodmouse with vMlstop and vMlre v
Considering the increase in macrophages in the absence of Ml expression, studies 
were performed to determine the mechanism of their activation and their secretion profile. 
CCSP expression was semiquantified using RNA-ISH. Secretion of TNF-a was assessed by 
immunohistology. Further cytokines were semiquantified using qPCR: IL-10, TNF-a, IFN- 
Y, MIPl-a, MIP-ip, RANTES, TGF-(3, HGF and IL-10p35. qPCR was also used to 
determine the relative expression of the enzymes Arginase 1 and iNOS.
3.2.1.8.1 Mock infected wood mice.
Wood mice instilled intranasally using PBS (mock infected) served to identify the 
baseline for the semiquantitative analysis of cytokine/enzyme expression and secretion.
CCSP expression in mock infected wood mice was seen to be restricted to Clara cells 
lining bronchioles (Figure 3.39). TNF-a secretion was seen sparsely in few scattered cells 
including occasional bronchiolar epithelial cells and macrophages within the pulmonary 
interstitium, mainly in close proximity to bronchioles (Figure 3.40). qPCR analysis was 
performed using the Pfaffl equation. In this analysis the baseline (the value of 1) 
corresponds to the values obtained in mock infected wood mice.
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Figure 3.39 Wood mouse, mock infected. Lung. CCSP mRNA expression.
CCSP expression by Clara cells (arrows with round tip) lining the lower bronchi and 
bronchiolar epithelium in all animals. RNA-1SH, NBT/BCIP, Papanicolaou’s haematoxylin 
counterstain. Bar = 25 pm
Figure 3.40 Wood mouse, mock infected. Lung. Immunohistology for demonstration of 
TNF-a.
TNF-a secretion is seen sparsely in few scattered cells including bronchial epithelial cells 
(dashed arrow) and macrophages in close proximity to bronchioles (arrow). ABC method 
Papanicolaou’s haematoxylin counterstain. Bars A = 25 pm
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3.2.1.8.2 CCSP in situ expression in the lower airways of infected wood mice
Expression of CCSP in the lower airways and lung was assessed by RNA-ISH using a 
CCSP riboprobe. This experiment was performed on sections of lung from vMlstop and 
vMlrev infected animals. The times chosen were day 3 and day 7 p.i, representative of 
acute infection.
At day 3 p.i. in comparison to the mock infected wood mouse, in the vMlstop 
infected mouse, there was a severe decrease in the expression of CCSP in cells (Clara cells) 
lining the lower bronchi and bronchiolar epithelium (Figure 3.41).
At day 7 the expression of CCSP in cells (Clara cells) lining the lower bronchi and 
bronchiolar epithelium was decreased in both types of infection. When comparing both 
types of infection, the decrease was greater in the vMlstop infected wood mice (Figure 
3.41).
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Figure 3.41 Wood mouse, mock, vMlrev and vMlstop infected, day 3 and 7 p.i. Lung 
CCSP mRNA expression.
A,C,E: vMlrev infected; B, D, F: vMlstop infected animals; CCSP expression by cells (Clara 
cells) lining the lower bronchi and bronchiolar epithelium in all animals. At day 3 p.i (A-D), in 
the vMlstop infected mouse, there was a severe decrease in the expression of CCSP in. At day 7 
(E, F) the expression of CCSP was decreased in both types of infection, the decrease being 
greater in the vMlstop infected wood mice. RNA-ISH, NBT/BC1P, Papanicolaou’s 
haematoxylin counterstain. Bars: A, B= 100 pm; C, D = 25 pm E,F= 50 pm
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3.2.1.8.3 TNF-a secretion in the lower airways and lung of infected wood mice
Secretion of TNF-a was assessed by immunohistology in vMlstop and vMlrev 
infected wood mice at day 3, 7, 14 and 28 p.i.
At day 3 (Figure 3.42) and to a greater extent at day 7 p.i. (Figure 3.43), in both 
vMlstop and vMlrev infection, TNF-a was seen in the cytoplasm of tracheal, bronchial 
and bronchiolar respiratory epithelial cells, macrophages within interstitium and type II 
pneumocytes. Secretion was also detected in numerous cells in close proximity to the 
bronchioles, including within the iBALT (Figure 3.42). However the proportion of positive 
cells was higher in the lung from vMlstop infected wood mice, in particular in the 
multifocal areas of increased cellularity (Figure 3.42).
At day 14 p.i. (Figure 3.44) in both infections, TNF-a presence was no longer 
detected in tracheal and bronchial respiratory epithelial cells but was still seen in 
bronchiolar respiratory epithelial cells, macrophages within interstitium and type II 
pneumocytes. Secretion was also detected in numerous cells in close proximity to the 
bronchioles, including within the iBALT. Secretion was severely decreased when compared 
to previous times and there were few differences between vMlstop and vMlrev infection.
At day 28 TNF-a presence was similar to that which was observed in mock infected 
wood mice.
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Figure 3.42 Wood mouse. Mock, vMlrev and vMlstop infected, day 3 p.i. Lung. 
Immunohistology for demonstration of TNF-a.
A, B: vMlrev; C, D: vMlstop infected; vMlrev and vMlstop infected animals show increased 
secretion of TNF-a in comparison to mock infected mice. TNF-a in the cytoplasm bronchiolar 
epithelial cells (dashed arrows), macrophages within interstitium (full arrow) and type II 
pneumocytes (arrow with round tip). Secretion was also detected in numerous cells in 
parenchyma in close proximity to bronchioles (arrow with square tip), including within the 
iBALT. The proportion of positive cells was higher in the lung from vMlstop infected wood 
mice, in particular in the multifocal areas of increased cellularity (D). ABC method 
Papanicolaou’s haematoxylin counterstain. Bars A-D = 25 pm
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Figure 3.43 Wood mouse, vMlrev and vMlstop infected, day 7 p.i. Lung. 
Immunohistology for demonstration of TNF-a.
A,C: vMlrev infected; B-D: vMlstop infected; TNF-a in the cytoplasm tracheal epithelial cells 
(dashed arrows), macrophages within interstitium and type II pneumocytes ((dashed arrow with 
round tip - binucleated). Secretion was also detected in cells in close proximity to bronchioles 
(arrow with square tip). The proportion of positive cells and the intensity of signal was higher in 
the lung from vMlstop infected wood mice. ABC method Papanicolaou’s haematoxylin 
counterstain. Bar = 25 pm
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Figure 3.44 Wood mouse, vMlrev and vMlstop infected, day 14 p.i. Lung. 
Immunohistology for demonstration of TNF-a.
A: vMlrev infected; B: vMlstop infected; TNF-a is severely reduced compared to previous 
times and there is little difference between types of infection. ABC method Papanicolaou’s 
haematoxylin counterstain. Bar = 25 pm
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3.2.1.8.4 Expression of enzymes and cytokines involved in macrophage activation
Cytokine expression was evaluated by real time PCR performed on cDNA
synthesised using RNA extracted from lung tissue of wood mice infected with vMlstop and 
vMlrev and culled at day 7 p.i. The gene expression ratio was determined using the Pfaffl 
equation 316 with values of test samples being normalized against the Ct values obtained 
from mock infected wood mice. Cytokines assessed were IL-10, TNF-a, IFN-y, MIPl-a, 
MIP-ip, RANTES, TGF-p? HGF, IL12p40 and IL-10p35.
Also analysed was the expression of the enzymes NOS2 and Arginase I in order to 
determine the main pathway leading to macrophage activation.
As Figure 3.45 shows in wood mice infected with vMlrev, there is almost a tenfold 
increase in IL-10 and NOS2 expression. To a lesser extent there is an increase in MIPl-f3, 
TNF-a and TGF-p and a decrease in HGF expression. When compared to the vMlstop 
infection it can be seen that there is the same trend in the expression of most cytokines. 
However, in the vMlstop infection, there is almost a tenfold further increase in expression 
of IL-10 and TNF-a. Other differences in expression seen in vMlstop infection were an 
increase in MIPla expression, a decrease in MIPl-p and arginase I expression, and no 
change in HGF expression.
3.2.1.8.5 Summary of findings in the in vivo studies of relative cytokine 
expression/secretion
The findings of CCSP transcript expression analysis by RNA-ISH, TNF-a secretion 
analysis by immunohistology and relative expression of IL-10, TNF-a, IFN-y, MIPl-a, 
MIP-lp, RANTES, TGF-p, HGF, IL12p40 and IL-10p35 analysis by qPCR, are 
summarized in Table 3.4.
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Figure 3.45 Cytokine/enzyme expression in vMIstop and vMIrev infected woodmice in 
comparison to expression in mock infected wood mice, at day 7 p.i.
Values obtained through qPCR performed on cDNA synthetized from RNA extracted from the 
lung tissue of infected wood mice. n=3 per time point, per infection. Error bars represent the 
standard error of the mean. Base level (dashed line) represents values obtained from mock 
infected mice. A: In both types of infection there is an increase in IL-10, TNF-a, NOS- and 
TGF-P The increase is however highest in the vMIstop infected animals which also showed an 
increase in MIP-la expression. The latter was not observed in vMIrev infected animals. B: In 
wood mice infected with vMIrev, there is little change in the expression of arginase I and in 
IFN-y. IFN-y shows also little change in the vMIstop infected animals. Contrary to the findings 
in vMIrev infected animals, in vMIstop infected woodmice, Arginase I and to less extent HGF 
and MIP1-P showed a decrease in expression. vMIrev infected animals showed a mild increase 
in MIP1-P expression. RANTES expression showed too much variability within types of 
infection in order to allow a conclusive interpretation.
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Lung vMlstop vMlrev
3 Immunohistology:
< CCSP by Clara cells 
»TNF-a by respiratory 
epithelial cells (trachea, 
bronchi & bronchioles), 
macrophages and type II 
pneumocytes (++)
Immunohistology:
No A in CCSP by Clara cells 
>TNF-a by respiratory 
epithelial cells (trachea, 
bronchi & bronchioles), 
macrophages and type II 
pneumocytes (+)
7 « CCSP by Clara cells 
>TNF-a by respiratory epithelial 
cells(trachea, bronchi & 
bronchioles), macrophages and type 
II macrophages (+++) 
qPCR (approximate fold change): 
75x > IL-10 
lOx > MDMa 
lOx: > TNF-a
5x <MIP1“P
No A in IFN-y 
lOx > iNOS 
lOx < Arginase I
5x > TGF-P
Little A HGF
< CCSP by Clara cells 
»TNF-a by respiratory epithelial 
cells (trachea, bronchi & 
bronchioles), macrophages and type 
II macrophages (++) 
qPCR(approximate fold change): 
10x> IL-10
No A in MIP-la
2.5x: > TNF-a
2.5x > MIPl-p
No A in IFN-y 
lOx > iNOS
Little A Arginase I
5x> TGF-p
10x<HGF
14 Immunohistology:
>TNF-a by respiratory 
epithelial cells(bronchioles), 
macrophages (inc. in iBALT) 
and type II pneumocytes (+)
Immunohistology:
>TNF-a by respiratory 
epithelial cells(bronchioles), 
macrophages (inc. in iBALT) 
and type II pneumocytes (+)
28 Immunohistology:
TNF-a secretion returned to 
baseline levels
Immunohistology:
TNF-a secretion returned to 
baseline levels
Table 3.4 summarising findings in the study of relative cytokine expression/secretion in the 
lung of vMlstop and vMlrev infected wood mice in comparison to mock infected wood 
mice.
Semiquantitative parameters used to represent number of cells: showing expression + (scattered 
cells); ++ (moderate numbers); +++ (numerous cells)
Scale for change >: significant increase; Csignificant decrease; A: change in expression
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3.2.2 Spleen
3.2.2.1 Mock Infected wood mouse. Histological, immunohistological examination
Mock infected wood mice served as negative controls in order to determine any 
potential effects of the infection protocol. Accordingly, the examination of this group of 
mice served to identify normal structure and baseline leukocyte numbers. The morphology 
of the spleen in wood mice is very similar to that of laboratory mice. In mock infected 
animals, the white pulp is composed of primary follicles and small T cell zones (Figure 
3.46), The red pulp is filled with a wide variety of leucocytes and haematopoietic cells 
including numerous megakaryocytes.
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Figure 3.46 Wood mouse, mock infected. Spleen, white pulp.
A: Close up of lymphoid follicle (arrow). B: Close up of red pulp. In the red pulp 
megakaryocytes are highlighted using arrows with round tip in A and B. HE stained section. 
Bars: A = 50pm; B= 25pm
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3.2.2.2 Changes in the wood mouse spleen in vMlstop and vMlrev infection
There were very little differences between the white pulp of mock and mice virally 
infected mice with either virus at day 3 p.i. At day 7 p.i,, in both infections, follicles had a 
paracentral cluster of lymphocytes, without evidence of plasma cell formation (beginning 
of secondary follicle formation) (Figure 3.47). From day 14 p.i., in both infections, 
secondary follicles showed numerous plasma cells, apoptotic figures, were well demarcated 
and large sized. In the red pulp, in vMlstop infected wood mice, megakaryocytes exhibited 
intracytoplasmic vacuolation (Figure 3.48), most severe at day 3 p.i. but also present on day 
7 p.i. (Figure 3.47). At day 14 and day 28 p.i., spleens of virally infected mice were grossly 
enlarged (Figure 3.49).
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Figure 3.47 Wood mouse, mock, vMlstop and vMlrev infected, day 3, 7, 14 and 28 p.i. 
Spleen, white pulp.
A, C, E: vMlrev; B, D, F: vMlstop infected wood mice. A, B: day 7 p.i.; C, D: day 14 p.i.; E, 
F: day 28 p.i. At day 7 p.i. follicles appear to have paracentral clusters of lymphocytes (arrow), 
without evidence of plasma cell formation (beginning of secondary follicle formation). 
Secondary follicles (dashed arrows) show numerous plasma cells and apoptotic figures and are 
well demarcated and large sized from day 14 p.i. There were very little differences in respects to 
the white pulp between virally infected mice throughout the infection time course. HE stained 
sections. Bars: A, B= 50pm; D-F:100 pm
142
Chapter 3 Results
Figure 3.48 Wood mouse, mock, vMlstop and vMlrev infected, day 3 and 7 p.i. Spleen, 
red pulp.
A, C: vMlrev; B, D: vMlstop infected wood mice; A,B: day 3 p.i; C,D: day 7 p.i.. At day 3 
p.i., in both infections, the red pulp showed a very high number of megakaryoctes (arrows) 
similarly to mock infected wood mice. In vMlstop infected wood mice, these frequently 
exhibited intracytoplasmic vacuolation (dashed arrow). At day 7 p.i., in both infections, the red 
pulp showed a very high number of megakaryoctes (arrows). In vMlstop infected wood mice, 
these frequently exhibited intracytoplasmic vacuolation but this change was milder than what 
was seen at day 3 p.i. (dashed arrow). HE stained sections. Bars= 25 pm
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Figure 3.49 Wood mouse, vMlstop and vMlrev infected, day 7 and 14 p.i. Macroscopic 
view of abdominal cavity.
Abdominal cavity at day 7 (A,B) and 14 (C,D) p.i. Arrow pointing towards spleen. A, C: 
vMlrev infected wood mice; B, D: vMlstop infected wood mice. Spleens are enlarged on day 
14 p.i. in both infections in comparison to day 7 p.i.
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3.2.2.3 Viral load in the spleen
The viral load was assessed in the spleen of vMlrev and vMlstop infected wood 
mice at day 3, 7} 14 and 28 p.i. It was highest in both types of infection at day 14 p.i. 
However, statistical analysis using an impaired t test, revealed there was no significant 
difference (P>0.05), this is likely due to the high biological variability in the results 
obtained per infection.
3.2.2.4 Presence of viral antigen in the spleen
Immunohistology was performed using anti-MHV-68 antibody with specificity for 
structural proteins and thus is an indicator of lytic infection. In the spleen, viral antigen was 
only detected in vMlstop infected animals at day 7 p.i. in lymphocytes within the splenic 
red pulp (Figure 3.51).
3.2.2.5 Viral gene expression in latently infected cells in the spleen
RNA-w situ hybridisation was performed using a vtRNA riboprobe. vtRNAs are 
expressed both in lytic and latent replication. If vtRNA transcript is detected and not 
associated with viral antigen, it is assumed that it represents latent infection. At day 3 p.i., 
vtRNA-transcripts were detected in multinucleated cells in the red pulp of both infections 
(Figure 3.52). At day 7 (Figure 3.53), 14 and 28 p.i., vtRNA transcripts were detected in 
both infections in follicular lymphocytes and in megakaryocytes.
3.2.2.6 Summary of findings in the spleen.
The findings in the spleen of wood mice infected with vMlstop and vMlrev are 
summarized in Table 3.5.
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days post infection
Z2 vMIstop 
□□ vMIrev
Figure 3.50 Wood mouse, vMIstop and vMIrev infected, day 3, 7, 14 and 28 p.i. Viral 
load in splenic tissue.
Representation of viral load determined by 2 separate real time PCR experiments, using 
genomic DNA extracted from the spleen of infected wood mice. n=3 per virus per time point. 
Error bars represent SEM. Viral load was highest in both types of infection at day 14 p.i. 
Significant statistical differences were not detected when analysis was performed by an 
unpaired student t test.
Figure 3.51 Wood mouse, vMIstop infected, day 7 p.i. Spleen. Immunohistology for 
demonstration of viral antigen.
Lymphocytes (arrow) in the red pulp were seen bearing antigen. PAP method Papanicolaou’s 
haematoxylin counterstain Bar= 25pm
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Figure 3.52 Wood mouse, vMlstop and vMlrev infected, day 3 p.i. Spleen RNA-ISH using 
vtRNA riboprobe.
A: vMlrev infected; B: vMlstop infected. Transcription of vtRNA is detected megakaryocytes 
in red pulp. RNA-ISH, NBT/BCIP, Papanicolaou’s haematoxylin counterstain. Bars=25 pm
Figure 3.53 Wood mouse, vMlstop infected, day 7 p.i. Lung vtRNA in situ hybridisation. 
A: vMlrev infected; B: vMlstop infected. Transcription of vtRNA is seen in lymphocytes at the 
periphery of follicles (arrows in A and B) and megakaryocytes in red pulp (arrows in C and D). 
RNA-ISH, NBT/BCIP, Papanicolaou’s haematoxylin counterstain. Bars A,B= 50 pm; C,D= 25 
pm
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Days
p.i.
Spleen of vMlstop
Infected wood mouse
Spleen of vMlrev 
infected wood mouse
3 Megakaryocytes (++) vacuolated (++) 
Mitosis in red pulp (+/++) 
vtRNA: megakaryocytes
Megakaryocytes (++)
Mitosis in red pulp (+/++) 
vtRNA: megakaryocytes
7 Megakaryocytes (++) vacuolated (+) 
Mitosis in red pulp (+) 
vtRNA: megakaryocytes; follicular 
lymphocytes
Megakaryocytes (++) vacuolated (+) 
Mitosis in red pulp (+) 
vtRNA: megakaryocytes; follicular 
lymphocytes
vAg: red pulp lymphocytes
14 Splenomegaly
Secondary follicle formation
Peak in viral load
Megakaryocytes (++)
Mitosis in red pulp (+)
vtRNA: megakaryocytes; follicular
lymphocytes
Splenomegaly
Secondary follicle formation
Peak in viral load
Megakaryocytes (++)
Mitosis in red pulp (+)
vtRNA: megakaryocytes; follicular
lymphocytes
28 Secondary follicle formation 
Megakaryocytes (+)
Mitosis in red pulp (+)
vtRNA: megakaryocytes; follicular
lymphocytes
Secondary follicle formation 
Megakaryocytes (+)
Mitosis in red pulp (+)
vtRNA: megakaryocytes; follicular
lymphocytes
Table 3.5 Summary of main findings in the spleen of wood mice over a 28 day timecourse 
following vMlstop or vMlrev infection.
Semiquantitative parameters used to represent number of cells: + (scattered cells); ++ (moderate 
number of cells); -H-+ (numerous cells); 
vAg: viral antigen.
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3.3 In vitro studies
The aim of this part of the study was to determine the effect of Ml expression in 
MHV-68 infection of cell cultures. For this, in vitro studies were performed using 
LHAMHV-68, vMlstop virus and its genetically repaired counterpart, vMlrev virus. 
LHAMHV-68 is a GFP labelled MHV-68 virus which expresses an immediate-early 
promoter-driven green fluorescent protein. In LHAMHV-68 infection, fluorescence in 
infected cells was used as an indicator of lytic infection. vMlstop virus is an MHV-68 virus 
with an in-frame stop codon in the Ml locus. The stop codon impairs expression of Ml 
without exerting interference with the remaining genome. The vMlrev virus has been 
genetically repaired so represents in this studies MHV-68 wild type virus. By comparing 
infections with vMlstop and vMlrev virus, the effect of Ml was assessed. Two cell lines 
were used in the in vitro studies of MHV-68 infection: NIH3T3 (murine fibroblasts) and 
MH-S (murine alveolar macrophages) cells.
The hypothesis tested with these experiments was that in cell cultures, the presence or 
absence of Ml transcription would lead to different pathogenesis induced by MHV-68 
infection and/or interfere with MHV-68 replication. Furthermore when these cells were 
macrophages this effect would be further enhanced.
3.3.1 NIH3T3
3.3.1.1 LHAMHV-68 infection
NIH3T3 cells infected with LHAMHV-68 were examined for morphological changes 
and fluorescence. Observations were made at 0, 24, 48, 72 h.p.i.
Mock infected NIH3T3 cells were observed in parallel to virally infected cells, in 
order to have a control. Prior to 48 h.p.i. there was little difference between viral and mock 
infected cells in respects to cell numbers and morphology. At 48 and 72 h.p.i. (Figure 3.54, 
in mock infected cells, the total number of cells kept increasing, contrary to virally infected 
cells (described later). Degenerative changes were only seen in a few scattered cells, 
probably as a result of over confluence and lack of media renewal.
In virally infected cells, fluorescence was detected as early as 3 h.p.i. (after 
incubation and removal of inoculum - Figure 3.55 A, B) in scattered cells. At 24 h.p.i. 
(Figure 3.55 C, D) all cells were observed to exhibit fluorescence indicating that all were
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infected and the virus was undergoing lytic replicating. Despite all cells being infected only 
scattered cells showed obvious degenerative changes such as a rounded cell morphology 
and cytoplasmic vacuolation. At 48 h.p.i,(Figure 3.55 E, F), cells still exhibited 
fluorescence throughout but this was accompanied by severely altered cellular morphology. 
All cells were rounded and intracellular components were inconspicuous. The number of 
cells was also reduced and there was abundant cellular debris in solution. This is consistent 
with extensive apoptosis. These observations were enhanced at 72 h.p.i. (Figure 3.55 G> H) 
with further reduction of identifiable cells and increase in the cellular debris.
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Figure 3.54 NIH3T3 cells. Mock infected at 3, 24, 48 and 72 h.p.i.
Mock infected NIH3T3 cells at 48 h (A) and 72 h p.i (B) continued dividing and only scattered 
cells showed degenerative changes.
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Figure 3.55 NIH3T3 cells. LHAMHV-68 infected at 3,24, 48 and 72 h.p.i.
At 3 h.p.i. (A,B), scattered virally infected cells showed fluorescence. At 24 h.p.i. (C, D) all 
virally infected cells showed fluorescence but few showed degenerative changes. At 48 h.p.i. (E, 
F), all virally infected cells exhibited fluorescence and extensive degenerative changes. The 
number of cells was reduced. These observations were enhanced at 72 h.p.i. (G, H).
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3.3.1.2 Infection of NIH3T3 cells with vMlrev and vMlstop MHV-68 viruses
3.3.1.2.1 Ml expression
NIH3T3 cells were infected with vMlrev virus at an MOI (multiplicity of infection) 
of 5. At 24 h.p.i. cells were fixed and a pellet was created. Ml mRNA-ISH was performed 
in order to see the extent of Ml expression in vitro in this cell type. Immunohistology was 
performed using a marker for the viral glycoprotein to determine which cells exhibited fully 
formed viral particles, an indicator of lytic replication. Ml expression was only seen in 
scattered cells (Figure 3.56) despite the fact that all of these cells were lytically infected. 
This indicates that Ml expression during the in vitro infection of NIH3T3 cells is minimal 
despite cells being permissive to infection.
3.3.1.2.2 Viral plaque morphology
NIH3T3 cells were infected with vMlrev and vMlstop MHV-68 viruses and 
examined under light microscopy for viral plaque morphology. Comparatively, infected 
cells showed no obvious difference in respects to the viral plaque morphology “comet like 
tails” (Figure 3.57).
3.3.1.2.3 One step and multi step growth curve
NIH3T3 cells were infected with vMlstop and vMlrev MHV-68 viruses using an 
MOI of 0.05 (multi-step growth curve) and 5 (one step growth curve). The cells were 
harvested at different timepoints and were collected together with the overlying media. The 
collected material was then assessed for viral titre using a plaque assay. Statistical analysis 
of one step (Figure 3.58 A) and multi step (Figure 3.58 B) growth curves yielded similar 
results. The statistical analysis performed using two way ANOVA and Bonferroni post test 
showed there was no significant difference between the different types of infections. The 
only source of variation that led to a significant difference in viral litres (PO.OOOl) was the 
post infection time. The statistical analysis comparing the different timepoints confirmed 
the significant differences between timepoints mostly between early timepoints and the 
later ones.
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Figure 3.56 NIH3T3 cells vMlrev infected. MlmRNA expression and immunohistology 
for demonstration of viral antigen.
A: Ml mRNA is seen in scattered cells (arrow). B: Immunohistology for demonstration of viral 
antigen. Abundant viral antigen is seen throughout in all cells, confirming 100% of the cells 
exhibiting viral lytic replication. Arrows seen in A and B represent the same cell in sequential 
sections. A: RNA-ISH, NBT/BCIP, Papanicolaou’s haematoxylin counterstain. B: PAP method 
Papanicolaou’s haematoxylin counterstain .Bars = 25 pm
Figure 3.57 NIH3T3 cells. vMlrev and vMlstop infected, viral plaques.
A, C, E: vMlrev infected; B, D, F: vMlstop infected. A, B: overview of 6-well plates; C, D: 
viral plaques at 4x 0.45; E, F: viral plaques at 40 x 0.45. Toluidine blue stained. There is little 
difference in viral plaque morphology.
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Figure 3.58 NIH3T3 cells. One step and multi step growth curve of vMIstop and vMIrev 
infection.
A Multistep growth curve. B: One step growth curve. Representation of viral titres determined 
from collected cells and media in NIH3T3 cells infected with vMIrev and vMIstop virus at an 
MOl of 0.05. n=2 per virus per time point. Error bars represent SEM and significant differences 
were determined using two way ANOVA and Bonferroni post test (*p<0.05, "‘♦pO.Ol 
***p<0.0001). There was no significant difference between the types of infections.
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3.3.1.2.4 Ultrastructural study of NIH3T3 infected with vMlrev and vMlstop
Cells showing active replication had a severely enlarged electrolucent nucleus and 
a large highly vacuolated cytoplasm. This led to an overall increase of cellular size in 
comparison with cells where active replication was not observed. The different stages of 
viral particles found are represented in Figure 3.59. In cells where active replication was 
observed, in the nucleus, multifocal areas of chromatin condensation (nucleolus) were 
observed and generally these contained numerous empty and packed capsids (~70-75 
rjm in diameter) at the periphery. These capsids were also seen disseminated in the 
nuclei (Figure 3.60 - Figure 3.62). In addition, in the nucleus, numerous vesicles, lined 
by a single or a double layer and containing viral particles that were larger than the ones 
seen in the nucleoplasm were frequently seen. These vesicles were seen in areas where 
the inner and/or outer nuclear membranes were irregular and likely represent deep 
invaginations of the nuclear membrane into the nucleoplasma. In multifocal areas 
between the inner and outer nuclear membrane and in the invaginations of the nuclear 
membrane there were viral particles larger than the packed capsids (~ 130-135 qm in 
diameter) suggesting that primary envelopment had occurred. In the dilated Golgi 
apparatus, viral particles were often surrounded or adjacent to abundant electrodense 
material-tegument.
Figure 3.59 Schematic representation of viral egress based on findings from 
ultrastructural examination.
1) Empty and packed capsid in the nucleus most frequently surrounding nucleoli. 2) Filled 
capsid (capsid and genome) after fusing with the inner nuclear membrane (primary 
envelopment) 3) Primarily enveloped virus as it migrates between inner and outer leaflet of 
nuclear membrane and smooth endoplasmatic reticulum. 4) Enveloped and tegumented viral 
particles migrating through Golgi apparatus. 5) Enveloped and tegumented viral particles in 
Golgi apparatus vesicle which continues with the space between the inner and outer leaflet 
of the cytoplasmic membrane 6) Tegumented viral particles in the extracellular space.
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Figure 3.60 NIH3Te. vMlrev and vMlstop infected. Ultrastructure.
A: vMlrev infected; B: vMlstop infected; a: cytoplasm; b: nucleus; c: cell without 
evidence of active viral replication. Full arrow: nuclear viral particles; Dashed arrow: 
cytoplasmic viral particles eggressing. Cells showing active replication exhibited severely 
enlarged electrolucent nucleus and large highly vacuolated cytoplasm. There is little 
difference between infections.
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Figure 3.61 NIH3T3 cells. vMlrev infected. Ultrastructure.
a: Cytoplasm; b: Nucleus; In the cell nucleus, numerous vesicles (arrow in A and B) lined 
by a single or a double layer and containing viral particles larger than the ones seen in the 
nucleoplasm were seen. In multifocal areas between the inner and outer nuclear membrane 
(arrow in C) and in the invaginations of the nuclear membrane (dashed arrow in C) there 
were viral particles larger (~ 130-135 r|m in diameter) than the packed capsids present in the 
nucleoplasm suggesting that primary envelopment had occurred. In the dilated Golgi 
apparatus, viral particles were often surrounded or adjacent to abundant electrodense 
material (arrow in D -tegument).
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Figure 3.62 N1H3T3 cells. vMlstop infected. Ultrastructure.
a: Cytoplasm; b; Nucleus; c: Nucleolus; Areas of chromatin condensation (nucleolus) with 
numerous empty (dashed arrow in A) and packed capsids (-70-75 T|m in diameter - arrow in 
A) at the periphery. Invaginations of nuclear membrane into nucleoplasm (dashed arrow in 
B and C) and of the cytoplasmic membrane into to extracellular space (arrow in C), 
contained viral particles (~ 130-135 T|m in diameter) equally sized and with similar 
morphology. These particles were larger than the ones seen in the nucleoplasm suggesting 
that these were enveloped. In the dilated Golgi apparatus (dashed arrow in D), viral particles 
were often surrounded or adjacent to abundant electrodense material (arrow in B and D - 
tegument?).
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3.3.2 MH-S (alveolar macrophages)
3.3.2.1 LHAMHV-68 infection
The cell line MH-S is a murine alveolar macrophage cell line. The particular 
interest in this cell line arose following a finding in the in vivo studies which indicated 
that infection of alveolar macrophages was increased in vMlstop infection compared to 
the vMlrev infection. MH-S cells were infected with LHAMHV-68 in order to assess if 
these cells became infected by MHV-68 virus and if so the rate of infection. To assess 
infection, cells were examined for morphological changes and fluorescence. 
Observations were made at 0, 24, 48, 72 h.p.i.
Normal cellular morphology consists of mostly round and to lesser extent 
spindloid or triangular shaped cellular outline (Figure 3.64). Preliminary experiments 
led to the observation that these cells were not infected as easily as NIH3T3 cells and so 
for the full experiment, a higher MOI of 10 was used and the incubation of the 
infectious inoculum was increased to 2 h.
Mock infected MH-S cells were observed in parallel with virally infected cells in, 
in order to have a control. There was little difference between viral and mock infected 
cells with respect to cell growth or morphology in the early timepoints observed. At 48 
h.p.i. mock infected cells showed mild degenerative changes that were enhanced at 72 
h.p.i. These changes were interpreted as secondary and due to lack of media renewal 
(Figure 3.63).
At 0 h.p.i., no fluorescence was observed (Figure 3.64). At 24 h.p.i. the 
percentage of cells exhibiting fluorescence varied within the plate between 15 to 25%. 
The cell morphology at this time was not altered. At 48 h.p.i., the fluorescence 
decreased greatly throughout and was variable within the plate, the percentage of cells 
exhibiting fluorescence being in the range of 3 to 18%. The cell morphology at this time 
was severely altered and the well demarcated rounded cellular profile was no longer 
apparent and instead it was irregular and cells exhibited a granular appearance, this is 
consistent with degenerative changes, most likely apoptosis. The number of cells was 
also reduced and there was abundant cellular debris in solution. The most confluent 
areas of cellularity were mostly seen at the periphery of the wells. These changes were 
enhanced at 72 h p.i and were accompanied by little fluorescence.
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Figure 3.63 MH-S cells. Mock infected at 3,24,48 and 72 h.p.i.
Mock infected at 3 (A), 24 (B), 48 (C) and 72 (D) h.p.i. At 48 h.p.i. mock infected cells 
starded showing mild degenerative changes that were enhanced at 72 h.p.i. At 72 h.p.i plates 
were not as cell rich as at 48 h.p.i. likely as a result of cell death as cellular debris was also 
present. The degenerative changes observed were interpreted as secondary and due to lack 
of media renewal.
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Figure 3.64 MH-S cells. LHAMHV-68 infected at 3,24, 48 and 72 h.p.i.
At 0 h.p.i. (A), no fluorescence was present and cell morphology was mostly unaltered. At 24 
h.p.i.(B) the fluorescence varied within the plate (15-25%) and cell morphology was unaltered. 
At 48 h.p.i. (C) the fluorescence decreased greatly throughout and varied within the plate (3- 
18%). The cell morphology at this time was severely altered and cellular profile was irregular 
and cells exhibited a granular appearance (apoptosis). The number of cells was also reduced 
and there was abundant cellular debris in solution. These changes were enhanced at 72 h.p.i. 
(D) and were accompanied by little fluorescence.
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3.3.2.2 One step growth curve
MH-S cells infected with vMlstop and vMlrev MHV-68 viruses using an MOI of 
10. The cells were scraped at different timepoints (0, 24, 48, 72, 96 h. p.i.) and were 
collected together with the overlying media. The collected material was then assessed 
for viral titre using a plaque assay. With these results a viral growth curve was drawn 
(Figure 3.65). Statistical analysis of the one step growth curves yielded similar results. 
The statistical analysis performed using two way ANOVA and Bonferroni post test 
showed that there was no significant difference when the two infections were compared.
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Figure 3.65 One step growth curve of MH-S cells infected with either vMIstop or 
vMIrev.
A and B represent the same viral titre results. Viral titres were determined from the collected 
MH-S cells and media infected with either vMIrev or vMIstop virus at an MOI of 10. n=2 
per virus per time point. Error bars represent SEM. Significant differences were determined 
using two-way ANOVA and Bonferroni post test (*p < 0.05, **p < 0.01 ***p < 0.0001).
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3.3.2.3 Ultrastructural study of MH-S infected cells
Ultrastructural examination was also performed on MH-S cells infected with 
either vMlstop or vMlrev virus at an MOI of 10 at 24 and 72 h.p.i. It was noted that the 
number of viral particles was much lower in both vMlstop and vMMlrev infection of 
MH-S cells, than those observed in NIH3T3 cells (Section 3.2.1.3). At 24 h.p.i., 
scattered cells infected with vMlrev vims showed viral particles clustered in large 
vacuoles within the cytoplasm (Figure 3.66). In these vacuoles, the size of the viral 
particles was highly variable (~28 t]m - 85r|m in diameter). These finding were similar 
to those described in SI 1 cells, which are cells derived from B lymphocytes from mice 
with persistent MHV-68 infection319. Cells that were exposed to vMlrev virus also 
exhibited a mild increase in cytoplasmic vacuolation and dilation of mitochondria, 
which showed a less demarcated profile of their cristae. These findings were 
independent of the observation of viral particles within cells. At 24 h.p.i., no viral 
particles were seen in cells infected with vMlstop virus. At 72 h.p.i., there was little 
difference between MH-S cells infected with either vMlrev or vMlstop (Figure 3.67, 
Figure 3.68). At this timepoint, the cellular architecture had altered notably in both 
types of infection. Extensive vacuolation, effacement of organelles, discontinuity of 
both cytoplasmic and, less frequently, nuclear membranes was observed. At 72 h.p.i.iral 
particles were much more numerous in both infection types and were morphologically 
similar to viral particles seen at 24 h.p.i. in the vMlrev infected cells. These viral 
particles were also seen within the nucleus but were often contained within a double 
lined space, suggesting that these were invaginations of the nuclear membrane. In 
vMlstop infected cells, binucleated cells were also present and cells with evident lytic 
replication showed frequent lipid droplets in the cytoplasm.
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Figure 3.66 MHS cells infected with either vMlrev or vMlstop infected at 24 h.p.i. 
Ultrastructure.
A: vMlrev infected cell with the cytoplasmic vacuole containing viral particles (arrow); B: 
vMlstop infected cell; C: cytoplasmic vacuole of vMlrev infected cell containing viral 
particles.
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Figure 3.67 MH-S cells infected with vMlrev at 72 h.p.i.
A: Overview of cell; B: Vacuoles with viral particles within the nucleus (full arrow) and 
cytoplasm (dashed arrow); C: nuclear vacuoles containing viral particles; D: cytoplasmic 
vacuole containing viral particles.
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Figure 3.68 MH-S cells infected with vMlstop at 72 h.p.i. Ultrastructure.
A: Overview of a binucleated cell; B: Overview of a mononucleated cell; C, D: nuclear (C) 
and cytoplasmic (D) vacuoles with viral particles. Vacuoles were observed with viral 
particles within the nucleus (full arrow) and the cytoplasm (dashed arrow). Lipid droplets 
were also frequently seen (arrowhead).
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3.3.2.4 Viral gene expression in MH-S cells infected with vMlstop and vMlrev
Viral gene transcript expression was monitored in MH-S cells infected with either 
vMlstop or vMlrev virus over a 72 hour time period. Two genes were selected: gplSO, 
a gene expressed during lytic replication, and ORF73, a gene expressed during latent 
replication. Expression of Ml transcripts were also monitored in cells infected with 
vMlrev virus. The gene expression ratio was determined using the pfaffl equation. 
Values obtained from test samples were normalized against the Ct values obtained from 
vMlrev infected cells at 0 h.p.i.
In vMlrev infected cells. Ml transcript expression was highest during the first 24 
h.p.i. (Figure 3.69). This increase in Ml transcript expression was accompanied by an 
increase in gpl50 transcript expression, a significant increase in the viral titre and a 
decrease in ORF 73 transcript expression. These findings were consistent with enhanced 
lytic replication during the first 24 hours of viral infection. Between 24 and 48 h.p.i. 
there was a decrease in Ml, gpl50 and ORF73 transcript expression. Furthemore, a 
plateau in the viral titre was noted. These findings were consistent with the absence of 
viral replication from 24 to 48 h.p.i. From 48 h to 72 h p.i, Ml transcript expression was 
unaltered. However, ORF 73 transcript expression increased and there was a significant 
decrease in the viral titre. These findings were consistent with latent replication from 48 
to 72 h.p.i.
In vMlstop infected cells, there was a decrease in the gpl50 transcript expression 
and an increase in ORF 73 transcript expression during the first 24 hours of viral 
infection (Figure 3.70). No expression of Ml transcript was detected. This was 
accompanied by an insignificant change in the viral titre. These observations were 
consistent with enhanced latent replication during the first 24 h p.i. Between 24 and 48 
h p.i., there was an equivalent decrease in gpl50 and ORF 73 transcript expression. This 
was accompanied by a significant change in the viral titre. This gene expression profile 
suggested that viral replication paused during this period. However, the increase in viral 
litres was not consistent with this conclusion. From 48 to 72 h.p.i., the gplSO transcript 
remained unaltered and there was an increase in ORF 73 transcript expression. Again, 
Ml transcript expression was not detected. This was accompanied by a significant 
decrease in the viral titre. These findings were consistent with latent viral replication 
from 48 to 72 h.p.i.
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Figure 3.69 MH-S cells. vMIrev infected. Relative viral gene expression and viral 
titres in infected cells.
Viral gene expression values obtained through qPCR performed on cDNA synthetised from 
RNA extracted from infected cells. n=l per virus per timepoint.. Base level (dashed line) 
represents values obtained from vMIrev infected cells. Significant differences in viral titres 
from sequential times after infection were determined using two way ANOVA and 
Bonferroni post test (*p<0.05, **p<0.01 *',‘*p<0.0001) as mentioned in section 3.3.2.2. In 
vMIrev infected cells. Ml expression was highest in the first 24 h.p.i.This rise accompanied 
the increase in the expression of gpl 50, a significant increase in the viral titre (Figure 3.65), 
and decrease in expression of ORF 73. Between 24 and 48 h.p.i. there was a decrease in Ml 
expression accompanied by a decrease in the expression of the other viral genes tested, 
gpl50 and ORF73 and a plateau in the viral titre. From 48 h to 72 h p.i. Ml expression was 
unaltered, this being accompanied by an increase in the expression of ORF 73 and 
significant decrease in the viral titre.
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Figure 3.70 MH-S cells. vMIstop infected. Relative viral gene expression and viral 
titres in infected cells.
Viral gene expression values obtained through qPCR performed on cDNA synthetised from 
RNA extracted from infected cells. n=l per virus per timepoint.. Base level (dashed line) 
represents values obtained from vMlrev infected cells. Significant differences in viral titres 
from sequential times after infection were determined using two way ANOVA and 
Bonferroni post test (*p<0.05, **p<0.01 ***p<0.0001) as mentioned in section 3.3.2.2. In 
vMIstop infected cells, in the first 24 h.p.i. there was a decrease in the expression of gpl50 
and an increase in expression of ORF 73. This was accompanied by an insignificant change 
in the viral litre. Between 24 and 48 h.p.i. there was a equivalent decrease in the expression 
of gp!50 and ORF 73. This was accompanied by a significant increase in the viral litre. 
From 48 h to 72 h.p.i., the expression of gpl50 mostly remained unaltered and there was an 
increase in expression of ORF 73. This was accompanied by a significant decrease in the 
viral litre.
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3.3.2.S Cytokine expression in MH-S cells infected with vMlstop and vMlrev
Expression of cytokines was determined in MH-S cells infected either with 
vMlstop or vMlrev virus and mock infected. The cytokines selected for study were 
TNF-a., RANTES and GM-CSF. The timepoints examined were 0, 24, 28 and 72 h.p.i.
TNF-a transcript expression followed a similar trend in cells infected with either 
vMlrev or vMlstop (Figure 3,71). At 0 h.p.i. in both vMlstop and vMlrev infected 
cells, TNF-a transcript expression was increased compared to mock-infected cells being 
highest in vMlrev infected cells. After 24 h.p.i. in both vMlrev and vMlstop infected 
cells, TNF-a expression decreased gradually. To assess is the experiment protocol 
altered the expression of TNF-a independently of viral infection, the expression of this 
cytokine was also monitored and compared at the different timepoints in the mock 
infected cells. For this values obtained from the different timepoints in the mock 
infected cells were normalized with those obtained at 0 h.p.i. in mock infected cells. 
Mock-infected cells exhibited a decrease of TNF-a expression, suggesting that the 
protocol used in the maintenance of the cell culture had an effect upon TNF-a transcript 
expression.
In addition, RANTES transcript expression was also monitored. In vMlrev 
infected cells, expression of this transcript was observed to be highest at 0 h.p.i. but 
decreased thereafter (Figure 3.72). However, in vMlstop infected cells RANTES 
transcript expression was lower than vMlrev infected cells at 0 h.p.i. and increased until 
24 h.p.i. Once again, to assess the effect of the experimental protocol on the expression 
of RANTES by these cells, the expression between the different timepoints was also 
compared within the mock infected cells by using as control the values obtained from 
mock infected cells at 0 h.p.i. There was no correlation between the changes in mock 
and viral infected cells, suggesting that the values obtained were not the effect of 
culturing.
When RANTES and ORF73 transcript expression patterns were plotted, it was 
noted that during the first 48 h.p.i, both followed the same trend for either vMlstop 
infection (Figure 3.73 A) or vMlrev infection (Figure 3.73 B).
3.3.3 Summary of in vitro studies findings
The findings from the in vitro studies using NIH3T3 and MH-S cells infected with 
vMlstop and vMlrev are summarized in Table 3.6,
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Figure 3.71 MH-S cells. Mock, vMlrev and vMIstop infected. TNF-a expression. 
Representation of difference ratios in cytokine expression. Values obtained through qPCR 
performed on cDNA synthetized from RNA extracted from infected cells. n=l per virus per 
timepoint. A: TNF-a expression in vMlrev and vMIstop infected MH-S cells. Values were 
normalized against the values obtained at each time point from mock infected cells. B: TNF- 
a expression in mock infected MH-S cells. Values were normalized against those obtained 
at 0 h.p.i. There was little difference in the expression of TNF-a when comparing the 
different viral infections. However, at 0 h.p.i. the expression of TNF- a was seen to be 
higher in virally infected cells when compared to mock infected cells with the difference 
being heightened in the vMlrev infected cells. Beyond 24 h.p.i. TNF-a expression 
decreased gradually in both virally and mock infected cells. These findings suggest that the 
decrease of TNF-a expression is an effect which is independent of the viral infection and 
likely related to the maintenance of the cell culture during the infection experiment.
173
Chapter 3 Results
A
RANTES
RANTES
h post infection
Figure 3.72 MH-S cells. Mock, vMlrev and vMlstop infected. RANTES expression. 
Representation of difference ratios in cytokine expression. Values obtained through qPCR 
performed on cDNA synthetized from RNA extracted from infected cells. n=l per virus per 
timepoint. A: RANTES expression in vMlrev and vMlstop infected MH-S cells. n=l per 
virus per timepoint.Values were norm alized against the values obtained at each time point 
from mock infected cells. B: RANTES expression in mock infected MH-S cells. Values 
were normalized against those obtained at 0 h.p.i. RANTES expression was observed to be 
highest initially at 0 h.p.i. in vMlrev infected cells but then decreased thereafter. In the 
vMlstop infected cells, the opposite occurred at the initial timepoints, with expression being 
lower at 0 h to then peak at 24 h.p.i. There was no correlation between the changes in mock 
and virally infected cells, suggesting that the trend obtained in virally infected cells were not 
the related to the maintenance of the cell culture during the infection experiment.
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vMIstop
o 0-
h post infection
vMIrev RANTES
ORF7315 6-
c 5-
o 0-
h post infection
Figure 3.73 MH-S cells. vMIrev and vMIstop infected. ORF73 and RANTES 
expression.
A; vMIstop infected cells; B: vMIrev infected cells. Representation of difference ratios in 
RANTES and ORF73 viral gene expression. Values obtained through qPCR performed on 
cDNA synthesised from RNA extracted from infected cells as mentioned in Sections 3.3.2.2 
and 3.3.2.4. n=l per virus per timepoint. A: Expression in vMIstop infected MH-S cells. B: 
Expression in vMIrev infected MH-S cells. In the first 48 h.p.i. these follow the same trend, 
in both types of viral infections.
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NIH3T3 cells MH-S cells
LHAMHV-68 24h: 100% fluorescence 
48h: 100% fluorescence 
++ morphological A 
72h: 100% fluorescence 
++ apoptosis
24h: 15-25% fluorescence 
48h: 3-18% fluorescence 
++ morphological A 
72h: little fluorescence 
++ apoptosis
OS Growth curves Plateau in titres at 30 h Plateau in titres at 24 h*
Ultrastructure Extensive lytic 
replication
Fewer viral particles and 
no evidence of viral 
factories
* No measurements made at 30 hours
MH-S vMlstop vMlrev
Ultrastructure Viral particles from 72 h 
> lipid
Viral particles from 24 h
Viral gene 
expression
24 h: <gpl50 
> ORF 73 
no A viral tire
48 h: <gpl50
< ORF 73
< viral tire
72 h: >ORF 73
< viral tire
24 h: >gpl50
~ no A ORF73 
>viral tire 
>M1
48 h: <gp!50
< ORF 73
no A viral tire 
<M1
72 h: >ORF 73
< viral tire
Cytokine
expression
RANTES:> first 24 h 
< after 24 h
RANTESmo A first 24 h 
< after 24 h
TNFa: < following 
infection
TNFa: < following 
infection
Table 3.6 Table summarising findings in NIH3T3 cells and MH-S cells infected with 
vMlstop, vMlrev and LHAMHV-68.
+, ++, +++: scale regarding number of cells: showing expression + (scattered cells); ++ 
(moderate numbers); +++ (numerous cells)
>, <, and A relates to relative change. >: increased; <: decreased; A: change; 
approximately
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Most MHV-68 studies are performed in laboratory mouse strains (Mits musculus). 
However, in the wild, MHV-68 does not infect Mus musculus293, 31S. Sequencing and 
serological studies have identified the wood mouse (Apodemus sylvaticus) as one of the 
natural hosts for MHV-68 infection5, 19, 293. The use of laboratory mouse strains, as 
opposed to a natural host, is useful but may not necessarily mirror what happens during 
the course of a natural infection. The need to study infection using a natural host is 
further justified by the fact that gammaherpesviruses are thought to have developed in 
parallel with their host18. These viruses are highly adapted to their host and often exert 
only mild pathogenicity except in the very young, foetuses, immunosupressed or 
accidental hosts150.
The aim of the present study was to ascertain the influence of the expression of 
Ml on MHV-68 infection in the natural host, the wood mouse. There are distinct 
differences in the infection profile between the wood and BALB/c mouse. In the wood 
mouse there is less lytic replication but latency is more efficiently established5. In the 
wood mouse, the infiltrate seen in the lung following infection, is macrophage 
dominated and there is a less intense lymphocytic infiltration mostly composed of B 
cells5. Unique to the wood mouse, bronchial associated lymphoid tissue (iBALT) is 
induced during MHV-68 infection5. The iBALT is structurally similar to secondary 
follicles in lymphoid tissues and is associated with inflammation/infection294 and has 
been shown to be the main site where cells latently infected with MHV-68 persist in the 
lung of an infected wood mouse9, 154. In the BALB/c mice, MHV-68 infection is not 
associated with iBALT formation and the infiltrate seen in the lung shows a higher 
predominance of T cells5.
Ml shares homology with the sequences encoding for poxvirus serpin (serine 
protease inhibitors) proteins . However, the Ml sequence lacks the critical 
domains/residues for serpin activity. Previous studies in laboratory mouse strains have 
indicated Ml as a suppressor of reactivation from latency6. This Ml activity is IFN-y 
dependent and is seen together with activation of Vp4+CD8+ T cells which resist 
functional exhaustion ' . In the wood mouse, MHV-68 infection does not lead to 
significant changes in IFN-y expression (Figure 3.31). This suggests the previously 
described role of Ml is not applicable to the wood mouse infection. Ml has been found 
to encode for a secreted protein6 and sequence homology suggests that the Ml protein 
shares functional similarities with the chemokine-binding proteins resulting from the 
closely related genes, M3 and M49. If M3 expression is inhibited in the MHV-68
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infection of wood mice, iBALT formation is no longer observed. Furthermore in the 
absence of M3 instead of a lymphocytic response which is B cell dominated, there is a 
relative increase in T cells5,9 similar to what is seen in the infection of BALB/c mice. 
As mentioned previously, in MHV-68 infection, B cells are the main cell type where 
latent replication occurs28, 82. Therefore it is of benefit to the virus to increase the 
availability of B cells which is achieved partly by preventing T cell activation9. 
Quantification of Ml, M2, M3 and M4 expression in the lung of infected wood mice at 
7, 10, 12 and 14 d.p.i found Ml to be the protein with highest expression at day 7 p.i.9. 
This time also coincided with when Ml was expressed the most9.
4.1 Ml expression in the lung of the wood mouse and BALB/c mouse
Ml expression was assessed by RNA-ISH in sections of lung from MHV-68 
infected BALB/c and wood mice. The aim of this study was to determine in which cells 
Ml expression occurs. Comparing the species determined whether there are similarities 
in the Ml expression pattern between an artificial and natural host. Ml expression was 
detected in type I pneumocytes in both BALB/c and wood mice, at day 3,7, 10 p.i. and 
also at day 14 p.i. in the wood mouse. Ml transcripts were also detected in interstitial 
and intravascular (migrating) lymphocytes of both mice at all the timepoints examined. 
The extent of Ml expression from day 14 p.i. was much reduced in the wood mouse, in 
agreement with previously published qPCR data9. In the BALB/c mouse, Ml expression 
was lower than in the woodmouse. Ml expression was not as frequent and decreased 
from day 3 p.i. onwards.
Additionally, in the BALB/c mouse Ml transcripts were detected in endothelial 
cells at day 3 p.i. In the BALB/c mouse, phlebitis is a feature of MHV-68 infection5,28. 
Ml expression in endothelial cells of BALB/c mice could indicate a possible role of Ml 
in the development of the phlebitis in the laboratory mouse strain.
In the wood mouse, lymphocytes exhibiting Ml expression were also seen within 
iBALT from day 7 p.i. Interestingly, in the wood mouse at day 5, 7, 10, 14 and 28 p.i 
tracheal and bronchial epithelial cells showed Ml expression. This is the first time a 
MHV-68 gene product has been described in this location. Intranasal infection is 
thought to be the main route of infection for MHV-6828. Following intranasal infection 
of laboratory mouse strains or wood mice there is development of pneumonia5,28. It is 
likely that the airway has a role in MHV-68 infection since it is interspaced between the
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nose (site of infection) and the lung (main site of acute viral replication). The expression 
of Ml in airway epithelial cells together with the fact that no other MHV-68 genes to 
date have been described in such a location, suggest that Ml expression could play a 
role in airway-mediated viral entry into the lung. Airway epithelial cells provide a 
physical barrier and regulate the host immune response55 by secreting anti-viral 
substances such as cytokines51. Cytokine expression in airway epithelial cells is mostly 
localized in the basolateral pole of the cells. The purpose of the secretion in this location 
is thought to be modulation of inflammatory cell migration into areas adjacent to the 
airways55. Respiratory viruses including Influenza A virus often target the basolateral 
membrane of airway epithelial cells and interfere with the cytokine expression at this 
site51,55,320. With Influenza A virus infection there is induction of MIPl-a and TNF-a 
secretion at the basolateral pole of airway epithelial cells55. In this study at the early 
timepoints, day 3 and 7 p.i., of vMlstop and vMlrev infection, there was mild 
respiratory epithelium hyperplasia which is a sign of regeneration. Regeneration and the 
presence of apoptotic cells in the bronchiolar lumina are an indication that viral 
infection only induced mild degenerative changes to airway epithelial cells. Taking 
these results together, one could extrapolate that the effect induced by the heightened 
Ml expression in these cells is not mainly cytopathic but instead leads to interference 
with the respiratory epithelial cell metabolism/function. Amongst the differences 
observed when comparing vMlstop to vMlrev infection was the extent of TNF-a 
expression. In vMlstop infection, there was almost a tenfold increase in TNF-a 
expression. This enhanced secretion was localized to various cells including the upper 
and lower airway epithelial cells (Figure 3.43). Likewise, qPCR studies at day 7 p.i. also 
found that in vMlstop infected animals, there was an increase in the expression of 
MIPl-a in approximately the same magnitude as TNF-a. However, the localization of 
MIPl-a expression was not determined. CCSP expression by airway Clara cells was 
decreased in the vMlstop infection with the difference being greater at day 3 p.i. 
(Figure 3.41). CCSP effects include a decrease in TNF-a in airway fluid and a decrease 
in TLR4 expression by alveolar macrophages leading to decreased chemotaxis of 
macrophages 321. TNF-a has also been described as an inhibitor of the CCSP promoter 
and thus of CCSP expression322. Furthermore, a decrease in CCSP expression has been 
associated with increased MIPl-a in various viral infections including in MHV-68 M3 
stop infection (mutated in the M3 locus)323'325. MIPl-a and TNF-a, secreted by airway
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epithelial cells, have been reported to exert a positive role on macrophage 
recruitment ’ . Another feature of vMlstop infection was an increase in macrophage
infiltration and activation which was most significant in the early timepoints following 
infection. Also, at day 14 p.i. in the vMlstop infection, there was a decrease in viral 
load. The evidence from this study suggests that the presence of Ml protein could be 
involved in the attenuation of TNF-a and MIPl-a expression by airway epithelial cells 
following MHV-68 infection. This could be a result of or lead to an increase in the 
CCSP expression, a potent anti-inflammatory cytokine secreted by Clara cells. 
Ultimately this would induce a decrease in macrophage migration to the site of infection 
and a decrease in phagocytosis of virally infected cells. The decreased lytic replication 
at day 14 p.i. in vMlstop infected mice may be secondary to a more efficient 
phagocytosis of infected cells earlier in infection, as the findings at day 3 and day 7 p.i. 
suggest.
Furthermore, Ml transcripts were observed in parabronchial ganglia specifically 
in the satellite cells surrounding the neuronal bodies in the woodmouse at day 7 and 14 
p.i. This is the first time that a MHV-68 gene product has been described in this 
location. All neuronal tissues examined, including the brain, did not exhibit evidence of 
neuronal pathogenesis. VZV viral proteins have been described in satellite cells within 
the dorsal root ganglia (DRG) and these cells are suggested to be a means of entry into 
the neuronal system328. In the wood mouse, pathological changes to neuronal system 
cells are not a feature of infection. However, meningitis has been described following 
intranasal infection of BALB/c mice that have a deletion of type-I interferon receptor 
gene230 or newborn BALB/c mice231. Furthermore, MHV-68 is able to persist in the 
central nervous system (CNS) during the infection of the laboratory mouse strain232. 
This indicates that in BALB/c mice MHV-68 shows neurotropism despite it not being 
the primary infected tissue following innoculation. Taking this into consideration and 
coupled to the finding of Ml expression in satellite cells of the parabronchial ganglia, 
neurotropism by MHV-68 in the wood mouse cannot be ruled out. Ml expression in 
satellite cells of parabronchial ganglia might represent a site of neuronal entry despite 
the lack of evidence for neuronal pathogenesis in this species. Further studies have to be 
carried out to frilly clarify this, particularly because the parabronchial ganglia was not a 
targeted in this study and was not present in all sections examined.
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When Ml expression was evaluated in in vitro in NIH3T3 cells. Ml transcripts 
were rarely detected despite all the cells being lytically infected. This indicates that Ml 
expression is enhanced in the animal model.
In summary, Ml expression was found to be higher in the natural host in 
comparison to the artificial host, with respects to intensity, frequency and cell types 
involved. Furthermore Ml expression was seen to be minimal in laboratory mouse 
strain derived cells that are highly permissive to infection. These findings indicate that 
the role of Ml is of more importance in the natural host than in the artificial one.
4.2 Ml effect on viral replication and virally induced pathogenesis in the lung of 
the wood mouse
In order to determine the effect of Ml expression in MHV-68 infection of the 
natural host, in vitro and in vivo studies were performed in the wood mouse using 
vMlstop virus and its genetically repaired counterpart, vMlrev virus. The vMlstop 
virus is a MHV-68 virus with an in-frame stop codon in the Ml locus. The stop codon 
impairs expression of Ml without interfering with the expression of the remaining 
genome. The objective was to ascertain the influence of Ml in MHV-68 infection 
through comparison of pathogenesis in the presence or absence of Ml expression.
The time at which viral load was highest was at day 3 p.i. Viral antigen was 
detected in both infections in type I pneumocytes, type II pneumocytes and 
macrophages. Ultrastructural examination of the lung in vMlrev infected animals, 
showed viral particles in scattered type II pneumocytes. The stages included nuclear 
“viral factories” and budding particles. Host infected cells showed degenerative changes 
proportional to the extent of viral replication. This is the first time that the different 
stages of MHV-68 viral particles have been described in situ in the lung by electron 
microscopy. Latent replication in both infections, was observed in lymphocytes in 
iBALT, alveolar interstitimn and intravascularly. In the vMlstop infected animals latent 
replication was also detected in type II pneumocytes and in macrophages. Histological 
examination of the lung showed that there was an overall increase in cellularity in both 
infections that was more severe in the vMlstop infected animals. This was mostly due 
to higher macrophage infiltration and more severe type II pneumocyte hyperplasia in the 
vMlstop infection. Another feature seen in the vMlstop infection was the presence of 
lipid droplets in the cytoplasm of macrophages within alveoli and interstitially and in
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the extracellularly in the pulmonary interstitium. The latter, likely represents 
macrophages that had degenerated and thus showed no obvious cellular outline. These 
lipid droplets were also seen in vitro in infected alveolar macrophages at 72 h.p.i. The 
presence of lipid in the single cell cultures of macrophages, rules out the lipid being 
related to altered surfactant production by the hyperplastic type II pneumocytes. In 
H1N1 IA30 (1918 pandemic derived) studies, a relationship between viral induced 
changes to lipid metabolism and cellular death early in infection (day 5 p.i) was 
established329. It is known that lipids play fundamental roles in Influenza infection 
including virus entry, assembly and budding and host cell repair329. The lipid droplets 
found in the current study are thought to represent enhanced degenerative changes.
At day 7 p.i., viral antigen presence was detected in both infections in type I 
pneiunocytes, type II pneumocytes and macrophages. The viral load was decreased 
compared to day 3 p.i but this decrease was not statistically significant. The number of 
cells exhibiting latent replication increased at day 7 p.i. in comparison to day 3 p.i. in 
both infections. Similarly to what was observed at day 3 p.i., latent replication at day 7 
p.i. was seen in both infections in lymphocytes in iBALT, alveolar interstitium and 
intravascularly. Furthermore, at day 7 p.i., in the vMlstop infection latent replication 
was also detected in type II pneumocytes and macrophages. These cells were seen either 
lining alveoli or desquamated in the alveolar space (Figure 3.35). Latent replication in 
these cells may be related in part to their increased presence in the vMlstop infection 
which showed a more severe type II pneumocyte hyperplasia and macrophage 
infiltration. Viral tropism for type II pneumocytes has been associated with increased 
pathogenesis in H5N1 influenza virus infection due to an infection induced increase in 
cellular metabolism62. Further morphological changes consisted of type I pneumocyte 
necrosis in both infections and iBALT formation. The iBALT formation was most 
frequent in the vMlstop infection which also exhibited multifocal foci of necrotic cells 
with fibrinous centres. The morphological changes occurred in a multifocal pattern in 
the vMlstop infection whilst in the vMlrev infection they occurred in a diffuse pattern. 
This pattern in the vMlstop infection suggests that the area where more extensive viral 
induced pathogenesis occurs, is at the periphery of the airways. The increased severity 
of changes in the vMlstop infection was not associated with a higher viral load, 
suggesting that pathological changes are not directly related to viral replication but 
possibly induced by host cell products (such as cytokines). In the vMlstop infection at 
day 7 p.i. there was almost a tenfold increase in TNF-a expression. This enhanced
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secretion was localized to airway epithelial cells, macrophages and type II 
pneumocytes. TNF-a is a known inducer of apoptosis but in viral infections such as 
RSV such an effect has been reported to be abrogated330. RSV infected cells are 
resistant to TNF-a induced apoptosis and fuse to form syncitia with cellular death 
occuring eventually due to necrosis330. In the present study syncitial cells were 
occasionally seen. When immunohistology was performed using a marker for caspase 3, 
there were very few cells showing its presence. These findings together with the cell 
morphology, indicate that in the current study cell degeneration occurs by induction of 
necrosis rather than apoptosis despite an increase in TNF-a expression. This indicates 
that in MHV-68 infection, as in RSV infection, cells are resistant to TNF-a induced 
apoptosis. In this study there was also an increase in TGF-P expression in both vMlrev 
and vMlstop infected wood mice (Figure 3.45). MHV-68 infection studies using 
laboratory mouse strains have found that infection led to increased TGF-p expression by 
alveolar fibroblasts, alveolar macrophages and latently-infected pneumocytes122. This 
increase in TGF-p expression was associated with increased resistance to apoptosis . 
Thus even though TGF-p increase results from MHV-68 infection it is not a direct result 
of the Ml expression, it is most likely related to the resistance against TNF-a induced 
apoptosis observed in the vMlstop infected wood mice.
Other TNF-a effects include the enhancement of tight junction permeability in 
alveolar epithelial cells112. Tight junctions are important for the maintenance of 
epithelium integrity, communication and transport between neighbouring epithelial 
cells51. In Influenza A virus infection of ex vivo human endothelial cells, TNF-a has 
been associated with increased cellular permeability331. Z07, a tight junction, is 
maintained by ATP331. TNF-a is known to increase mitochondrial O2 species production 
and decrease ATP production consequently leading to Z07-actin dissociation . The 
TNF-a increase in the absence of Ml, may play an important role in the enhancement of 
the endothelial and epithelial permeability and consequently in the leakage of fibrin 
explaining its presence in the vMlstop infection.
At day 14 p.i. the differences in viral load between vMlstop and vMlrev 
infections were statistically significant. In vMlstop infected animals there was more 
than a tenfold decrease in viral load at day 14 p.i when compared to the vMlrev 
infected animals. At the earlier timepoints, day 3 and 7 p.i. in vMlstop infection, there 
were increased pathological changes when compared to vMlrev infection. Decreased
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lytic replication at day 14 p.i. in vMlstop infected mice may be due to a more efficient 
phagocytosis of infected cells earlier in infection. In both vMlstop and vMlrev 
infection latent replication at this timepoint was restricted to lymphocytes present in the 
iBALT. There was no noticeable difference in the pathological changes induced in the 
lung following vMlstop or vMlrev infection. In comparison to previous timepoints, 
there was a marked decrease in the overall cellularity in the lung. As in the mock 
infected mice, the alveoli were mainly lined by type I pneumocytes and type II 
pneumocytes were rarer. The interstitial infiltration by macrophages was however more 
intense than at previous timepoints. In both vMlstop and vMlrev infection, the iBALT 
was still composed mainly of B cells, but at this time point also contained a high 
number of T cells. These findings suggest a more elaborate immune response in the 
vMlstop infected animals, which showed an increased presence of B cells mainly in the 
iBALT, an increase in APC and to lesser extent a increase in T cells.
At day 28 p.i. in the lung of vMlstop infected animals, the viral load did not 
significantly change in comparison to the observations at day 14 p.i. On the contrary, in 
vMlrev infected mice, at day 28 p.i. there was a large decrease in viral load of 
approximately a hundredfold when compared to the values on day 14 p.i. These findings 
suggest that in vMlstop infection, lytic replication is maintained for a longer period. In 
both infections, cells exhibiting latent replication were restricted to lymphocytes present 
in the iBALT. There was very little difference between the overall cellularity in the lung 
of animals infected with either virus. The most significant morphological difference was 
the presence of more frequent and pronoimced iBALT in the lung of vMlstop infected 
mice. TNF-a and its binding to TNFR1 has been shown to be essential in secondary 
lymphoid follicle formation113'115. This suggests that the increase in the expression of 
TNF-a in the vMlstop infection might play a role in the more pronounced iBALT seen 
in infection with this virus. Furthermore, at day 14 p.i. in the vMlrev, there was still a 
mild infiltration by macrophages into the interstitium.
In summary, these findings indicate that in the presence of Ml there is greater 
lytic replication at day 14 p.i. but this subsides by day 28 p.i. Ml presence is not 
associated with latent replication in type II pneumocytes and macrophages as it is seen 
in the absence of Ml. Furthermore, the presence of Ml is associated with decreased 
pathological changes in the lung such as infiltration by macrophages and less 
pronounced/frequent iBALT. The iBALT being more exuberant in the vMlstop 
infection is likely related to the increase in B cell priming by the macrophages which
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are also more frequent at day 3 and 7 p.i. Furthermore, in the presence of Ml, the 
infected cells, including macrophages, show less extensive degenerative changes. The 
degenerative changes seen in the macrophages in the vMlstop infection could be related 
to increased activation or metabolism that is reflected in the severe necrosis seen in the 
lung of the vMlstop animals. Furthermore the presence of Ml downregulates TNF-a 
and upregulates CCSP expression by airway epithelial cells. This cytokine expression 
profile favours an anti-inflammatory response and could explain the multifocal pattern 
of more severe pathogenesis seen in the absence of the Ml protein which is is seen 
mostly surrounding airways.
4.3 Ml influence on macrophages in the wood mouse infection
Considering the increase in macrophages in the absence of Ml expression, studies 
were performed to determine the mechanism of their activation. These included the 
qPCR assessment of transcript expression of cytokines and enzymes with known roles 
in macrophage activation and function. Lung sections from wood mice infected with 
vMlrev and vMlstop at day 7 p.i. were tested. Arginase I and iNOS were examined for 
relative expression. These enzymes are commonly used as indicators of classic versus 
alternative activation of macrophages145'147, 332. When macrophages are classically 
activated they express iNOS * . On the other hand, alternatively activated
macrophages (M2) express arginase I145'147,332.
In the vMlstop infection, arginase I expression was reduced by more than tenfold. 
This indicates Ml protein plays a role in an alternative activation of macrophages in 
MHV-68 infection of the wood mouse. Surprisingly there was little difference in the 
levels of arginase I expression by vMlrev and mock infected wood mice. This suggests 
that in wood mice the macrophage population resident in the lung exhibits an 
alternatively activated phenotype which is maintained following MHV-68 infection in 
the presence of the Ml protein.
The expression of iNOS showed little difference between viral infections, being 
mildly reduced in the vMlstop infected wood mouse. The iNOS reaction product is 
nitric oxide (NO) which exhibits cytotoxic properties143, 145‘147, 332. The arginase I 
reaction products include proline, which is a known inducer of collagen production145' 
147, 332. Arginase j ancj iNOS compete for a common substrate, arginine145'147, 332. The 
cytokines produced by classically activated macrophages inhibit alternative macrophage
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proliferation, and vice versa, through blockage of arginine metabolism at the 
translational level145’148. As mentioned previously, iNOS expression is increased in both 
vMlstop and vMlrev infections, being mildly increased in the vMlrev infection. This 
indicates that following the MHV-68 infection of wood mice there is a shift in 
macrophage activation into the classic activation route. If the expression profile was 
seen on its own, it would suggest that in the vMlstop infection there was a decrease in 
the overall activation of macrophages since there was a reduction in alternatively 
activated macrophages and no major change in classically activated ones. However, the 
morphological study of the lung from vMlstop infected wood mice indicated this is not 
the case. In the vMlstop infection, macrophages are more frequent and highly activated. 
iNOS is a persistently active enzyme141 and in the vMlstop infection there is a decrease 
in the expression of the enzyme that competes for its substrate, arginase I. So it is safe 
to assume that in the vMlstop infection, iNOS will have higher substrate availability. 
The end result could be an increase in NO production despite no major change in iNOS 
expression. NO high-dose effects include vasodilation, disruption of the endothelial 
barrier and cytotoxicity143. The increase in NO could explain the augmented 
pathological changes observed in the lung of vMlstop infected mice. A possible 
interpretation of these results would be that Ml induced maintenance of alternatively 
activated macrophages is a step in the viral evasion to the immune system by decreasing 
NO induced cytotoxic effects on infected and neighbouring cells.
iNOS derived NO has been found to induce an increase in TNF-a expression142. 
TNF-a has on the other hand been implicated in the activation of IkB-NFkB complex 
phosphorylation resulting in the induction of iNOS expression141,333. Both TNF-a and 
iNOS expression was increased in the vMlstop infection in comparison to the vMlrev 
infection. However, there was a lesser fold change in the increase in iNOS expression 
than that of the increase in TNF-a expression. This suggests that TNF-a is not a single 
activator of iNOS expression. The decrease in arginase expression in the vMlstop 
infection likely results in a increase in the availability of arginine for iNOS and could 
lead to the increased NO. Ultimately if NO is increased this could secondarily induce 
TNF-a expression.
Alternative activation of macrophages can be divided with respects to the source 
of their activation. M2a macrophages are the result of stimulation by Th2 cytokines 
(mainly IL-13 and IL-4)145,146. M2b macrophages are induced by immune complexes, 
TLR and IL-1R agonists145. M2c macrophages are induced by IL-10, TGF-fl and
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glucocorticoids145. IL-10 is also the main cytokine released by alternatively activated 
macrophages145. In the current study, the expression of both IL-10 and TGF-p was seen 
to increase following MHV-68 infection of the wood mouse. There was little difference 
between the expression of TGF-p in the vMlstop and vMlrev infected wood mice. 
IL-10 is increased in vMlstop infected wood mice to a greater extent, being tenfold 
more in the vMlstop infected than in the vMlrev infected mice (Figure 3.45). Thus it is 
unlikely that changes in expression of IL-10 and TGF-p are related to the shift in the 
route of macrophage activation seen between the vMlstop and vMlrev infection in 
wood mice.
The increase in IL-10 in vMlstop infected animals is at odds with the decrease in 
IL-10 producing alternatively activated macrophages and thus indicates that the increase 
of IL-10 is due to secretion by another cell type. IL-10 is one of the main cytokines 
produced by B cells and Th2138. Considering that there is a decrease in alternatively 
activated macrophages in vMlstop infection, an increase in Th2 cells is unlikely to be 
responsible as this would result in activation of M2b macrophages. So, the IL-10 
increase in the vMlstop infection is most probable due to secretion from B cells. This is 
further supported by the fact that at day 7 p.i., in the vMlstop infected animals there 
was a more frequent and better demarcated, B cell dominated iBALT. IL-10 is a known 
inducer of B cell maturation and/or survival. In the milieu of MHV-68 infection such 
role has been described to be associated with expression of the MHV-68 M2 protein334. 
NO has also been described as an inducer of IL-10 expression142 and if increased in 
vMlstop infected wood mice could be related to the increase seen in IL-10. IL-10 is of 
major importance in epithelial cell maintenance. Other IL-10 effects include inhibition 
of pro-inflammatory cytokine expression including Thl cytokines, leading to an 
immime response towards healing136,138.
TGF-p expression in mouse primary bronchiolar-alveolar cell lines (composed 
mostly of type II pneumocytes and fewer Clara cells) and pulmonary fibroblasts has 
been reported to be increased by TNF-a activation of the NF-kB pathway125'128. This 
TNF-a induced increase in TGF-p expression was also observed in RAW 624 cells 
(murine macrophage cell line) co-cultured with A549 cells (human lung 
adenocarcinoma cell line) and was related to an increased expression of TGF-p which 
led to the transformation of A549 cells from epithelial to a mesenchymal phenotype128.
In this study there was little difference between expression of TGF-p in the 
vMlstop and vMlrev infected wood mice. This was accompanied by an increase in the
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expression of TNF-a in the vMlstop infection. This suggests that the increase in TNF-a 
expression is not mediated by TGF-P in this case. Furthermore infection with either 
vMlstop or vMlrev was not associated with a mesenchymal differentiation of airway 
epithelial cells, a common change in pulmonary infections associated with increase in 
expression of TGF-p.
In the MHV-68 infection of laboratory mouse strains, IFN-y is upregulated 
particularly in latent infection98. IFN-y controls reactivation by interacting with the 
ORF50 promoters, encoding for RTA101, The IFN-y effect on reactivation is specific to 
macrophage dominated and not B cell dominated cell populations82. During MHV-68 
infection of IFNR'7' mice studies there was extensive fibrosis in the lung at 2 weeks p.i. 
and in mediastinal lymph nodes and spleen at 3 weeks p.i. 214'216. The splenic fibrosis 
was caused by alternative activation of macrophages209. As mentioned previously, IL-10 
expression was augmented in both vMlrev and vMlstop infection and this increase is 
likely related to the iBALT formation observed in this study. The formation of iBALT 
is a feature of MHV-68 infection in the wood mouse that is not seen in the BALB/c 
mouse5. Considering the inhibitory effect of IL-10 on expression of Thl expressed 
cytokines, IL-10 increase in the infection of the wood mouse could explain the lack of 
change in expression of IFN-y. An important role in the immune response induced by 
IFN-y is the induction of expression of MHC Class I and II molecules92’97. This taken 
together with the specificity effect of IFN-y effect on macrophage cell populations and 
the findings in IFNR_/' mice could indicate that in the wood mouse, the lack of an IFN-y 
increase allows the virus to replicate in macrophages. Furthermore, IFN-y prevents to 
some extent macrophages from being classically activated, and thus possibly represents 
a viral mechanism to evade host recognition of viral antigens. Classical activation of 
macrophages occurs mostly upon stimulation by Thl cytokines such as IFN-y and a- 
a145’ 146. Since in this study there was no evidence of an IFN-y increase following 
infection with vMlstop or vMlrev virus (Figure 3.45), this cytokine is unlikely to have 
a role in the classical macrophage activation in the wood mouse infection. However in 
the vMlstop infection, in comparison to vMlrev and mock infected wood mice, there 
was a tenfold increase in TNF-a expression. The increase in expression of TNF-a 
occurred in airway epithelial cells, macrophages and type II pneumocytes. These 
findings suggest that this cytokine could be partly involved in or be a result of the 
macrophage classical activation in the vMlstop infected wood mice. A feature of
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classically activated macrophages is enhanced expression of MHC Class I and II and 
complement factors which aid antigen recognition and phagocytosis ’ . In classically
activated macrophages there is also activation of IRF3 ultimately leading to IFN-p 
secretion337. IFN-P takes part in the host anti-viral response by inducing secretion of 
proteins which interfere with viral replication, protein synthesis and trafficking 
processes51. Thus the maintenance of alternatively activated macrophages in the 
presence of the Ml protein, allows MHV-68 to evade APC recognition and IFN-p 
mediated anti-viral immune response.
Weinheimer et al. suggested that the pathogenicity of viruses is not always 
correlated with the level of cytokine modulation, as is observed in the study of low 
pathogenicity H5NI and HPAIV-H5N1, They found that the low pathogenicity virus 
induced a greater increase of cytokines such as MIPl-a .
Infection and viral replication in MH-S cells, an alveolar macrophages cell line, 
and NIH3T3, a fibroblast cell line, was compared. MH-S and NIH3T3 cells lines are 
both derived from laboratory mouse strains. The studies showed evidence of active 
MHV-68 replication in both cell types. MH-S cells were less permissive to infection, 
requiring a higher multiplicity of infection (MOI) and longer incubation times. Ml 
presence or absence did not lead to a significant difference in lytic replication in either 
MH-S or NIH3T3 cells over a 72 h time course. Ml expression in vMlrev infected MH- 
S cells was quantified and seen to increase over the first 24 h and decrease thereafter. In 
vMlrev infected cells, during the first 24 h there was an increase in the expression of 
gp!50 (a glycoprotein expressed during lytic replication) and an inversely proportional 
decrease in the expression of ORF73 (expressed during latency). This was observed 
together with a significant increase in viral titres. On the other hand in vMlstop infected 
cells, during the first 24 h, there was a decrease in the expression of gp!50 (a 
glycoprotein expressed during lytic replication) and an inversely proportional increase 
in ORF 73 expression. This was seen together with no significant change in viral titre. 
Studies in laboratory mouse strains showed Ml controls reactivation from latency in a 
T-cell dependent manner6'8. The finding that the rise in Ml expression accompanies the 
rise in gpl50 expression in this cell line, suggests Ml expression is driving MHV-68 
lytic replication in macrophages. This is further supported by the fact that latently 
infected macrophages were identified in the vMlstop infected wood mice and not in 
vMlrev infected wood mice. It is not fully understood why some cells enter latency 
rather than the lytic cycle, however it is suspected that latency is due to failure in the
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expression of IE genes, as happens in VZV166. This can be overcome when changes in 
the host cell occur (cell differentiation etc.), leading to lytic replication150. Both 
vMlstop and vMlrev infected MH-S cells showed an increase in RANTES expression 
within the first 24 hours, this was more pronounced in vMlstop infected cells. This 
increase was similar to the pattern of increase in expression of ORF73. RANTES 
(CCL5) is a potent chemeoattractant for T cells in particular for CD8+ cells338, 339. 
RANTES expression can be induced by TNF-a and IFN-y340. HSV infection of 
macrophage cell lines also leads to the increased expression in RANTES but this is 
driven by an immediate-early (IE) gene product, ICP10341. Contrary to this, the findings 
in this study suggest that during MHV-68 infection of the macrophages, increases in 
RANTES expression occur together with the expression of a latency associated 
transcript, ORF73.
In summary, evidence shows that in the wood mouse, macrophages are a site for 
MHV-68 lytic and latent viral replication, with the latter being enhanced in the absence 
of the Ml protein. The presence of Ml in the infection of wood mice leads to less 
intense macrophage infiltration likely related to Ml driven maintenance of macrophage 
alternative activation. Alternative activation, besides producing a lower pro- 
inflammatory response, also leads to decreased macrophage recognition of virally 
infected cells by reducing expression of MHC. Furthermore in laboratory mouse strain 
derived macrophages, the expression of Ml induces lytic replication but the absence of 
Ml induces latent replication. This latent replication is accompanied by an increase in 
RANTES expression.
4.4 Ml expression in the spleen
Ml expression was assessed by RNA-ISH in sections of the spleen from MHV-68 
infected BALB/c and wood mice. The aim of this study was to determine in which cells 
Ml expression occurs. Comparing the different mice showed where there are 
similarities in the Ml expression pattern between an artificial and natural host. In both 
species, Ml expression in the spleen increased gradually until day 14 p.i. and was 
maintained at approximately at the same level on day 28 p.i. The viral load was highest 
in the wood mouse spleen at day 14 p.i., following infection with either vMlstop or 
vMlrev virus. When comparing Ml expression between BALB/c and wood mice, 
significant differences were seen at day 3 p.i., when expression was most intense in the
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wood mouse. In both species Ml expression was seen in lymphocytes within follicles 
and subcapsularly. In the wood mouse. Ml expression was also seen in multinucleated 
cells in the red pulp. These multinucleated cells had morphologies consistent with 
megakaryocytes. This is the first time MHV-68 gene expression has been described in 
megakaryocytes. Megakaryocytes are precursors of platelets the main function of which 
is to seal areas of vascular damage. Interference with megakaryocytopoiesis can result 
in dysmegakaryocytopoiesis and thrombocytopaenia342'346 and ultimately bleeding 
disorders. In the current study there was no evidence of coagulopathies within the mice 
examined. In HIV infection, platelets and megakaryocytes have been described as 
harbouring unaltered viral particles within the cytoplasm. This evidence suggests HIV 
viral entry occurs in megakaryocytes by endocytosis rather than fusion since the 
internalized virions retained the envelope. Infected platelets expressed a macrophage 
receptor (CD62) on their cellular membrane. It was hypothesised that the aim of 
megakaryocyte infection by HIV was to perform a protective role towards the virus347.
4.5 Ml effect on the spleen of the wood mouse
The viral load in the spleen of wood mice infected with vMlstop and vMlrev 
virus was assessed by qPCR at day 3, 7, 14 and 28 p.i. It was highest at day 14 p.i 
coinciding with the time when splenomegaly was present and the time when secondary 
follicles were first observed. No statistically significant difference was seen between the 
vMlstop and vMlrev infection. Morphologically there were no extensive differences in 
the changes seen in the spleen following vMlrev and vMlstop infection. Unique to 
vMlstop infected wood mice megakaryocytes in the red pulp showed vacuolated 
cytoplasm. As mentioned previously megakaryocytes were shown to exhibit Ml 
expression. Furthermore latent replication was detected in megakaryocytes in both 
vMlstop and vMlrev infected wood mice. This indicates that the absence of Ml led to 
enhanced degeneration of megakaryocytes but did not impede latency establishment in 
these cells. vMlstop infected wood mice showed no signs of thrombocytopaenia, such 
as increased haemorrhages. This indicated that the degenerative changes in 
megakaryocytes were not sufficient to decrease the megakaryocyte population to a 
significant degree. Considering that there were no significant differences in the viral 
load observed with vMlstop or vMlrev infection, the protective role provided by 
megakaryocytes to HIV is unlikely present in this case. The changes in vMlstop
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infection and the expression of Ml in megakaryocytes indicate that Ml protects 
megakaryocytes from degenerative changes induced following viral entry and 
replication. Additionally, they suggest that Ml does not exert a major role in the virally 
induced changes to the spleen in the wood mouse. The spleen is the main site of 
MHV-68 latency establishment.
4.6 Conclusion
The expression of Ml in the BALB/c mouse is much reduced compared to the 
wood mouse. Furthermore Ml expression in laboratory mouse strain cell lines is also 
minimal. These observations indicate that the role of the Ml is more significant in the 
natural host. Differences between MHV-68 infection in both species include levels of 
IFN-y expression. In BALB/c mice IFN-y is increased following infection with MHV- 
68, however, in the current study neither vMlstop or vMlrev infection led to changes in 
the expression of IFN-y. The lack of IFN-y increase in the wood mouse infection 
possibly represents a viral mechanism to evade host recognition of viral antigens. In 
laboratory mouse strain studies the Ml protein has been indicated as a suppressor of 
reactivation following induction of IFN-y production by Vp4+CD8+ cells. Taking all of 
the above into consideration this IFN-y mediated role of Ml is unlikely to occur in 
wood mouse infection. However studies into the reactivation process would have to be 
performed in the wood mouse to confirm this.
Ml is not essential for latency establishment or lytic replication since latently and 
lytically infected cells were detected in infected wood mice infected with vMlstop. In 
fact, when Ml expression was inpaired, at day 7 p.i. more cell types were seen to be 
latently infected including macrophages and type II pnemnocytes. This was associated 
in the vMlstop infection with an increase in the frequency of iBALT, the main site of 
latent replication in the lung. At this time there was no significant difference in the viral 
load in the lung between the vMlstop and vMlrev infection. At a later timepoint, day 
28 p.i., the viral load in the vMlstop when compared to the vMlrev infection was 
significantly higher indicating that lytic replication is maintained for longer in the 
absence of Ml expression. In the spleen however there were no significant differences 
with respect to cell types showing viral latent or lytic replication or in the viral load. 
These findings indicate that instead of controlling lytic replication, in the wood mouse 
Ml controls latency establishment. However this effect is restricted to the lungs since
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the presence or absence of Ml does not affect significantly latency establishment in the 
spleen.
There was increased severity in pathological changes and increased macrophage 
infiltration following infection in the vMlstop infection at the early timepoints of 
infection, day 3 and 7 p.i. At day 7 p.i. this was seen together with a decrease in 
alternatively activated macrophages in the lung. Alternatively activated macrophages 
express arginase I which competes with iNOS for a common substrate, arginine. Thus 
the increased cytopathic effect could be related to an increase in NO production. The 
increased macrophage infiltration on the other hand is probably secondary to the 
increased cytopathic effect observed in vMlstop infection. This suggests that Ml 
abrogates cytopathic effects and/or the immune response ssociated with MHV-68 
infection. Since there were no significant differences in the lytic replication at day 7 p.i. 
between the vMlstop and vMlrev infection this abrogation is probably not related to 
the viral replication itself but rather results from host produced substances such as 
cytokines. Ml expression was seen together with a significant decrease in the mainly 
anti-inflammatory cytokine IL-10, the mainly pro-inflammatory cytokines TNF-a and 
MIPl-a, and the growth factor HGF. IL-10 secretion is probably a result of B cell 
proliferation in the iBALT. TNF-a, expression was seen to be down regulated mainly in 
airway epithelial cells, a site where Ml is extensively expressed. In the airways there 
was also an increase in CCSP expression, an anti-inflammatory cytokine from Clara 
cells. The airways are interspaced between the site of entry, the nose and the site of 
acute replication, the lung and thus are likely essential for viral entry. This cytokine 
expression profile favours an anti-inflammatory response and could explain the milder 
pathogenesis seen in the presence of Ml. These findings suggest that the main effect of 
Ml is the modulation of cytokine expression in order to elicit a less severe 
inflammatory response. This was not associated with a significant difference in viral 
replication at day 7 p.i., however, the extent of pathological changes could lead to 
changes in the behaviour of the host. Considering that this virus is transmitted via nasal 
route, viral spread will be enhanced if its host is not severely affected since it is less 
likely to have an effect in its natural behavior, including isolation from other animals.
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4.7 Future work
The determination of the relative expression of cytokines and enzymes performed 
in this study enabled us to ascertain how infection by the vMlstop and vMlrev altered 
the expression profile in comparison to mock infected wood mice. However this was 
only performed on day 7 p.i. In order to folly evaluate the Ml effect on the modulation 
of cytokine expression, the timecourse analysed should be extended to ealier and later 
timepoints. Furthermore, these relative expression values did not allow the 
determination of the baseline levels for the expression of the different 
cytokines/enzymes in the wood mouse. Since the virus induced pathogenesis in the 
wood mouse is different to that seen in laboratory strains of mice, it is possible that 
there are differences between the immune system of these species including factors 
controlling the secretion of cytokines. This could explain the different effects of MHV- 
68 infection. In order to ascertain this, absolute quantification of the expression would 
be of benefit and enable further interpretation of the results obtained. Furthermore, apart 
from CCSP and TNF-a, the in situ expression and the presence of the folly formed 
cytokines/enzymes was not determined. Consequently it would be of interest to analyse 
these by RNA-ISH and immunohistology respectively in order to better understand the 
cause-effect mechanisms. These studies could be combined with techniques such as in 
situ chemokine binding assays348.
The presence of NO should also be assessed in order to confirm or disprove the 
hypothesis that by maintaining the alternatively activated macrophages, Ml decreases 
the production of NO by iNOS and thus abrogates the virus induced pathogenesis.
Other studies to be considered would be the quantification of cell populations in 
the lung by fluorescence-activated cell sorting (FACS) coupled with histological 
examination. It is important to maintain the histological examination as the localization 
of the cell is fulcral to the understanding of the virally induced pathogenesis.
The main effects of Ml in the MHV-68 infection encoimtered during this study 
were seen in airway epithelial cells, macrophages, type I and type II pneumocytes in the 
lungs of infected wood mice. Considering that Ml was not seen highly expressed in the 
laboratory mice strain derived cell cultures, it would be of value to perform in vitro 
work on primary cell cultures obtained from non infected and infected wood mice. The 
benefit of using primary cell cultures would be to establish the direct cause-effect 
relationships since the environment is controlled. The establishment of these types of
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cultures for primary airway epithelial cell cultures349'351, macrophages352 and 
pneumocytes353 has been successful.
Also further studies investigating the potential neurotropism of MHV-68 possibly 
associated to the targeting of satellite cells of parabronchial ganglia, as seen in this 
study, should be investigated. The finding of Ml expression in satellite cells of 
parabronchial ganglia was an unexpected and suprising finding in this study and so the 
presence of these ganglia was not targetted during sampling and was not seen in all lung 
sections examined. Future work should include sampling aiming at including 
parabronchial ganglia in the lung sections examined and in all timepoints.
Another unexpected finding was the presence of Ml expression in 
megakaryocytes together with vacillation of megakaryocytes early in infection. 
However this was not accompanied by clear evidence of thrombocytopaenia or evidence 
of haemorrhagic disorders. A simple study that would allow to assess if Ml expression 
in megakaryocytes, the precursor of platelets, has an effect on their function, would be 
to carry out coagulation time studies.
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Harlan Health Monitoring Report
Test Date | Species |______ Submitter______ I________ Area________ | Profile
02 December 10 Mouse University of Liverpool 8735 51M(S)
Viruses
Minute virus of mice 
Mouse hepatitis virus 
Mouse parvovirus 
Mouse rotavirus (EDIM)
Pneumonia virus of mice 
Sendai virus
Theiler’s murine encephalomyelitis virus
Bacteria. Mycoplasma and Fungi
Clostridium pilifonne 
Mycoplasma spp
Positive/T ested Test Method
0/1 Bead
0/1 Bead
0/1 Bead
0/1 Bead
0/1 Bead
0/1 Bead
0/1 Bead
Positive/Tested Test Method
0/1 Bead
0/1 Bead
Figure 5.1 Example of health monitoring report provided by Harlan.
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